A bound volume submitted for the degree of Masters of Applied Epidemiology by Roberts, Leslee Anne
Leslee Anne Roberts 
A Bound Volume Submitted for the degree of Masters of Applied 
Epidemiology 
National Centre for Epidemiology and Population Health 
of the 
Australian National University 
February 1994 
Acknowledgments 
I thank the following people for their support and advice throughout my placement as 
a Master of Applied Epidemiology (MAE) Student; 
Professor Mike Lane, 
Dr Robert Hall, 
Dr Cathy Mead, 
Dr Aileen Plant, 
Professor Bob Douglas, 
Professor Norman Noah, 
Mr Virgil Peavy, 
Dr Matt Gaughwin, 
and my colleagues in the MAE program from 1991 to 1993. 
In the development of the LabDOSS system, processing of results in my absence, 
support and encouragement I thank; 
Mr David Evans, 
Ms Sheila Beaton, 
Dr Anura Ponutharai, 
Dr Lance Sanders, 
Ms Toni Hogan, 
all CDI contributing laboratory staff , 
and all members of the CDI production team. 
The work contained in this volume is my own, where appropriate I have 
acknowledged my co-workers . 
.......................................................................... 
Leslee Anne Roberts 
Table of Contents 
Section 1 A New Surveillance Scheme 
Laboratory Database of Organisms from Sterile Sites LabDOSS 
1.1 Development of LabDOSS 
1.1.1 Objectives 
1.1.2 History of Development 
1.1.3 Feedback; Communicable Diseases Intelligence(CDI) Fortnightly Reports, 
Review of Meningitis Reports 1992 
1.2 Analysis of Data January 1992 to September 1993 
1.2.1 Introduction 
1.2.2 Methods 
1.2.3 Results 
1.2.4 Discussion 
1.3 Haemophilus influenzae, LabDOSS January1992 to December 1993 and 
National Notifiable Diseases Surveillance System 1991 to 1993 , 
Communicable Diseases Network Australia 
1.3 .1 Introduction 
1.3 .2 Methods 
1.3 .3 Results 
1.3.4 Discussion 
1.4 Evaluation of LabDOSS 
Appendix A LabDOSS Manual 
Appendix B CD I Reporting forms. 
Appendix C LabDOSS Analysis Programs 
Section 2 Outbreak Investigation 
2.1 Introduction 
2.2 Winter Rubella Outbreak in the ACT: Investigation of One Primary School , 
Published in CDI, 
2.3 Winter Rubella Outbreak in the ACT, Reproduced in Weekly Epidemiological 
Record (WER). 
Section 3 Infectious Diseases In Child Care Settings 
3.1 Introduction: Staying Healthy in Child Care , NHMRC endorsed November 1993 
3.2 The Sick Care Program 
Appended Bound Volume "Staying Healthy in Child Care" 
Appendix A "Draft Chapter 11 Sick care Programs" 
Section 4 General Public Health Experience 
4.1 Child Care Centre Investigations and Advice 
11
1 4.1.1 A case of Pertussis in an ACT Child Care Centre 
4.2 Australian Government Involvement in E coli 0157:H7 outbreak: in USA, January 
1993 
4.3 Blue Green Algae 
4.4 Laboratory reports of Toxoplasmosis, CDI Laboratory "Pathogen Surveillance 
Scheme" 1986 to 1991 
4.4.1 Results 
4.4.2 Discussion 
Section 5 Summary of Practical Epidemiological Experience 
1.1 Development of LabDOSS 
Surveillance may be defined as the timely, ongoing collection, analysis and 
dissemination of information to those who need to know. The World Health 
Organisation defines surveillance as the continuing scrutiny of all aspects of the 
occurrence and spread of disease that are pertinent to control; it is characterised by 
methods distinguished by their practicability , uniformity , and frequently by their 
rapidity, rather than complete accuracy 1 • 
Important features in any surveillance scheme are: 
• useful data, 
• accessible data, 
• simple reporting process and 
• timely feedback. 
A surveillance scheme entitled the "pathogen scheme" had been in operation by CDI 
for 4 years. The aim of this scheme was to extend the successfully established virus 
reporting scheme to other pathogenic organisms. However, the "pathogen scheme" 
had struggled to gain acceptance because reports encompassed all "pathogens" from 
reports of Candida species in vaginal isolates to Giardia in stool and meningococcus 
in cerebrospinal fluid. This meant that only small laboratories contributed to the 
scheme as directors of larger laboratories found the exhaustive, encyclopaedic 
number of pathogens to report was prohibitive. Therefore, the data in this scheme 
was not representative as only small country laboratories contributed. 
My approach to the "pathogen scheme" was to establish objectives for the scheme and 
limit isolates reported to those obtained from normally sterile sites. This allowed for 
organisms causing invasive disease to be reported, eg organisms from cerebrospinal 
fluid, blood cultures, peritoneal dialysate, joint fluid aspirates. 
1.1 Development of LabDOSS 
This approach had an added advantage in that collection of surveillance information 
by site of sepsis , rather than specific organism coincides with the processing function 
of the laboratory. For example blood cultures are all processed in the same section 
of the laboratory. Site based surveillance means that surveillance of common invasive 
pathogens as well as rare and new pathogens can occur. More information may be 
obtained than is currently provided though the notifiable diseases system. For example 
in cases of meningitis , N eisseria m ening itidis and Haem ophilus influenz ae are 
notified to each State Health department which is appropriate as both these diseases 
may require immediate public health intervention. However, other causes of 
meningitis are not notified, for example Streptococcus pneumoniae which may be 
prevented by immunisation is not under surveillance. 
Reference 1 Last JM. A Dictionary of Epidemiology. New York: Oxford University 
Press, 1988 
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1.1.1 Development of LabDOSS, Objectives of the Scheme 
The goal of any surveillance system is to prevent or control disease. Within this major 
goal the LabDOSS scheme has a number of objectives; 
• To improve understanding of the epidemiology of disease caused by invasive 
organisms in Australia; 
Unlike the United Kingdom , Australia has no central agency that collates and repons 
on invasive organisms. Victoria is the only state with and organised system for sterile 
site reports and this is through the Victorian Hospitals Pathogen Surveillance Scheme 
(VHPSS). Studies of reports of bacteraemia and meningitis are occasionally reported 
in the literature. Similarly, epidemiology of disease caused by invasive organisms are 
presented at professional meetings of the Australian Society for Microbiology and the 
Australian Society of Infectious Diseases. 
• To monitor trends of disease caused by invasive organisms over time; 
Recognition of trends in disease may lead to modification or evaluation of public 
health interventions. Seasonal patterns may be identified ; it could mean timely 
identification of emerging trends and changes in pattern of disease due to other 
environmental factors could become more obvious. 
• To identify emerging pathogens causing invasive disease; 
With the increased use of antibiotics, emerging pathogens in the United States and 
United Kingdom include enterococcus species, and fungi. 
• To identify outbreaks; 
Epidemics of disease such as pneumococcal septicaemia may occur in Australia and 
remain unidentified. Outbreaks of septicaemia from contaminated infusate have been 
widely reported in the US and UK but currently not likely to be identified in 
Australia. 
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1.1.1 Development of LabDOSS, Objectives of the Scheme 
• To use the knowledge gained from surveillance to develop public health policy. 
For example, improved vaccines for pneumococcal and meningococcal disease are 
being developed. Incorporation of these vaccines in Australia, appropriate risk groups 
and expected outcomes may be suggested and evaluated by the Lab DOSS scheme. 
1.1.2 History of Development of LabDOSS 
In the six months prior to my placement Dr Robert Hall had written to laboratories 
around Australia raising the issue of expansion of CDI surveillance. There was 
negative feedback from the laboratories because of the prohibitive numbers of 
pathogens requested to be reported. I proposed a scheme more focused on invasive 
disease. The response from medical microbiologists was supportive and suggested a 
sterile site surveillance scheme was attainable. 
I was kindly invited by Dr Joe Forsyth director of the VHPSS to observe the 
VHPSS functioning, and discuss the role of a CD/ surveillance scheme. I discussed 
the possible virtues of a national scheme and the practicalities of development . 
Doctors Forsyth and Hogg considered that collection of such data would be best 
managed at a local or state level. If all states were collecting such information then 
the data could be collated nationally. 
I reviewed the method by which the VHPSS obtain , collate and report data. Data are 
entered on a VHPSS card by laboratory staff and then mailed to VHPSS located at 
the Microbiological Diagnostic Unit, University of Melbourne. There is a delay in the 
receipt of cards which may be received weeks to months after the onset of the sepsis. 
Reporting from some hospitals was intermittent. When received, the cards are viewed 
by a scientist and computer operator, the organisms are coded and the data are then 
entered into a database. Feedback of data is through VICBUG, published every three 
months. 
1.1.2 History of Development of LabDOSS 
The experience of a observing the operation of a sterile site surveillance system was 
invaluable and I identified the following issues. 
• What was the viability of national scheme ? 
The continuation of the virus surveillance scheme for over 10 years suggested 
surveillance of sentinel laboratories could be co-ordinated from one centre. 
• Would data be reliably sent to Canberra , a location far from the laboratory ? 
This occurs in the CDI virus scheme. 
• Should efforts be directed to establishing state based surveillance schemes that 
could be subsequently be collated nationally? 
This would probably be the ideal arrangement. However, establishing surveillance in 
this manner would be beyond existing resources. 
• What data are reasonable to collect e.g. date of admission, clinical information, 
hospital acquired, significant organism ? 
The date of admission of the patient provides a useful reference for determining 
onset of hospital acquired infections. However, the date of admission may not be 
readily available to laboratory scientists. 
Clinical information is useful for analysis and interpretation. However, this must be 
viewed with awareness that the clinical information is provided by laboratory staff 
who do not have direct contact with the patient. 
It is important to assess the clinical significance of organisms identified by culture as 
contaminating organisms are frequent and may not be a cause of sepsis. In the 
VHPSS scheme some laboratories refuse to comment on whether an organism was 
significant as this was considered a clinical decision. Laboratory staff gain 
information from the requesting physician , nursing staff or microbiology registrars. 
For this reason organisms in LabDOSS may be coded by the laboratory staff as 
"probable contaminants". These data are analysed separately. This obviates the need 
for laboratory staff to make a definite decision on significance, yet allows CDI to 
consider the significance doubtful. 
1.1.2 History of Development of LabDOSS 
• How would the data be collected ? 
The CD/ , at this stage, only received hand completed forms Similar reporting forms 
could be collected for sterile sites. 
• Where would the data be coded for computer entry? 
The options were in the peripheral laboratory or CD/ central office. CDI Virus 
reports are mostly coded in the periphery with additional codes added if data are 
incomplete. VHPSS reports are all coded centrally. It was suggested that coding 
needs to be performed centrally to avoid inappropriate coding and extra work by the 
laboratories. Central coding required greater resources than the CD/ section was able 
to commit. 
1.1.2 History of Development of LabDOSS 
A Pilot Scheme, LabDOSS Version 1 
As a surveillance scheme was functioning well in Victoria I elected to trial a sterile 
sites surveillance pilot program in NSW. Three laboratories were involved in the 
pilot project from June to December 1991. One laboratory stated they would prefer 
to enter data directly into a CD/ computer program rather than complete paper 
forms. I designed LabDOSS version 1 , in Epilnfo. The data collected included 
demographic , clinical ( patient diagnosis and risk factor for sepsis) and 
microbiological information. The pilot showed the laboratory staff were able to enter 
information easily and quickly. Data were provided by mailing floppy discs to CDI 
on a monthly basis. 
Although data were entered easily into LabDOSS version 1 , there was difficulty in 
extracting recent data to send to CDI. Selecting data by dates proved to be a 
confusing and time consuming process. I established a two tier system of LabDOSS 
data files (Figure 1 and Appendix A LabDOSS Manual) . Data could then be 
entered into an interim file . When the staff were ready to send data to CDI, a 
program placed interim data on floppy disc. At the same time this program merged 
the interim file data into the main file stored on the laboratory computer. This two 
tier approach has been very successful and readily allows the system to be tailored 
for individual laboratory use . Only core CDI data, are copied onto floppy disc. 
More detailed data for example the whole patient name are kept in the main 
LabDOSS file. 
Patient confidentiality is ensured in the LabDOSS scheme, names are not forwarded 
to the CD I. Two initials of the surname, two initials of the first name , the date of 
birth of the patient and a laboratory specimen code are used to remove duplicate 
records and follow up incomplete data. 
I , 
1.1.2 History of Development of LabDOSS 
Figure 1 . Two Tier Approach of Data Entry and Extraction , CDI , LabDOSS 
The LabDOSS system is two tiered, as follows:-
i) An interim file (LDCDI.REC) is created for entry of data and for reporting via a file 
(LD###.REC) on diskette to the Communicable Diseases Intelligence bulletin 
(CDn. (The### refers to the laboratory number.) 
ii) A main file (LABooss2.REC) is created for your own laboratory, in which you may 
do your own analysis, by incorporating the interim file into it. 
Data Entry 
Interim File 
LDCDI.REC 
Main File 
LABDOSS2.REC 
Note: WCDI JIBC is ~ for entering all records. 
LABDOSS2.REC is the main file that is used to analyse data. 
LD###.REC is copied to diskette for CDI. 
Reporting File 
LD117.REC 
1.1.2 History of Development of LabDOSS 
Development of a generic CDI fonn for paper reports 
Until 1992 all data provided to the CDI were on paper forms. Two forms of 
different structure were used; a virus reporting form and pathogen reporting form. It 
would have been inappropriate and confusing to create a third reporting form for the 
next CDI scheme. The obvious , but not necessarily simple solution was to 
consolidate the existing forms into one. This was a difficult process. Introduction of 
the generic CDI form took place in July 1993. ( Appendix B ) 
LabDOSS versions 2 and 3 
The pilot program provided testing of the LabDOSS system in Epilnfo. David Evans 
and I developed LabDOSS version 2. A further refinement, LabDOSS version 3, 
was developed in 1993. Full operation of the Lab DOSS scheme began in 1992. A 
LabDOSS manual was distributed with each installation disc, along with Epilnfo 
installation discs and manual. 
Laboratories were recruited to the scheme by three processes: 
• Individual teaching hospital laboratories in Sydney and Brisbane were asked if 
they would like to participate. Those with established computer systems expressed a 
wish to down load data. This has been successful for one laboratory and has been 
shown to be a time consuming process in establishment. 
• Description of the LabDOSS scheme and aims were published in the CDI and 
laboratories were invited to join the scheme. 
• Presentations were made at the Australian Society for Microbiology Annual 
Scientific Meetings 1991, 1992 and 1993. 
There has been an overwhelming response and more laboratories have expressed 
interest in joining the scheme than can currently be accommodated To date, all 
laboratories provide data from the Lab DOSS - Epilnf o system. One of the greatest 
assets of the scheme is its ability to be tailored for each laboratory's use. This is also 
the most time consuming process of the scheme as recruitment of each laboratory 
requires alteration of the system and follow up. 
1.1.2 History of Development of LabDOSS 
LabViSe 
Success in the implementation of the LabDOSS scheme in Epilnfo stimulated the 
creation of an Epilnfo system for the virus reporting scheme. Lab.Vise, Laboratory 
Virology and Serology system, is a copy of the LabDOSS system; identical in 
structure to LabDOSS with altered look up tables for viruses and clinical history 
codes.I assisted with the development of Lab ViSe. 
Reporting Process 
LabDOSS Data are provided formightly to the CDI on floppy disc. The closing date 
for receipt of files is two days before CDI is forwarded for printing, four days prior 
to mailing to recipients. After processing the discs all files are deleted and discs are 
returned to the laboratory. One laboratory sends data via telephone line. I check data 
fortnightly to exclude duplicate records, to ensure results are correctly coded and 
the organisms are fully identified. 
A two step analysis program has been developed in a process of continual 
evolution. ( Appendix C LabDOSS analysis programs) Data are decoded, grouped 
into age groups and organism type for preparation of the fortnightly report. Some 
laboratories elect to report all organisms, including those classed as probable 
contaminants. Contaminant organisms are not included in the CDI report, however 
the contaminant list is searched for unusual organisms or an unusually large number 
of common organisms. 
1.1.3 Development of LabDOSS, Feedback 
Feedback for the CDI surveillance scheme is through printing in the CDI and 
presentations at scientific meetings. In 1992 the surveillance data were collected , 
analysed and printed in CDI each month. Fortnightly collection and feedback began 
in 1993. Reports printed in CDI for LabDOSS surveillance data in 1992 and 1993 
are presented; 
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LAB DOSS (Laboratory Database 
of Organisms from Sterile Sites) 
l..abOOSS is a new CDI laboratory reporting 
scheme which has been set up to monitor 
significant isolates from sterile sites. A pilot 
for the scheme has been opera ting in several 
Sydney laboratories for the last six months, 
and it is hoped that eventually it will be 
expanded throughout Australia. 
Regular reports of the Scheme will be pub-
lished in the Communicable Diseases 
Surveillance section of CDI, starting with this 
issue. 
Aims of the CDJLabDOSS Scheme 
l..abora tory reports collected in the scheme 
will supplement the National Notifiable Dis-
eases reports and the limited number of 
reports of significant isolates collected in the 
'Pathogens Reporting Scheme'. (It is planned 
that LabOOSS will eventually take over the 
collection of sterile site data from the 'Patho-
gens Reporting Scheme,' and that the 
'Viruses Reporting Scheme' will incorporate 
the serological reports from the pathogens 
scheme to become a more general virus and 
serology reporting scheme.) 
The scheme will collect information which is 
not normally collected or compiled for cases 
reported in the National Notifiable Diseases 
Reports. For Haemophilus infiuenz.ae for ex-
ample, it will collect type information, and 
the clinical characteristics (meningitis, bac-
teraemia, cellulitis) of each infection. This 
type of information is currently unavailable 
Australia-wide, and will prove invaluable in 
any future assessment of the impact of 
Haemophilus infiuenz.ae type b vaccination of 
children. 
Reports of organisms which cause diseases 
which are not notifiable will also be col-
lected, enabling the surveillance of 
meningitis and other invasive disease 
caused by organisms such as Streptococcus 
pneu.moniae, Cryptococcus neoformans and 
Group B Streptococcus. When the Scheme is 
fully operational, epidemiological patterns 
of these organisms will be able to be charac-
terised for the first time onan Australia-wide 
basis. 
l..abOOSS sterile sites surveillance also has 
the potential to enable recognition of out-
breaks of unusual organisms causing 
bacteraemia or other invasive disease. For 
example, the recent cases of non-toxigenic 
Corynebacterium diphtheriae endocarditis 
(CDI 15:277) were brought to the attention of 
CDI through this scheme. 
Table 2. Lab DOSS reports of blood isolates for January 19921 
Organism Number of Clinical Risk Factors 
Isolates Information 
GRAM POSITIVE BACTER1A 
Diabetes 2, IV central line 2, Trauma 1, 
Preterm neonate 1, IV peripheral line 
2, Malignancy 1, Neutropaenia 1, 
Other vascular prosthesis 1, Urinary 
S tar}i v/oa:xx:us au reus 14 Gastrointestinal 1 tract surgery 1 
Malignancy 4, Preterm neonate 1, IV 
St arJi t/loa:xx:us epidermi dis 12 LRT11 central line 3, Neurological su~ery 1 
St arJ, tjtocoa::u.s coa g-u I ase negative 7 LRTI 3, Osteomyletitis 1 Other immunocomprosmised 1 
St repl oa:xx:us pn eu m on i ae 2 LRTI 1 Neutropaenia 1 
Streuloaxr:us mi1leri 4 Neutropaenia 1 
Endocarditis (native 
S treutoroccus "bovis 1 valve) 1 Abdominal su~ery 1 
St reploa:xx:us viridans 1 IV central line 1 
Streutocoa::u.s alpha-haemolytic 1 
S treploax:cus s p. 1 Other Immunocompromised 1 
Endocarditis (prosthetic Other vascular prosthesis 1, Preterm 
Entercx:occus faeazlis 1 valve) 1 neonate 3 
Bacillus sp. 1 Postnatal 1 
Corynebacterium JK 1 Neutropaenia 1 
Corynebacterium sp 1 
Volume 16, Number 4 
The system will also provide research oppor-
tunities through the provision of data, 
published in CDI and otherwise supplied. 
LabOOSS is thus similar to the Bacteraemia 
and Meningitis Surveillance scheme of the 
Victorian Hospital Pathogens Surveillance 
Scheme of the Standing Cammi ttee on Infec-
tion Control of the Health Department of 
Victoria. This scheme publishes reports of 
Victorian blood and CSF isolates in its regu-
lar report VICBUG. 
Data Collected in the CDI LabDOSS 
Scheme 
Reports in the LabOOSS scheme are of sig-
nificant isolates cultured from normally 
sterile sites. One report is made for each 
episode of infection and comprises three 
types of data: 
1. Clerical data: laboratory patient identifica-
tion, the first two letters of the patient's 
first two names (to allow for checking for 
duplicates), date of specimen collection, 
sex, date of birth or age, and patient loca-
tion information (postcode); 
2. Clinical data: for example endocarditis, 
meningitis or cellulitis, risk factors such 
as recent surgery or an immunocom-
Table 2. Lab DOSS reports of blood isolates for January 19921, continued 
Organism · Number of 
Isolates 
GRAM NEGATIVE BACTERIA 
Escherichia coli 22 
Klebsiella oxvtoca 1 
Klebsiella pneumoniae 4 
Prcieus mirabilis 2 
Prcieus vulsraris 1 
Gitrobader sp. 2 
Entercbader cloacae 2 
Entercbader sp. 5 
Mor~anella morcnznii 1 
Serratia liquefaciens 1 
Pseudomonas aeru~nosa 4 
Pseudomonas fluorescens 1 
Xanthcmonas maltophilia 2 
Pseudomonas sp. 1 
Salmonella ti/Phi 1 
Aeromonas httdrophila 1 
Haemophilus influenz.ae (not typable) 2 
Haemophilus influenz.ae type b 2 
Neisseria menin~tidis group B 1 
Neisseria sicai /subflava 1 
Acinetcbader SP 1 
Flaoobaderium s p 1 
Cardicbaderium hominis 1 
ANAEROBF.5 
Baderoides frflJ?llis 1 
Pe,:iostre,:ioax;cus sp. 1 
Oootridium perfrin~ens 1 
FUNGI .. 
Candida albicans 1 
Torulovsis trldn-ata 1 
Total 119 
1. LRTI - Lower respiratory tract infection/ pneumonia 
UTI - Urinary tract infection 
Clinical Information Risk Factors 
LRTllGastrointestinal 3, UTI 
6, Diabetes 1, IV central line 
1, Malignancy 2, Transplant 
1, HIV infection 1 
Gastrointestinal 1 
UT11 Traumal 
LRTI 1 
Urinary tract surgery 1 
Malignancy 1 
Transplant 1 
IV central line 1, Preterm 
Endocarditis (prosthetic neonate 1, Other 
valve) 1 immunocompromised 1 
Gastrointestinal 1 Abdominal surgery 1 
Malignancy 
UTI (catheter, Neutropaenia, Abdominal 
instrumentation) 1 surgery 1 
Neutropaenia 1 
Gastrointestinal 1 IV central line 1 
Neutropaenia 1 
Preterm neonate 1 
LRTI 2 
Sk.in/cellulitis / wound 1 Diabetes 1 
Thyroglossal cyst 1 
Preterm neonate 1 
Gastrointestinal 1 Other vascular prosthesis 1 
Endocarditis (native value) 1 
Gastrointestinal 1 Malignancy 1 
Transplant 1 
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Table 3. Lab DOSS CSF isolates and meningitis reports for January 1992 
Number of Age 
Organism Isolates (years) 
Cryptoccccus neo{ormans 1 
Stap/ntlocoa:us epidermidis 1 
Klebsiella oxtlfoca 1 
Acinetobader calcoaceticus 1 
promised state, and whether or not the 
patient died as a result of the infection; 
3. Microbiological data: source specimen, 
method of diagnosis (isolation, antigen 
detection, antibody detection) and an 
identification of the organism which is as 
full as the laboratory has determined. 
LabOOSS reports can be provided to CDI on 
paper forms, or data can be entered into a 
computer using the LabOOSS program and 
then sent on floppy disk. 
The LabOOSS program has been written in 
Epilnfo, a program which was developed at 
the Centers for Disease Control in Atlanta, 
USA. It combines word processing, data base 
management, statistical analysis and graph-
ics into a package which can be used by those 
with minimal experience with computers. 
The Epilnfo software, LabOOSS programs, 
Epilnfo manual and LabOOSS manual are all 
provided free of charge to laboratories that 
may wish to contribute to the LabOOSS 
scheme. (An IBM compatible personal com-
puter is required.) 
An important feature of the system is that the 
LabOOSS programs can be tailored to the 
individual needs of the laboratory whilst re-
taining the ability to generate reports for 
CDI. Laboratories can record data other than 
those required for CDI reports, for example, 
full names and addresses of patients, refer-
31 
25 
25 
34 
Source Specimen ·. Risk Factors 
Blood HIV infection 
CSF Neurological surgery 
CSF Neurological surgery 
CSF Neurological surgery 
ring practitioners, and details of 'contami-
nants'. They can then use the programs to 
store and analyse both the data that are sent 
to CDI and their supplementary data. 
Enquiries from laboratories wishing to join 
the LabOOSS Scheme, or general enquiries 
on the system are welcome. The contact per-
son is Dr Leslee Roberts, phone (06) 289 7217. 
Tabulated LabOOSS data will be published 
regularly in CDI as will assessments and re-
views of the data. Data for January 1992from 
the pilot scheme is presented in this edition 
of CDI in three groups; bacteraemia reports 
(Table 2), meningitis and CSF reports (Table 
3) and other sterile site isolate reports (Table 
4). 
Contribution laboratories for Janaury were 
the Institute of Clinical Pathology and Medi-
cal Research, Sydney ( 47 reports), the 
South-west Area Pathology Service, Liver-
pool (26 reports), and the Royal Prince 
Alfred Hospital, Camperdown (54 reports). 
Table 4. LabDOSS reports from other 
sterile sites for January 1992 
Site Org:anism 
Peritoneal dialysate Pseudomonas aeroginosa 
Staphylococcus epidermidis 
Candida trovicalis 
Peritoneal fluid Stap/ntlococcus aureus 
1 
1 
1 
1 
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Lab DOSS (Laboratorx Database of 
Organisms from Stenle Sites) 
The data are from the three Sydney laborato-
ries in the pilot scheme. Since so many types 
of organisms are reported each month, the 
tables of blood isolates and CSF /Meningitis 
reports will include only organisms which 
have been reported 5 or more times from 
now on. Other isolates will be briefly men-
tioned in text. 
The format of the blood isolates table has 
been changed by grouping the risk factors 
and clinical information categories. The de-
tails of these data, and other data such as age, 
sex and postcode, will be presented peri-
odically, and is available to those who are 
interested. 
The response to the invitation for laborato-
ries to join LabOOSS has been very positive; 
12 laboratories in 3 capital cities have indi-
cated their interest in joining the scheme. 
Further information on the scheme was in-
cluded in CDI 16:80-81, and enquiries are 
welcome on (06) 289 7217. 
Interesting isolates reported for February 
were a Gemella haemolysans isolated from 
blood samples of a patient with a central IV 
line, a Corynebacterium aquaticum from the 
blood of an immunocompromised patient, a 
Staphylococcus epidermidis from the CSF of 
a 17 year old neurological surgery patient, a 
Yersinia enterocolitica from blood of a preg-
nant woman and Salmonella typhi from 
blood of two patients who had travelled 
overseas (India and the Philippines). 
Other reports not included in the Table were 
3 Streptococcus pneumoniae, 1 Streptococcus 
Group A, 2 Streptococcus Group B, 1 Strepto-
coccus Group G, 1 Streptococcus sanguis, 1 
Streptococcus milleri, 1 Streptococcus mitis, 2 
Enterococcus faecalis, 1 Enterococcus sp, 1 Co-
rynebacterium JK, 1 Bacillus cereus, 1 
Morganella morganii, 1 Citrobacter freundii, 1 
Enterooacter cloacae, 4 Enterooacter sp, 1 Serra-
tia sp, 1 Pseudomonas cepacia, 2 Pseudomonas 
sp, 2Xanthomonas maltophila, 2Aeromonas hy-
drophilia, 1 Neisseria meningitidis group C, 1 
Acetinooacter sp, 1 Acetinooacter calcoaceticus, 
2 Bacteroides fragili s, 1 Propionibacterium 
avidium, 1 Candida albicans, 1 Mycobacterium 
sp, 1 Klebsiella sp (from CSF of a 22 year old), 
and 1 Staphylococcus aureus and 1 Staphylococ-
cus epidermidis from peritoneal dialysates . 
Table 8. l.abOOSS reports of blood isolates for February 19921 
,/t=i>?t=t:Y?Jfilld~l@MAJ)t:}/1/l -l\HtJJ\ctMMfr'IAM~lffak/Jt:tI 
Staphylococcus aureu.s2 22 2 :1 Staphylccocx:ys epidermis 24 1 
Staphylococcus - coagulase neg 7 2 
Esrichia cdi 21 :1 Kld:Jsiella spp3 8 
4 
41 I 21 
I 11 21 
1 
2 
I I 2 
3 
1 
4 I 2 
1 
Pseudcmonas aeru,zinosa I 7 I 1 I 4 I 1 I I I I I I I I I 1 
l. Only organisms with 5 or more isolations are included in this Table. 
2. Includes 3 MRSA (Methicillin-Resistant S. aureus). 
3. Includes 2 K. pneumoniae and 1 K. oxytoca. 
1 I 1 
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Sterile Sites Surveillance 
There has been continued support of and 
interest in LabOOSS (Laboratory Database of 
Organisms from Sterile Sites), and the sys-
tem has now been sent out to 16 laboratories. 
Data for March have been provided by five 
laboratories, with the welcome additions of 
the Central Queensland Pathology Labora-
tory and the Central Coast Area Health 
Service (NSW). 
A total of 180 reports were received for 
March (Westrnead 48, Liverpool 28, Royal 
Prince Alfred 83, Central Queensland Pa-
thology 4 and Central Coast Area Health 
Service 17). 
Organisms reported 5 or more times from 
blood are detailed in Table 2. Other interest-
ing blood isolates reported include Vibrio 
cholerae in a male (unknown age) with a 
history of watery diarrhoea and travel to 
Tonga 5 weeks previously. There were two 
reports of Haemophilus influenzae: type Bin 
a 2 year old male with epiglottitis, and no 
type provided for a 30 year old female. 
Other blood isolates not included in the Ta-
ble were: 
Gram positive: 4 Streptococcus pneumoniae, 1 
Streptococcus Group A, 2 Streptococcus Group 
B, 1 Streptococcus Group G, 1 Streptococcus 
sanguis, 3 Streptococcus viridans group, 3 
Streptococcus 'rnilleri', 1 Streptococcus constel-
latus, 1 Streptococcus mitis, 1 Streptococcus sp, 
1 Lactococcus cremoris, 1 Gemella sp, 1 Bacillus 
sp. 
Gram negative: 2 Proteus mirabilis, 1 Citrchac-
ter diversus, 2 Citrchacter freundi, 3 
Xanthomonas maltophila, 3 Salmonella spp, 1 
Eikenella corrodens. 
Anaerobes: 3 Bacteroides fragilis, 1 Bacteroides 
uniformis, 1 Peptostreptococcus sp, 2 Clostrid-
ium perfringens. 
Fungi: 2 Candida parapsilosis, 1 Candida 
guillermondii, 3 Candida albicans, 1 Candida sp, 
1 T orulopsis s p. 
Mycobacteria: 1 atypical and 1 not identi-
fied. 
Table 2. Sterile sites surveillance reports of blood isolates for March 19921 
Clinical information Risk Factors 
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Stavht/lococcus aureus 192 1 2 1 2 4 5 1 
Stavhulococcus evidermidis 22 1 1 1 5 7 1 
Stavht/lococcus coagulase negative 10 1 2 2 
Enterococcus species i3 1 1 3 2 
Eschericia cdi 25 1 15 3 8 1 2 
Klebsiella species 54 1 1 2 
Enterobader species 115 1 5 1 1 4 2 
Pseudcnwnas aeruKinosa 8 2 1 1 2 
1. Only organisms with 5 or more isolations are included in this table 
2. Includes 1 MRSA 
3. E. faecdis (6) E. faecium (1) 
4. K pneumoniae (4), Klebsiella sp (1) 
5. E. dazcae (7) E. aerogenes (2) Enterobacter sp (2) 
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CSF Isolates and Meningitis Reports 
Listeria monocytogenes in a 49 year old male. 
Neisseria meningitidis group Cina 32 year old 
male. 
Klebsiella sp in a 16 year old male. 
Staphylococcus epidermidis in males aged 64 
years, 31 years, 56 years and 23 years, and 
females aged 45 years and 28 years. Five of 
these were associated with neurological sur-
gery. 
Acinetobacter calcooceticus in a 2 week old 
male with a IV central line. 
Pseudomonas aeruginosa in a 77 year old male. 
Isolates from sites other than blood or CSF 
Peritoneal dialysate: 2 Staphylococcus epider-
midis, 1 Streptococcus viridans, 1 Klebsiella 
oxytoca.. 
Joint fluid: 1 Staphylococcus aureus, 1 Staphy-
lococcus epidermidis, 1 Streptococcus group G. 
Other: Escherichia coli (prosthetic joint tis-
sue) and Streptococcus group A 
(retro-peritoneal abscess). 
COMMUNICABLE DISEASES INTELLIGENCE 
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Sterile Sites Surveillance 
The LabOOSS (Laboratory Database of Or-
ganisms from Sterile Sites) system has now 
been sent out to 24 laboratories. Data for 
April have been provided by six labora to-
ri es, of which repatriation General Hospital, 
Concord, Royal North Shore Hospital and 
Toowoomba General Hospital are new addi-
tions to the Scheme. 
A total of 183 reports were received for April 
(Royal Prince Alfred 53, Liverpool 27, Con-
cord 43, Royal North Shore 49, Central 
Queensland Pathology Laboratory 3 and 
Toowoomba 8). 
Organisms reported 5 or more times from 
blood are detailed in Table 2. Other blood 
isolates reported include 2 Haemophilus infiu-
enz.ae type B. One was from 4 year old female 
with pneumonia and the other was from a 6 
month old female with forearm osteomyeli-
tis. 
Other blood isolates not included in Table 2 
were: 
Gram positive: 3 Staphylococcus coagulase 
negative, 4 Streptococcus pneumoniae, 2 Strep-
tococcus Group B, 1 Streptococcus sanguis, 1 
Streptococcus 'rnilleri', 3 Streptococcus species, 
l Enterococcus species, 1 C01-ynebacterium JK, 
l Corynebacterium species, 2 Bacillus cereus, 1 
Bacillus species. 
Gram negative: 1 Proteus mirabilis, l Morgan-
ella morganii, l Enterchacter aerogenes, 2 
Enterchacter species, 1 Pseudomonas species, 
2 Aeromonas hydraphila, l Acinetchacter cal-
cooceticus, 3 Acinetobacter species, 
1 Citrchacter freundii, l Camylobacter jejuni, 2 
)(_anthomonas maltaphilia, 2 Serratia liquefa-
cums. 
Anaerobes: 3 Bacteroides fragilis, 2 Bacteroides 
corporis, 2 Bacteroides species, 1 Fusobacterium 
sp. 
Mycobacteria: 1 Mycchacterium species. 
Fungi: 3 Candida albicans 
CSF Isolates and Meningitis Reports 
There were two reports of meningitis due to 
Streptococcus pneumoniae isolated from 
blood. One was a 7monthold female and the 
other was a 15 month old child. Other CSF 
isolates were Acinetobacter iwoffi from a 32 
year old male, Prapionibacterium acnes from a 
67 year old male, and Staphylococcus epider-
midis from a 75 year old male. 
Isolates from Sites other than Blood or CSF 
Peritoneal dialysate: 1 Enterchacter cloocae, l 
Escherichia coli, 5 Staphylococcus epidermidis, l 
Micrococcus species, 1 Pseudomonas stutz.eri. 
Joint fluid: 1 Acinetchacter species, 2 Staphy-
lococcus aureus, l Staphylococcus epidermidis. 
Pleural fluid: 1 Baderoides species, 1 Pseuder 
monas species, 1 Staphylococus aureus. 
Other: Escherichia coli (peritoneal swab from 
perforated appendix), Staphylococcus aureus 
(thoracic diskitis). 
Table 2. Sterile sites surveillance of reports of blood isolates for April 19921 
Clinical Information Risk Factors 
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StapJntlccoccus aureus 20 1 1 1 1 7 2 3 9 
St apJntl ccoccu.s epi derm i dis 17 1 1 1 1 13 1 
Enterococcus faecalis 6 2 1 3 1 
Eschericia coli 29 4 15 2 13 1 1 
Klebsiella species2 15 4 3 1 2 4 2 
Pseudcmonas aeru~nosa 7 1 2 3 1 4 
Enterobacter cloocae 8 2 2 2 1 2 3 1 
1. Only organisms with 5 or more reports are included in this table. 
2. Includes 12 K. pheumonia and 1 K. oxytoca. 
COMMUNICABLE DISEASES INTELLIGENCE 
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Sterile Sites Surveillance 
(LabDOSS) 
Data for May have been provided by eight 
laboratories, of which Narnbour General 
Hospital, Royal Brisbane Hospital (with 
Royal Women's and Royal Children's Hos-
pitals, Brisbane) and Gosford Hospital are 
new additions to the Scheme. 
A total of 462 reports were received (Royal 
Prince Alfred 47, Royal North Shore 51, Gos-
ford 15, Concord 35, Brisbane 244, Central 
Queensland Pathology Laboratory 3, Nam-
bour 2 and Toowoomba 16). Most of the 
reports were for May isolates, but the Royal 
Brisbane Hospital's report covered the pe-
riod January to May. 
Blood Isolates 
Organisms reported 5 or more times from 
blood are detailed in Table 2. Other blood 
isolates not included in Table 2 were: 
Gram positive: 4 Streptococcus Group A, 
3 Streptococcus milleri, 3 Streptococcus Group 
G, 4 Streptococcus species, 1 Enterococcus spe-
cies, 1 Corynebacterium xerosis, l Listeria 
monocytogenes. 
Gram negative: 3 Klebsiella species, 2 
Klebsiella oxytoca, l Enterchacter aerogenes, 2 
Enterchacter cloacae, 2 Enterchacter species, 
l Pseudomonas cepacia, l Pseudomonas fluores-
cens, l Pseudomonas paucimobilis, 
4 Pseudomonas species, 2 Serratia liquefaciens, 
l Proteus species, 1 Citrchacter diversus, 3 Sal-
monella Typhi, 1 Neisseria meningitidis, 3 
Xanthomonas maltophila, 4 Acienetchacter spe-
cies, 1 Kingella kingae, l Gemella species, 2 
Flavobacterium species. 
Anaerobes: 4 Bacteroides fragilis, l Bacteroides 
corporis, l Baderoides melaninogenicus, l Bac-
teroides thetaiotaomicron, l Bacteroides avatus, l 
Peptostreptococcus species, 3 Propionibac-
terium species, 3 Clostridium perfringens, 
l Clostridium species. 
Fungi: 2 Candida species. 
Table 2. LabDOSS reports of blood isolates for May 1992 
Clinical Information Risk Factors 
-0 
>. QI 
U'J ... 
U'J _g t!l QI ... t!l C: u 0. ... <Fl _. 
0. 0. ·z C1) t!l -~ ~ C: ::, U'J -0 cS -QI ·o «i ... ... C: c c t!l t!l ·o ,-, c:; - -... 8 - ::, QI t!l t!l QI ... t!l QI C: C: C: ~ _. C: QI C: ~ E ·- 0 -0 ti) c:; ·;: 0 C: t!l ·c 0 :,.Q ::, E > QI QI Organism Tota1 1 -J u.J c.:, :::::> c:o V"J V"J ..... - 0... z 
Staplntlococcus aureus 51 3 1 2 3 9 11 15 10 1 1 
Staplntlococcus epidermidis 49 7 1 1 1 7 5 10 19 1 
Staplntlococcus coagulase ne~tive 52 8 1 4 2 2 4 7 14 6 2 
Streptococcus pneumoniae 12 6 1 1 
Streptococcus group B 7 1 1 2 
Streptococcus viridans 5 3 1 1 
Streptococcus san~is 5 1 1 1 1 
En terococcus faecal is 5 1 2 1 1 2 
Conpubacterium species 6 2 1 3 1 
Bacillus species 6 1 1 2 1 
Escherichia coli 64 3 6 24 1 1 11 4 3 1 
KldJsiella pneumoniae 16 5 2 3 4 5 2 
Proteus mirabilis 6 3 2 2 1 
Enterobad er cloocae 16 4 1 3 4 4 2 
Pseudcmonas aeru~nosa 26 5 1 3 4 7 13 1 
Haernor:Jiilus influenzae 9 1 2 
, 
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CSF Isolates and Meningitis Reports 
There were eight cases of meningitis re-
ported during this period. One was an 
isolate of Haemophilus infiuenzae type B from 
a one year old female. Other CSF isolates 
were Corynebacterium species in a male after 
surgery, Cryptococcus neoformans in a immu-
nocompromised female, Escherichia coli in a 
female, Staphylococcus aureus from a 14 year 
old female, Staphylococcus epidermidis from a 
23 year old female, and Staphylococcussanguis 
and Streptococcus mitis from males after sur-
gery. 
Isolates from Sites other than Blood or CSF 
Peritoneal dialysate: 1 Klebsiella pneumoniae, 
1 Streptococcus viridans, 2 Staphylococcus 
epidermidis. 
Joint fluid: 1 Streptococcus Group G, 3 Staphy-
lococcus aureus. 
Other: 1 Escherichia coli, 3 Staphylococcus 
aureus (1 MRSA), 1 Candida albicans, 1 Proteus 
mirabilis, 1 Xanthomonas maltophilia. 
COMMUNICABLE DISEASES INTELLIGENCE 
Volume 16, Number 14 - 13 July 1992 
Sterile Sites Surveillance 
(Lab DOSS) 
Data for June have been provided by seven 
laboratories. The Prince Charles Hospital, 
Brisbane, Northern Tasmania Pathology 
Service and Royal Hobart Hospital are new 
additions to the Scheme this month. 
A total of 155 reports were received (Royal 
Prince Alfred 63, Royal Hobart Hospital 21, 
Liverpool 28, The Prince Charles Hospital 10, 
Northern Tasmania Pathology Service 1, 
Nambour 10 and Toowoomba 22). 
Organisms reported 5 or more times from 
blood are detailed in Table 5. Other blood 
isolates not included in Table 5 were: 
Gram positive: 1 Streptococcus Group A, 1 
Streptococcus Group B, 1 Streptococcus Group 
C, 3 Streptococcus milleri, 2 Streptococcus 
Group G, 2 Staphylococcus coagulase nega-
tive, 1 Aerococcus species, 1 Enterococcus 
faecium, 1 Corynebacterium species. 
Gram negative: 3 Klebsiella species, 2 
Klebsiella oxytoca, 2 Klebsiella pneumonia, l En-
terobacter species, 1 Pseudomonas cepacia, 4 
Pseudomonas aeruginosa, l Serratia liquefaciens, 
l Proteus species, 2 Proteus mirabilis, l Neisse-
ria meningitidis, l Xanthomonas maltophilia, 2 
Acinetobacter species, 3 Haemophilus infiuen-
zae type b, 1 Citrchactor freundii, 1 Mora.xella 
species. 
Anaerobes: 2 Bacteroidesspecies, 1 Bacteroides 
thetai, l Peptostreptococcus species, 1 Clostrid-. . 
zum species. 
Fungi: 1 Candida albicans, 1 Pseudallescheria 
baydii, 1 Torulopsis glabrata. 
Mycoplasma: 1 Mycoplasma species, 1 Ure-
aplasma urealyticum. 
CSF Isolates and Meningitis Reports 
There were seven reports of meningitis dur-
ing this period. One was an isolate of 
Haemophilus influenzae type b from a 10 
month old male. Other CSF isolates were 
Neisseria meningitidis in a 5 month old female, 
Cryptococcus neoformans in an immunocom-
promised female and in a 57 year old 
immunocompromised male and Nocardia 
species in a 24 year old male. Both Staphyler 
coccus aureus and Staphylococcus epidermidis 
were isolated from a 44 year old male follow-
ing neurosurgery. 
Isolates from Sites other than Blood or CSF 
Peritoneal dialysate: 1 Staphylococcus aureus, 
2 Staphylococcus epidermidis, and 1 Enterchac-
ter agglomerans from persons with peritonitis 
complicating chronic ambulatory peritoneal 
dialysis. Escherichia coli was isolated from a 
45 year old female with gastrointestinal ill-
ness . 
Joint fluid: Clostridium perfringens from a 88 
year old male with no history of injury. 
Other: 4 Staphylococcus aureus (1 from femur 
tissue, 1 MRSA from a patient with endo-
carditis who died) 1 Streptococcus Group B, 2 
Pseudomonas aeruginosa following orthopae-
dic surgery. 
Table 4. Lab DOSS reports of blood isolates for June 1992 
Clinical Information Risk Factors .,., 
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St aprn;lcaxx:us au reus 20 1 1 2 3 7 1 8 1 
Stapln,lcaxx:us evidermidis 15 1 2 1 2 2 4 3 
Streptococcus pneumoniae 5 3 
Streptcaxr:us sanx-uis 5 1 1 1 1 
Enterococcus faecalis 6 2 2 1 1 
Escherichia coli 27 2 5 10 4 7 2 
Enterobader cloocae 6 2 1 4 
1. Only organisms with 5 or more reports are included in this table. 
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Sterile Sites Surveillance 
(LabDOSS) 
Data for July have been provided by ten 
laboratories, and Concord Hospital, Gosford 
Hospital, Northern Tasmania Pathology 
Service, Central Queensland Pathology 
Laboratory and Royal Hobart Hospital have 
also provided data for June. 
A total of 394 reports have been included for 
this report (Royal Prince Alfred 53, Royal 
Hobart Hospital 14, Liverpool Hospital 90, 
Concord Hospital 91, Royal North Shore 
Hospital 33, Gosford Hospital 56, Northern 
Tasmania Pathology Service 25, Central 
Queensland Pathology Laboratory 10 Nam-
hour Hospital 9 and Toowoomba Hospital 
13). 
Sixty four isolates of Staphylococcus aureus 
were reported during this period. Of these, 
thirty isolates were further identified as 
methicillin resistant Staphylococcus aureus 
(MRSA) and were reported by six laborato-
ries (Liverpool Hospital 3, Royal Prince 
Alfred Hospital 17, Gosford Hospital 3, 
Toowoomba Hospital 2, Northern Tasmania 
Pathology Service 4 and Royal Hobart Hos-
pital 1). These isolates were obtained from 
patients aged between 40 and 89. 
Concord Hospital reported a case of enteric 
fever in a 12 year old male. Salmonella paraty-
phi was isolated from a blood sample of this 
patient who probably acquired the infection 
in Sri Lanka. 
Organisms reported 5 or more times from 
blood are detailed in Table 3. Other blood 
isolates not included in Table 3 were: 
Gram positive: 2 Streptococcus Group A, 4 
Streptococcus Group B, 1 Streptococcus Group 
G, 1 Streptococcus milleri, 2 Streptococcus viri-
dans, 1 Streptococcus mitis, 1 Listeria 
moncxytogerzes, 1 Corynebacterium Group JK, 1 
Corynebacterium xerosis, 1 Corynebacterium 
speaes. 
Gram negative: 2 Campylobacter jejuni, 1 Cam-
pylobacter species, 3 Klebsiella species, 1 
Enterchacter aerogerzes, 1 Serratia marcescens, 1 
Proteus species, 4 Xanthomonas maltophilia, 4 
Acinetchacter species, 2 Citrobacter freundii, 1 
Citrchacter diversus, 1 Citrchacter species, 1 
Aeromonas hydrophila, 1 Aeromonas species, 1 
Flavobacterium species. 
Table 3. LabDOSS reports of blood isolates for July 1992 
Clinical lnformation Risk Factors 
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StapJntlococcus aureus 64 4 7 1 2 6 8 3 10 16 1 
Slapln/lococcus epidermidis 22 1 2 1 2 3 10 1 
Straphlococcus coagulase negative 8 1 1 
Streptococcus pneumoniae 33 23 3 
Streptococcus san~is 7 2 1 1 
Streptococcus species 7 3 1 4 
Enteroaxrus faecalis 9 1 1 4 3 1 
Escherichia roli 60 8 21 1 5 11 1 
Haemop1ilus influenz.ae type b 9 1 1 
Klebsiella axttf.oca 6 1 1 1 1 1 
Klebsiella pneumoniae 5 1 1 2 1 1 
Proteus mirabilis 9 3 2 3 2 
Pseudcmonas aeru~nosa 13 2 1 2 1 7 1 
Candida albicans 6 1 4 1 
1. Only organisms with 5 or more reports are included in this table. 
'I 
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Anaerobes: 1 Bacteroides species, 4 Baderoides 
Jragilis, 1 Bacteroides loescheii, 1 Peptostrepto-
coccus species, 2 Clostridium species, 1 
Clostridium perfrigens, 1 Fusooacterium nuclea-
tum, 1 Fusooacterium species. 
Fungi: 2Candidaspecies, 1 Debryomyeceshan-
sentt. 
CSF Isolates and Meningitis Reports 
There were 20 reports of meningitis during 
this period. Haemophilusinfiuenzae cype b was 
isolated from 5 cases. All were under the age 
of 4 years and one isolate was reported as 
methicillin resistant. There was one isolate of 
Haemophilus parainfluenzae reported, from a 
23 year old male following surgery. Neisseria 
meningitidis was isolated from 5 cases. Three 
cases were under the age of 1 year and one 
isolate was reported in a 15 year old female. 
One Staphylococcus aureus was reported in a 
67 year old male following lower respiratory 
tract infection. Streptococcus pneumoniae was 
reported in 2 females under the age of 1 year. 
Streptococcus sanguis was reported in a 77 
year old female following surgery. Coryne-
bacterium species was isolated from 2 
females, aged 25 and 28, following shunt 
surgery. Cryptococcus neoformans was iso-
lated from 2 immunocompromised males. 
Salmonella species was reported from a 29 
year old female. 
Isolates from Sites other than Blood or CSF 
Peritoneal dialysate: 9 Staphylococcus aureus 
isolates were reported during this period; 
chronic ambulatory peritoneal dialysis was 
the risk factor for 7 of these. Staphylococcus 
epidermidis was reported from a 76 year old 
with chronic liver disease. Enterooacter fae-
calis was reported from a male and a female, 
both aged 74 years. Other isolates were Es-
cherichia coli in a 70 year old male, Klebsiella 
pneumonia in a 74 year old female, Acinetobac-
ter species in a 42 year old female with peri-
tonitis, Citrooacter freundii in a 70 year old 
male with chronic renal failure, 1 Streptococ-
cus sanguis, 1 Streptococcus Group B, 1 
Streptococcus species, 1 Pseudomonas aerugi-
nosa. 
Joint fluid: 5 Staphylococcus aureus reported 
from males whose ages ranged from 28 to 64 
years. There were 2 reports of Staphylococcus 
epidermidis, one from a 70 year old male with 
an infected prosthetic knee join~ and the 
other from a 78 year old male with 
osteoarthritis. Streptococcus Group A was re-
ported from a 23 year old male with 
pre-patellar bursitis, Peptostreptococcus spe-
cies was reported from 84 year old female, 
Pseudomonas species reported from a 69 year 
old male, and Y ersinia enterocolitica from a 27 
year old female with chronic ambulatory 
peritoneal dialysis as a risk factor. 
Pleural fluid: 5 Staphylococcus aureus re-
ported from males whose ages ranged from 
56 to 87 years. Clinical diagnosis of these 
cases included lung abscess, empyema, per-
forated oesophagus and mediastinitis. 
Staphylococcus epidermidis was reported from 
a 66 year old male with aspiration pneumo-
nia, Streptococcus sanguis from a 21 year old 
male with lower respiratory tract infection, 
Streptococcus milleri from a 39 year old male 
with empyema, 1 Pseudomonas ae,·uginosa, 1 
Klebsiella pneumoniae, 2 Enterooacter aerogenes 
(one from a 71 year old male with a perfo-
rated oesophagus), and 1 Candida albicans 
from a 71 year old male with empyema. 
Other: 1 Candida albicans and 1 Candida spe-
cies from renal cysts of 2 male patients. 
'I 
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Sterile Sites Surveillance 
(LabDOSS) 
Data for August have been provided by nine 
laboratories, and Dr TB Lynch, Pathologist, 
Rockhampton is a new addition to the Lab-
DOSS system. 
A total of 285 reports have been included for 
this report (Royal Prince Alfred 54, Liver-
pool Hospital 70, Concord Hospital 44, Royal 
North Shore Hospital 63, Northern Tasma-
nia Pathology Service 16, Central 
Queensland Pathology Laboratory 2, Nam-
bour Hospital 14, Toowoomba Hospital 9 
and TB Lynch Pathologists Rockhampton 
13) . 
• 
• 
Sixty-six isolates of Staphylococrns 
aureus were reported during this period. 
Of these, nine isolates were further iden-
tified as methicillin resistant 
Staphylococcus aureus (MR.SA) and were 
reported by three laboratories (Liver-
pool Hospital 2, Concord Hospital 6 and 
Nambour Hospital 1). Eight isolates 
were obtained from patients aged be-
tween 70 and 90 years. 
Liverpool Hospital reported a case of 
enteric fever in a 12 year old female. 
Salmonella Typhi was isolated from a 
blood sample of this patient. 
• Two cases of Plasmodium vivax were 
reported in males aged 31 years and 36 
years, following travel to the Solomon 
Islands. 
Organisms reported 5 or more times from 
blood are detailed in Table 2. Other blood 
isolates not included in Table 3 are: 
Gram positive: 2 Streptococcus Group G, 
2 Streptococcus milleri, 1 Streptococcus viridans, 
3 Streptococcus sanguis, 1 Corynebacterium 
Group JK, 1 Corynebacterium species, 1 
Staphylococcus saprophyticus, 1 Enterococcus 
species. 
Gram negative: 3 Klebsiella species, 1 
Klebsiella oxytoca, 1 Enterooacter aerogenes, 3 
Enterooacter cloacae, 1 Enterooacter species, 
2 Serratia marcescens, 3 Proteus mirabilis, 3 Pro-
teus vulgaris, 1 Xanthomonas maltophilia, 
1 Citrooacter freundii, 1 Citrobacter species, 1 
Aeromonas hydrophila, 2 Pseudomonas species, 
2 Neisseria meningitidis, 1 Salmonella species. 
Anaerobes: 1 Bacteroides species, 1 Bacteroides 
thetai, 1 Clostridium species. 
Fungi: 2 Candida species, 1 Candida albicans. 
Table 2. LabDOSS reports of blood isolates for August 1992 
Clinical Information Risk Factors 
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Stapht/lococcus aureus 54 2 2 1 4 13 5 12 6 
Staphvlococcus epidermidis 25 1 5 2 4 13 4 
Staphvlococcus coagulase negative 5 1 1 1 1 1 1 
Strevtococcus rmeumoniae 23 12 1 1 
Enteroax:cus faecalis 9 2 2 1 2 2 1 1 
Escherichia coli 48 1 7 14 1 6 15 
Bocterades fra~lis 5 2 1 
Haemo-,:liilus influenzae type b 5 1 1 1 1 
Klebsiella pneumonia 8 1 3 1 1 
Pseudanonas aeruxinosa 9 1 2 1 1 3 1 3 2 
l. Only organisms with 5 or more reports are induded in this table. 
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CSF Isolates and Meningitis Reports 
There were 15 reports of meningitis during 
this period. Haemophi lus influen zae type b was 
isolated from a 2 year old male child. There 
was an isolate of Klebsiella pneunwnia re-
ported from a 54 year old female following 
surgery for multiple trauma injury. Neisseria 
meningitidis was isolated from 2 cases. One 
isolate was from a 2 year old male and other 
isolate was from a 22 year old immunocom-
promised female who later died. One 
Staphylococcus aureus was reported in a 4 
month old immunodeficient infant There 
were 4 cases of Streptococcus pneumoniae re-
ported from patients whose ages ranged 
from 34 to 84 years. Immunodeficiency was 
reported as the risk factor for 2 cases. The 84 
year old male (no risk factor) died. Streptococ-
cus epidermidis was reported in a 25 year old 
female following shunt surgery. Streptococ-
cus viridans was reported in a 28 year old 
female following shunt surgery. A Strepter 
coccus Group B isolate was reported from 42 
year old female following delivery. Crypter 
coccus neofarnums was isolated from 2 
imrnunocompromised males, aged 32 and 
53. Adinooacillus urea was reported from a 58 
year old male with a skull fracture. 
Isolates from Sites other than Blood or CSF 
Peritoneal dialysate: 3 Staphylococcus aureus 
isolates were reported during this period; 
chronic ambulatory peritoneal dialysis was 
the risk factor for 2 of these. Staphylococcus 
epidermidis was reported from 7 cases, all 
with chronic ambulatory peritoneal dialysis 
as the reported risk factor. Escherichia coli was 
reported in a 65 year old male with perito-
neal dialysis. 
Joint fluid: 7 Staphylococcus aureus reported 
from 5 males and 2 females whose ages 
ranged from 28 to 64 years. Staphylococcus 
epidermidis was isolated from a 24 year old 
male with synovitis in both knees. Enterococ-
cus faecalis was reported from a 55 year old 
female with a fractured femur. Neisseriagon-
orrhoea was reported from 17 year old female 
with septic arthritis . 
• 
• 
Pleural fluid: 1 Klebsiella pneumoniae 
from a 69 year old male following oe-
sophagus rupture, 1 alpha-haemolytic 
Streptococcus from a 89 year old female 
with plural effusion, and 2 Serratia mar-
cescens isolates, from a 56 year old male 
and an 81 year old female following sur-
gery. 
Other: Streptococcus Group B and Bac-
teroides species were isolated from 
tissues around renal stone of a female 
patient Enterococcus cloacae was reported 
from a 32 year old male with granuloma 
following the removal of plate in the 
humerus. Staphylococcus aureus was iso-
lated from the anterior chamber fluid of 
30 year old male with endophthalmitis. 
Pseudomonas aeruginosa isolated from the 
bile fluid of a 69 year old male. 
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Sterile Sites Surveillance 
(LabDOSS) 
Data for September have been provided by 
nine laboratories, and Gosford Central Coast 
Area Health Service also provided data for 
August. 
A total of 238 reports have been included for 
this report (Royal Hobart Hospital 8, Liver-
pool Hospital 49, Concord Hospital 34, Royal 
North Shore Hospital 25, Northern Tasma-
nia Pathology Service 14, Nambour Hospital 
11, Toowoomba Hospital 19, TB Lynch Pa-
thologists, Rockharnpton 4 and Gosford 
Central Coast Area Health Service 74). 
Thirty nine isolates of Staphylococcus aureus 
were reported during this period. Of these, 
eight isolates were further identified as 
methicillin resistant Staphylococcus aureus 
(MRSA) and were reported by two laborato-
ries (Gosford Central Coast Area Health 
Service 4 and Concord Hospital 4). Seven 
isolates were obtained from males aged be-
tween 69 and 80 years. 
Gosford Central Coast Area Health Service 
reported a case of enteric fever in a 38 year 
old Philippino male. Salmonellatyphi was iso-
lated from a blood sample of this patient 
Organisms reported 5 or more times from 
blood are detailed in Table 2. Other blood 
isolates not included in Table 2 were: 
Gram positive: 1 Streptococcus Group A, 1 
Streptococcus Group B, 4 Streptococcus Group 
G, 3 Streptococcus milleri, 2 Streptococcus spe-
cies, 2 Corynebacterium species, 1 Enteroccxcus 
species, Aerococcus species, 1 Listeria monocy-
togenes. 
Gram negative: 3 Klebsiella species, 4 
Klebsiella oxytoca, 2 Entercbacter aerogenes, 2 
Entercbacter cloacae, l Entercbacter species, 
l Serratia marcescens, l Citrobacter diversus, l 
Pseudomonas species, 1 Neisseria meningitidis, 
l Salmonella typhi, l Y ersinia enterocolitica, 3 
Morganella morganii. 
Anaerobes: 2 Bacteroides species, 3 Bacteroides 
thetai, 2 Clostridium species, 1 Clostridium clos-
tridii, 2 Clostridium perfringenes, l 
Peptostreptococcus species, 1 Propionibacterium 
speaes. 
Table 2. LabDOSS reports of blood isolates for September 1992 
Clinical Information Risk Factors 
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Stadit/lococcus aureus 39 1 3 4 9 7 9 8 
S ta,)1 v[ococcus epi d erm id is 9 1 1 1 2 1 
Star}iv{ococcus CX>aJnl[ase ne.[alive 14 1 1 2 1 2 1 
Stre,iococcus pneumoniae 18 15 1 1 
S lre,iococcus san ~ is 6 1 1 1 1 
En teraxx:cu s faecal is 9 1 1 3 2 1 
Escherichia coli 37 2 6 15 4 10 
Haemovhilus influenzae 6 2 
Bocteroides fr~lis 5 1 1 3 
Klebsiella pneumonia 5 2 1 1 
Prdeus morabilis 6 3 1 1 
Pseudomcmas aeruxinosa 7 1 1 1 1 2 3 1 
Candida albicans 5 3 2 
l. Only organisms with 5 or more reports are included in this table. 
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CSF Isolates and Meningitis 
Reports 
There were 12 reports of meningitis during 
this period. Haemophilus influenme type b was 
isolated from six of these cases. Four isolates 
were reported from children under the age 
of 1 year and two were reported from 
children under the age of 2 year. Two 1 year 
old children were reported by Liverpool 
Hospital from an area with same postcode. 
Neisseria meningitidis was isolated from 2 
cases. One isolate was from a 3 year old male 
and other isolate was from a 18 year old 
male. There were 3 cases of Streptococcus 
pneumoniae reported from patients whose 
age ranged from 3 to 34 years. 
Immunodeficiency was reported as the risk 
factor for the 34 year old male. Cryptococcus 
neoformans was isolated from a 45 year old 
immunocompromised male. 
Isolates from Sites other than 
Blood or CSF 
Peritoneal dialysate: Campylobacter jejuni 
isolate was reported from a 56 year old im-
munocompromised male following 
gastrointestinal illness. The patient later 
died. Staphylococcus epidermidis was reported 
from a 27 year old male with chronic ambu-
latory peritoneal dialysis. Alciligenes faecalis 
was reported in a 45 year old immunocom-
promised female. 
Joint fluid: Staphylococcus aureus reported 
from a male with no risk factors. Streptococ-
cus species was isolated from a 63 year old 
male with discitis. 
Pleural fluid; Escherichia coli was reported 
from a 66 year old female following colec-
tomy and ileostomy. Pseudomonas aeruginosa 
also reported from this patient. 
Other: Staphylococcus aureus was isolated 
from a paraspinal abscess for a 61 year old 
male patient. 
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Sterile Sites Surveillance 
(LabDOSS) 
Data for October have been provided by 
eight laboratories, and Royal Prince Alfred 
Hospital also provided data for August and 
September (Table 3). A total of 433 reports 
have been included (Royal Brisbane Hospi-
tal 245, Royal Prince Alfred Hospital 48, 
Central Queensland Pathology Laboratory 
8, Royal Hobart Hospital 44, Liverpool Hos-
pital 41, Northern Tasmania Pathology 
Service 13, Nambour Hospital 8, and Gos-
ford Central Coast Hospital Services 26). 
Sixty-six isolates of Staphylococcus aureus 
were reported during this period. Of these, 
five isolates were further identified as 
methicillin resistant Staphylococcus aureus 
(MRSA) and were reported by 3 laboratories. 
Organism reported five or more times from 
blood are detailed in Table 3. Other blood 
isolates were: 
Gram positive: 4 Clostridium species, 4 Strep-
tococcus milleri, 3 Corynebacterium species, 1 
Micrococcus species, 1 Entercx:occus faecium, 2 
Listeria monocytogenes and 1 unidentified 
gram positive bacillus. 
Gram negative: 1 Citrooacter freundii, 1 En-
terobacter aerogenes, 2 Enterooacter cloacae, 2 
Enterooacter species, 1 Flavobacterium species, 
4 Klebsiella species, 2 Neisseria meningitidis, l 
Pseudomonas cepacia, 1 Pseudomonas paucinur 
bilis, 3 Salmonella species, 1 Serratia 
liquefaciens, 2 Serratia species, 1 Y ersinia en-
tercx:olitica and 1 Xanthomonas maltophila. 
Anaerobes: 4 Bacteroides fragilis, 1 Bacteroides 
meaninogenicus, l Bacteroides thetai, l Bac-
teroides species, 1 Fusooacterium species and 1 
Propionibacterium species. 
Yeasts: 1 Candida species, 1 Saccharomyces 
species. 
CSF Isolates and Meningitis 
Reports 
There were 23 reports of meningitis during 
this period. Haemophilus influenzaetype b was 
isolated from one of these cases. One isolate 
(non b) was reported from a 26 year old 
female who had previously had a splenec-
tomy. The organism type was not recorded 
for the other cases. 
Neisseria meningitidis was isolated from 7 
cases. Five of the isolates were from children 
under the age of 3 (3 male, 2 female), one was 
from a 3 year old male and one from a 19 year 
old female. 
There were 4 cases of Streptococcus pneunur 
niae reported. One was from a 3 month old 
female, one from a 16 year old female, and 
one from a 72 year old male. One isolate was 
from a 21 year old male who had had a 
splenectomy and hypogamrnaglobulinae-
m1a. 
Cryptococcus neoformans was isolated form 
two immunocompromised males, aged 31 
and 47. A Klebsiella species was isolated from 
a 70 year old male. 
Isolates from Sites other than Blood or CSF 
Peritoneal dialysate: 3 Staphylococcus aureus, 
2 Staphylococcus epidermidis, 1 Escherichia coli. 
A nosocomially acquired Corynebacterium 
species was isolated on 3 occasions from a 65 
year old female. 
Joint fluid: 2 Staphylococcus aureus, l Staphy-
lococcus epidermidis, 1 coagulase negative 
Staphylococcus. 
Pleural fluid: Escherichia coli and Pseudo-
monas aeruginosa were reported from a 66 
year old female following colectomy and 
ileostomy. 
Other: Staphylococcus aureus was isolated 
from a paraspinal abscess of a 61 year old 
male. 
Volume 16, Number 23 
Table 3. Lab DOSS reports of blood isolates for October 1992 
Clinical Information Risk Factors 
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Acinetobacter species 8 1 4 1 
Candida albicans 5 2 1 2 
Enterococcus faecalis 7 1 2 2 1 1 
Escherichia coli 35 3 31 3 16 2 1 
Haemomilus influenzae 5 3 2 1 
Klebsiella pneumoniae 11 3 1 1 1 1 7 
Proteus mirabilis 9 1 1 2 
Pseudomonas aeru~nosa 19 2 3 2 6 1 
Pseudomonas species 6 1 1 
Stapln/lococcus aureu.s 66 4 3 1 3 6 6 13 9 1 
Stapln/lococcus epidermidis 33 1 7 1 
Stapln/lococcus coagu lase negative 29 2 1 1 2 9 3 
Strepococcus group A 5 2 1 
Strepcx:occus group B 5 2 1 2 
Streptococcus pneumoniae 30 19 1 1 1 
Streptococcus san~is 6 1 1 4 
Streptococcus viridans 5 1 1 1 
Streptococcus species 6 1 1 
Streptococcus group G 5 1 1 2 
1. Only organisms with 5 or more reports are included in this table. 
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LabDOSS 
The Laboratory Database of Organisms from 
Sterile Sites (LabOOSS) was established in 
1992 to monitor significant isolates from nor-
mally sterile sites. It will be used on a 
national basis to compile more detailed in-
formation than is available to the National 
Notifiable Diseases Surveillance System on 
infections such as those caused by Haemophi-
lus inftuenzae type b. It also collects 
information on diseases which are not noti-
fiable, such as meningitis caused by 
Streptococcus pneumoniae and by Cryptococcus 
neoformans. 
Ten to fifteen laboratories from around Aus-
tralia contribute reports to this scheme on a 
monthly basis. As for Lab VISE, each report 
is a anonymous modified line listing includ-
ing the laboratory identification, the data of 
specimen collection, the organism identifica-
tion, and data on the source specimen and 
any identification methods used supplemen-
tary to the isolation. The reports usually 
contain the postcode of the patient, data on 
the patient's age and sex, and information on 
the clinical diagnosis and risk factors, and 
can also contain additional relevant informa-
tion as comments. Partial or coded patient 
identification is also included to enable fur-
ther follow-up with laboratories, as 
required, and duplicate reports to be deleted 
or amalgamated. 
The LabOOSS data are published monthly as 
Sterile Sites Suroeillance in the Communicable 
Diseases Suroeillance section of CDI. Organ-
isms (or genus groups) reported five or more 
times from blood are presented in a table 
which details the total number of reports for 
the month, and selected information on the 
reported clinical information and risk fac-
tors. Other organisms reported fewer than 
five times from blood are listed in the text 
Listings and some further information of iso-
lates from CSF (and meningitis reports) and 
other sites, such as peritoneal dialysate and 
joint fluid, are also presented as text. 
It is proposed that annual reports for Lab-
00SS will be published each year, and, as 
more laboratories begin to contribute, the 
commentary on the reports received will be 
expanded. 
As for LabVISE, the number of reports of 
isolates made to LabOOSS is influenced by 
various factors, including the number, type 
and location of participating laboratories, 
and current diagnostic techniques and hab-
its, as well as the actual occurrence of 
infections. These factors must always be 
taken into account and the data interpreted 
with appropriate caution. The delay be-
tween the date of specimen collection and 
the date of publication ranges from two 
weeks to a few months. 
The CDILaboratory Reporting Schemes rely 
on the voluntary participation of laborato-
ries and we wish to acknowledge our 
gratitude to them for their contributions. 
The participation of additional laboratories 
in both the public and private sectors in these 
schemes is welcomed (see CDI Notice to 
Readers in this issue). 
Sterile Sites Surveillance 
(LabDOSS) 
Data received in the December to January 
period have been provided by nine labora to-
ri es, to make a total of 231 reports (Liverpool 
Hospital 37, Concord Hospital 37, Royal 
North Shore Hospital 46, Nambour Hospital 
7, Central Queensland Pathology Service 5, 
Toowoomba General Hospital 26, T.B. Lynch 
Pathologists - Rockhampton 4, Gosford Cen-
tral Coast Hospital Services 25, and Mackay 
Base Hospital who provided 44 reports from 
April 1992). 
Organisms reported 5 or more times from 
blood are detailed in Table 2. Other blood 
isolates not included in Table 2 were: 
Gram positive: 1 Streptococcus Group A, 2 
Streptococcus Group B, 3 Streptococcus Group 
G, 1 Streptococcus milleri, 2 Streptococcus san-
guis, 2 Streptococcus 'viridans', 1 Streptococcus 
sp, 2 Corynebaderium species. 
Gram negative: 3 AcinetdJacter sp , 2 Aero-
monas sp, 4 EnterdJacter sp (1 E. aerogenes,1 E. 
cloacae), 4 Haemophilus influenzae (3 type b, 
two cases of epiglottitis ), 1 Haemophilus 
parainfluenzae, 1 Proteus mirabilis, 3 Serratia 
sp (2 S. marcescens, 1 S. liquefaciens), 1 Citro-
bacter sp, 1 Pseudomonas sp, 1 Neisseria 
meningitidis (no serogroup provided), 1 
Morganella morganii, 1 Flavobacterium sp. 
Anaerobes: 1 Adinomyces odontolyticus, 3 
Clostridium sp (1 C. perfringens), 1 Ureaplasma 
urealyticum. 
Fungi: 4 Candida sp (3 C. albicans, 1 C. krusez) 
, 1 T orulopsis glabrata. 
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Table 2. LabDOSS reports of blood isolates for December 1992 
Clinical Information Risk Factors 
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Bacteroides sp 72 1 1 4 
Escherichia coli 49 7 15 1 1 11 2 
Pseudanonas aeru~nosa 9 1 1 1 3 1 
Klebsiella sp 63 
Salmonella sp 54 3 
S tapfutl a:::oo::u s au reus 425 2 2 1 1 4 14 3 13 3 1 
Stapfutlococcus coagulase ne~tive 136 3 1 
Strepta:::oo::us pneumoniae 15 7 1 
Enterococrus faecalis 6 1 1 1 2 1 1 
1. Only organisms with 5 or more reports are induded in this table. 
2. 2 Bacteroides fragilis, 2 B. thetaiotanicron . 
3. 4 Klebsiella pneumoniae. 
4. 2 Salmonella Virchow. 
5. 9 MRSA. 
6. 9 Staplylococcus epidennidis, 1 S. scheiferi. 
CSF Isolates and Meningitis Reports 
There were 2 Haemophilus injluenzae (l type 
b, both isolates from children aged 2 years), 
l Neisseria meningitidis (no group provided), 
1 Streptococcus pneumoniae and 2 Cryptococ-
cus neoformans. 
Isolates from Sites other than Blood or CSF 
Peritoneal dialysate: 1 Staphylococcus aureus 
, 2 coagulase negative staphylococci, 1 Chae-
tomium globosum. 
Joint fluid: 1 Corynebacterium species, 8 
Staphylococcus aureus, l Pseudomonas paucimo-
bilis. 
Pleural fluid: 1 Enterococcus faecalis, l Pseudo-
monas aerugznosa. 
Other: 1 Acremonium sp , 1 Corynebacterium 
species D2, 1 Pseudomonas aeruginosa, 2 
Staphylococcus aureus, l Staphylococcus epider-
midis. 
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Sterile Sites Surveillance 
(LabDOSS) 
Additional data received in the last fortnight 
for specimens collected in November and 
December 1992 have been provided by six 
laboratories. A total of 203 records have 
been included (6 Royal Hobart Hospital, 115 
ICPMR Westmead, 39 Royal Prince Alfred 
Hospital, 38 Royal North Shore Hospital, 4 
Nambour Hospital, 1 Dr TB Lynch Patholo-
gist, Rockhampton). 
A total of 705 records were provided by 
ICPMR Westrnead for the period May to 
October 1992. These retrospective data have 
been included in the total year data base; a 
report of 1992 LabOOSS data will be publish-
ed in the near future. 
Organisms reported 5 or more times from 
blood are detailed in Table 2. Other blood 
isolates not included in Table 2 were: 
Gram positive: 1 Streptococcus Group A, 3 
Streptococcus Group B, 1 Streptococcus Group 
G, 2 Streptococcus 'milleri', 2 Streptococcus 
pneumoniae, 1 Streptococcus sanguis, 1 Strepto-
coccus species, 2 ConJnebacterium JK, 4 
Enterococcus species, 1 Bacillus cereus. 
Gram negative: 1 Serraiia species, 1 Serraiia 
marcescens, 1 CitrdJacter freundii, 4 Haemophi-
Table 5. Lab DOSS reports of blood isolates 
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Acinetcbocter sp 5 
Entercbacter sp 152 
Eschericia coli 31 
Klebsiella sp 143 
Pseudomonas sp 114 
Stadivlococcus aureus 21 2 
Sta,}iylococcus coagulase negative 225 
lus influenz.ae (3 type B) 1 Neisseria meningitidis 
serogroup C (5 months old), 2 Xanthomonas 
maltophilia, 1 Flavobacterium species. 
Anaerobes: 1 Bacteroides corporis. 
Fungi: 4 Candida species (3 C. albicans). 
CSF Isolates and Meningitis Reports 
Fourteen reports of meningitis were re-
ceived: 2 Haemophilus influenz.ae type b 
(males aged 7 months and 1 year), 1 Listeria 
monocytogenes (76 year old female), 1 Neisseria 
meningitidisserogroup B (16 year old female), 
3 Streptococcus pneumoniae (ages 1 month, 8 
years, and 57 years), 1 Cryptococcus neofor-
mans (23 year old immunocompromised 
male), 1 Corynebacterium species (65 year old 
male -shunt), 1 Staphylococcusaureus (51 year 
old male), 1 Streptococcus group A (5 year old 
female), 1 Xanthomonas maltophilia (11 year 
old male - shunt), 1 Streptococcus 'milleri' (52 
year old male). 
Isolates from Sites other than Blood or CSF 
Peritoneal dialysate: 1 Candida albicans, 1 Co-
rynebacterium species, 1 Bacteroides corporis, 1 
Klebsiella pneumoniae, 2 Eschericia coli. 
Joint fluid: 3 Staphylococcus aureus. 
Clinical Information Risk Factors 
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1 1 2 2 1 
1 1 4 4 2 
3 13 1 3 9 1 1 
3 2 7 1 3 
1 2 3 5 
1 1 1 8 5 7 4 
1 2 5 5 4 4 
1. Only organisms with 5 or more reports are included in this table. 
2. 1 E. aerogenes, 6 E. cloocae, 4 E. faecal is. 
3. 2 K. a:rytoca, 7 K. pneumoniae. 
4. 9 Pseudcmonas aeruginosa. 
5. 7 Staphylococcus epidermidis. 
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Sterile Sites Surveillance 
(LabDOSS) 
LabOOSS data will be presented fortnightly 
from this issue of CDI. Data for the fortnight 
ending 3 February have been provided by 
four laboratories. A total of 55 reports have 
been included (36 Northern Tasmania Pa-
thology Service, 4 Dr TB Lynch Pathologist, 
Rockhampton, 6 Central Queensland Pathol-
ogy Service, 9 Toowoomba General 
Hospital). There are fewer reports than 
usual because of the change to fortnightly 
reports; no table has been included. There 
were no reports of meningitis. 
Blood Isolates 
Gram positive: 6 Staphylococcus aureus, 4 
Staphyloccoccus epidermidis, 1 Staphylococcus 
coagulase negative, 1 Streptococcus Group B, 
2 Streptococcus sanguis, 1 Carynebaderium 
jekeium, 1 Bacillus species. 
Gram negative: 2 Haemophilus influenz.ae 
type b (a 6 month old female with 
osteomyelitis and a 6 year old female with 
epiglotittis), 1 Yersinia kristensenii (73 yr old 
male, no clinical history), 1 Acinetchacter spe-
cies, 4 Escherichia coli, 3 Klebsiella species (1 
K oxytoca, 2 K. pneumoniae) 1 Proteus mirabi-
lis, 1 Citrchacter diversus, 1 Morganella 
morganii, 1 Xanthomonas maltophilia. 
Anaerobes: 3 Bacteroides fragilis, 1 Bacteroides 
thetaiotomicron. 
Isolates from Sites other than Blood or CSF 
Peritoneal dialysate: 2 Acinetobacter species, 
1 Bacteroides fragilis, 2 Staphylococcus aureus, 1 
Staphylococcus epidermidis. 
Peritoneal fluid: 1 Bacteroides species, 1 Can-
dida albicans, 1 Citrchacter freundii, 1 
Xanthomonas maltophilia, 1 Staphylococcus 
aureus, 1 Streptococcus 'viridans', 1 Escherichia 
coli. 
Joint fluid: 3 Staphylococcus aureus. 
Other: 1 Klebsiella pneumoniae, 1 Staphylococ-
cus aureus, 1 Streptococcus 'milleri'. 
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Sterile Sites Surveillance 
(LabDOSS) 
Data for this fortnight have been provided 
by six laboratories. Records have only 
been included in this report if the specimen 
collection date, and therefore the date of ill-
ness, is later than the first day of the previous 
month. Records in this report are therefore 
for specimen collection dates no earlier than 
1 January 1993. 
A total of 152 reports have been included for 
this report (56 Royal Prince Alfred Hospital, 
33 Royal North Shore Hospital, 23 Concord 
Hospital, 22 Royal Hobart Hospital, 17 
Northern Tasmanian Pathology Service, 1 
TB Lynch, Pathologist, Rockhampton). 
Organisms reported 5 or more times from 
blood are detailed in Table 3. Other blood 
isolates were: 
Gram positive: 2 Streptococcus pneumoniae, 1 
Streptococcus Group A, 1 Streptococcus Group 
B, 2 Streptococcus sanguis, 1 Streptococcus 
mitior (endocarditis), 1 Streptococcus, 
pyridoxal dependent, 1 Streptococcus species, 
1 Corynebacterium jekeium, 1 Listeria 
monocytogenes (21 year old pregnant female 
with chorioamnionitis). 
Gram negative: 2 Acinetooacter sp, 1 Aero-
monas hydraphila, 1 Haemophilus influenzae 
(not type b), 1 Salmonella paratyphi A (history 
of travel), 2 Salmonella species, 1 Salmonella 
Panama, 1 Morganella morganii, 4 Proteus 
mirabilis, 2 Xanthomonas maltaphilia, 1 Hafnia 
alvei, 1 Alcaligenes xylosoxidans, 4 Pseudomonas 
aeruginosa, 1 Ps. Jluorescens, 1 Ps. pseudamallei 
(59 year old male, no risk factors reported). 
Anaerobes: 1 Bacteroides fragilis, 1 Bactermdes 
distasonis, 1 Bacteroides thetaiotaomicron. 
Fungi: 2 Candida albicans, 1 C. tropicalis. 
CSF Isolates and Meningitis Reports 
1 Neisseriameningitidisgroup B (male aged 15 
years), 3 Cryptococcus neoformans (immuno-
compromised males aged 28, 37 and 43 
years), 1 Proteus mirabilis. 
Isolates from Sites other than Blood or CSF 
Peritoneal dialysate: 1 Staphylococcus aureus, 
4 Staphylococcus epidermidis, 1 Bacillus species, 
1 Bactermdes species, 2 Candida albicans, 1 Co-
rynebacterium species, 1 Enterococcus avium, 1 
Eschericia coli. 
Joint fluid: 1 Staphylococcus aureus. 
Other: 1 Flavobacterium species, 1 Xantho-
monas maltaphilia. 
Table 4. LabDOSS reports of blood isolates for the reporting period 4 to 17 February 1993 
Clinical Information Risk Factors 
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Stapln;lococcus aureus 21 3 1 7 4 4 5 1 
Stapln;loc.oa:us epidermidis 28 1 1 1 1 6 6 1 
Enteroaxr:us speci.es2 5 3 1 1 
Escherichia coli 23 4 14 4 
Kld:Jsiella species3 8 1 3 2 1 
Enterobader species4 6 1 1 2 2 1 1 
1. Only organisms with 5 or more reports are included in this table. 
2. 4 E. faecalis, 1 E. faecium. 
3. 6 K.pneumoniae, 1 K. oxytoca, 1 Klebsiella species. 
4. 2 E. aerogenes, 4 E. cloacae. 
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One Bordetella pertussis isolate was also re-
ported, from a 4 month old female. This was 
an isolate from a pernasal swab, and there-
fore not from a sterile site, but has 
nevertheless been included in the database. 
Laboratories wishing to report such isolates 
though LabOOSS are welcome to do so, and 
B. pertussis diagnoses made by immunofluo-
rescence or serological techniques can be re-
ported through the CD/ Virology and 
Serology Reporting Scheme (Lab VISE). 
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STERILE SITES SURVEILLANCE 
REPORTS, 1992 
(Leslee Roberts, Communicable Disaeses Sedion, 
Department of Health, Housing and Community 
Services, and Na!.ional Centre for Epidemiology 
and Population Health, ANU) 
In 1992, 16 laboratories provided 3,936 re-
ports of organisms from sterile sites to 
LabDOSS (CDI Sterile Sites Laboratory Re-
porting Scheme). Reports for 1992 yet to be 
submitted to CDI will be added to the dataset 
as provided. Isolates reported to CDI but 
coded as contaminants are not included in 
the analysis of LabDOSS data. 
The numbers of reports provided by each 
laboratory were: 947 from ICPMR West-
mead; 596 from Royal Prince Alfred 
Hospital; 578 from Royal Brisbane Hospital; 
460 from Liverpool Hospital (South West 
Area Pathology Service); 342 from Royal 
North Shore Hospital; 284 from Concord 
Hospital; 197 from Gosford Central Coast 
Hospital Services; 129 from Toowoomba 
General Hospital; 110 from Royal Hobart 
Hospital; 99 from Northern Tasmanian Pa-
thology Service; 69 from Nambour Hospital; 
43 from Central Queensland Pathology 
Laboratory, Mackay; 43 from Mackay Base 
Hospital; 29 from T.B. Lynch Pathologist, 
Rockhampton; 10 from Prince Charles Hos-
pital Brisbane. 
1992 was the first year of the LabDOSS 
Scheme and therefore there is not a large 
Figure 1. Lab DOSS reports, 1992, by month 
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volume of data. However, the utility of the 
LabDOSS database will improve in time 
with anticipated increase in contributions. 
Analysis of several aspects of the 1992 data 
will be included in the next few issues of CDI. 
In this edition, an overview of the 1992 data 
is presented, followed by reports of menin-
gitis, and reports of bacteraemia without 
meningitis caused by Haemophilus influenwe, 
Neisseria meningitidis and Streptococcus pneu-
mantae. 
The 1992 reports originated largely from 
New South Wales as this was where Lab-
DOSS was initially trialled. The number of 
reports for each month ranged between 181 
and 422 (Figure 1). (Data for December from 
some laboratories are yet to be received.) The 
month of each report is based on the collec-
tion date of the specimen rather than the date 
the isolate was reported. It is therefore a 
better indication of the date of illness than 
the reporting date and allows more valid 
interpretation of seasonal trends. 
There were more reports of isolates from 
males than from females, with a ratio of 1.3 
males to 1.0 female. 
As expected there was a predominance of 
reports of organisms isolated from normally 
sterile sites in the elderly (Figure 2). 
Meningitis Reports, 1992 
There were 173 cases of meningitis reported 
in 1992 (Table 1). Most reports were in chil-
dren under the age of five years (Figure 3). 
Figure 2. LabDOSS reports, 1992, by age 
group 
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Table 1. Lab DOSS reports of meningitis, 1992, by organism and age group 
Months 
<1 1-11 1-4 
v\cinetobocter species 1 
IAdinobacillus species 
Candida albicans 1 
torynebacterium species 
~ryptococcus neoformans 
IEnterobacter species 
'Escherichia ccli 1 
IJiaemophilus injluenzae 6 21 
'fl aemophilus parainjluenzae 
J(Jebsiella oxytoca 
1/(lebsiella pneumoniae 
iJ(Jebsiella species 
Listeria monocytogenes 
Morganella species 
INeisseria sicca subjlava 
INeisseria meningitidis 5 10 
IN ocardia species 
IPropionibocterium acnes 
Pseudomonas aeruginosa 
Salmonella species 
!Stap-iyloaxus aureus 1 1 
IStap-iyloaxx:us roagulase negative 
lS tap-i ylococcus epi dermi dis 
IStreptoaxx:us group A 
Streptoaxx:us group B 
Streploax:cus "milleri" 
!Streptococcus pneumoniae 1 5 2 
lStreplO<XJccus sanguis 
Streploax:cus "viridans" 
IXanthomonas maltophilia 
rTotal 5 17 33 
Figure 3. LabDOSS reports of meningitis, 
1992, by age group 
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5-14 
1 
1 
1 
2 
5 
Age 
Years 
15- 25- 35- 45- 55- 65-
24 34 44 54 64 74 75+ Unknown Total 
1 
1 
3 
1 
8 
1 
2 
5 
2 
1 
1 
26 
2 1 1 5 
1 1 
1 
2 1 1 4 
4 1 5 1 1 1 3 16 
1 1 2 
2 
3 1 5 36 
1 
1 1 
1 1 
1 1 1 6 
2 1 3 
1 
1 1 
1 2 26 
1 
1 1 2 
1 1 2 
1 1 
1 1 1 2 10 
1 1 1 1 5 
5 1 1 2 1 15 
1 
1 1 
1 1 
3 1 1 2 2 21 
1 1 2 
1 1 3 
1 
24 8 15 6 8 7 19 173 
The three most frequently reported organ-
isms are well recognised as the common 
causative agents of meningitis: Haemophilus 
influenzae: 36 cases, Neisseria menigitidis: 26 
cases and Streptococcus pneumoniae: 21 cases. 
Twenty-four of the 36 reports of Haemophilus 
influenzae meningitis were reported as due to 
Haemophilus influenzae type b (Table 2). There 
were 19 males and 17 females. Twenty-six 
(72%) of the reports of Haemophilus influenzae 
meningitis were in children less than three 
years of age and 14 (38%) were in children 
less than 18 months of age (Figure 4). Haenur 
philus influenzae type b meningitis has been 
reported to exhibit a biphasic seasonal pat-
tern with peaks in spring and autumn. This 
trend was not apparent with the few reports 
in the LabOOSS data (Figure 5). 
There were 26 reports of Neisseria menigitidis 
meningitis. Fifteen (57%) of these were in 
Volume 17, Number 5 
Figure 4. Haemophilus influenzae 
meningitis reports, 1992, by age 
group 
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Figure 5. Haemophilus influenzae meningitis 
reports, 1992, by month of 
specimen collection 
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Figure 6. Neisseria meningitidis meningitis 
reports, 1992, by month of 
specimen collection 
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Figure 7. Streptococcus pneumoniae 
meningitis reports, 1992, by age 
group 
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Table 2. Haemophilus influenzae meningitistis reports, 1992, by serogroup and age group 
Age 
Months Years 
1-11 1-4 25-34 55-64 Unknown Total 
Serogroup b 4 14 2 0 4 24 
No grouo 2 4 1 1 4 12 
Total 6 18 3 1 8 36 
Table 3. Neisseria meningitidis meningitis reports, 1992, by serogroup and age group 
Age 
Months Years 
<1 1-11 15-24 25-34 Unknown Total 
Se~i-uup B 1 1 4 0 0 6 
Serogroup C 0 2 0 1 0 3 
Polvvalent ACYW135 0 0 1 0 0 1 
Not Provided 4 7 3 0 2 16 
Total 5 10 8 1 2 26 
r 
Ii I 
Volume 17, Number 5 
Figure 8. Streptococcus pneumoniae 
meningitis reports, 1992, by month 
of specimen collection 
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children under 5 years of age. Serogroup 
information was provided for 10 reports (Ta-
ble 3). The seasonal trend of meningococcal 
meningitis occurring in winter and spring is 
evident even with the few cases reported in 
1992 (Figure 6). 
Twenty-one cases of pneumococcal menin-
gitis were reported in 1992. The cases were 
equally distributed between the sexes (10 
females, 10 males and 1 unknown), and oc-
curred in all age groups (Figure 7). Usually 
the cases occur in the elderly, the young and 
those with a predisposing risk factor. In the 
1992 LabOOSS reports, pneumococcal men-
ingitis occurred predominantly in the winter 
months (Figure 8). 
Immunodeficiency was reported for 15 of the 
16 cases of cryptococcal meningitis reported; 
Table 4. Meningitis reports with a risk factor of surgery reported, 1992, by organism and 
surgery type 
Risk Factor 
.. Organism Surgery Neurosurl Vascular 
erv surgery 
Acinetobacter species 2 
Con!nebacterium species 3 
Escherichia col.i 1 
Haemovhilus varainfluenzae 1 
Klebsiellaoxt{foca 1 
Klebsiella pneumoniae 1 
Mor![anella species 1 
Propionibacterium acnes 1 
Staph11lococus aureus 3 
Stavhulococcus evidermidis 13 1 
Strevtococcus "milleri" 1 
Streptococcus san£Uis 2 
Streptococcus "viridans" 3 
Xanthomonas maltovhilia 1 
Total 1 33 1 
Table 5. Meningitis reports with a risk factor of immunodeficiency reported, 1992, 
by organism 
: Risk Factor .... . . 
: .. •. 
HIV Neutro- Diabe Renal Other Malig •.·.•. 
: 
tes : -
Organism .. Infectior .· paenia Failur nancy 
: .-·. : 
e 
Cnmtococcus neoformans 12 2 1 
Haemovhilus influenzae 1 
Listeria monOCl{t~enes 1 
Neisseria menin![itidis 1 
Pseudomonas aeru£'-inosa 1 
Staph11lococcus coagulase negative 1 
Total 
2 
3 
1 
1 
1 
1 
1 
1 
3 
14 
1 
2 
3 
1 
35 
... 
Total 
''.!::u: -
15 
1 
1 
1 
1 
1 
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Sterile Sites Surveillance 
(LabDOSS) 
Data for this fortnight have been provided 
by 8 laboratories. CDI welcomes The In-
stitute of Medical and Veterinary Science, 
Adelaide, to the LabOOSS scheme. Royal 
Brisbane Hospital also provided 96 rerords 
which will be added to the 1992 database. 
A total of 241 reports have been included in 
this issue (96 IMVS Adelaide, 47 Royal 
Prince Alfred Hospital,29 Concord Hospital, 
32 Royal North Shore Hospital, 14 Northern 
Tasmania Pathology Service, 10 New Eng-
land Pathology Tamworth, 8 Nambour 
Hospital, 5 TB Lynch Pathologists - Rock-
hampton). 
Organisms reported 5 or more times from 
blood are detailed in Table 2. 
Other blood isolates not included in Table 2 
were: 
Gram positive: 
1 Bacillus cereus, 2 Streptococcus Group A, 2 
Streptococcus mitis, 1 Streptococcus Group B, 2 
Streptococcus Group G, 3 Streptococcus 
milleri,3 Streptococcus pneumoniae, 1 
Streptococcus sanguis, 3 Streptococcus 
"viridans", 3 Streptococcus species, 1 
Corynebacterium JK. 
Gram negative: 4 Acinetooacter sp, 2 Aero-
monas sp (1 hydrophila), 5 Serratia species (3 
marcescens), 1 Cardiooacterium hominis,1 Citro-
bacter freundii, 1 Pasteurella sp, 1 Pseudomonas 
species,l Pseudomonas flourescens, 1 Haenur 
philus injluen-zae, 1 Neisseria meningitidis, 1 
Salmonella typhi (F 33), 1 Salmonella sp ,1 Mor-
ganella morgani, 1 Xanthomonas maltophilia. 
Anaerobes: 1 Bacteroides fragilis, 1 Bacteroides 
species, 1 Baderoides loeschii. 
Fungi: 2 Candida species (1 parapsilopsis, 1 
kruseit). 
CSF Isolates and Meningitis Reports 
2 Haemophilus injluen-zae (M 3 type b, F 41) , 
3 Neisseria meningitidis (F 27 group B, M 1, M 
12), 2 Cryptococcus neoformans, 1 Candida albi-
cans, 1 Staphylococcus aureus, 1 Staphylococcus 
epidermidis, 1 Klebsiella pneumoniae. 
Isolates from Sites other than Blood or CSF 
Peritoneal Dialysate: 2 Staphylococcus 
aureus,2 ~taphylococcus epidermidis, 1 Klebsiella 
pneumontae. 
Joint fluid: 1 Escherichia coli, 1 Staphylococcus 
aureus,1 Staphylococcus epidermidis, 1 Strepto-
coccus group G. 
Other: 1 Nocardia sp, 2 Staphylococcus aureus, 
1 Escherichia coli. 
Table 2. Lab DOSS reports of blood isolates for the reporting period 4 March to 17 March 
1993 
Cliniatl Information Risk Factors 
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~ .3 C: «s ~ ::, E > <1,1 <1,1 Omanism Total1 w c., ;:) U) U) ..... ...... Cl.. z 
s tam vloroccus aureu.s 39 3 1 1 10 3 10 16 
S tadi vloroccus epidermidis 16 1 2 3 7 4 
Stadtvlocoa::us coagulase negative 14 1 2 1 6 
Enterococcus sp 62 3 2 
Escherichia cdi 50 3 16 
Klebsiella sp 143 2 
Prcieus mircvilis 5 1 
Pseudomonas aeru~na:;a 11 3 1 6 
Entercbacter sp 104 4 
1. Only organisms with 5 or more reports are in duded in this table. 
2. 3 Entercx:occus faeailis 
3. 11 Klrosiella pneumoniae, 1 Klebsiella cytoc 
4. 2 Entercbacter aerogenes, 3 Entercbader cloocae 
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Sterile Sites Surveillance 
(Lab DOSS) 
Data for this fortnight have been provided 
by 4 laboratories. A total of 264 reports 
have been included for this report (169 
ICPMR Westmead, 54 Liverpool Hospital, 29 
Concord Hospital, 12 Toowoomba General 
Hospital). 
Organisms reported 5 or more times from 
blood are detailed in Table 2. 
Other blood isolates not included in Table 2 
were: 
Gram positive: 1 Streptococcus Group A, 4 
Streptococcus Group B ( 3 neonates, 1 aged 5 
weeks) 1 Streptococcus Group G, 3 Strepto-
coccus milleri,2 Streptococcus sanguis,2 
Streptococcus "viridans ", 3 Streptococcus pneu-
moniae l Streptococcus uberis, 4 Streptococcus 
mitis, 1 Streptococcus bouis,2 Streptococcus sp, 
1 Corynebacterium Group A-4 ( immunocom-
promised), 1 Listeria monocytogenes (neonate). 
Gram negative: 2 Alcaligenes sp, 3 Serratia 
marcescens, 2 Citrobacter sp (1 freundii) , 3 
Pseudomonas ( 2 paucimobilis, ), 1 Haemophilus 
influenz.ae type b, 1 Y ersinia enterocolitica, 4 
Proteus mirabilis, 3 Xanthomonas maltophilia, 2 
Aeromon as sp 
Anaerobes: 3 Bacteroides sp ( 1 fragilis, 1 vul-
gatus), 1 Clostridium ramosum, 2 
Fuse.bacterium sp( 1 nucleatum), 
Fungi: 2 Rhodotorula sp, 2 Cryptococcus neofor-
mans var neoformans ( Both HIV) 
CSF Isolates and Meningitis Reports 
1 Haemophilusinfluenz.ae type b (3M), 1 Group 
B Streptococcus ( M neonate ) 1 Bacillus sp, 1 
Entercbacter aerogenes (neonate) 2 Coagulase 
negative Staphylococci, 1 Serratia Marcescens, 2 
Cryptococcus neoformans (both HIV). 
Isolates from Sites other than Blood or CSF 
Peritoneal dialysate:l Acinetcbacter sp, 1 Es-
cherichia coli, 2 Staphylococcus aureus, 3 
Staphylococcus epidermidis,1 Coagulase nega-
tive staphylococcus 
Joint fluid: 1 Escherichia coli 2 Staphylococcus 
aureus 
Pleural fluid: 1 Comomonas sp, 1 Rhodotorula 
sp,l Acinetobacter sp,l Enterococcus sp,1 Es-
cherichiacoli,4Staphylococcusaureus (1 MRSA) 
, 6 Coagulase negative staphylococci,! Strep-
tococcus sanguis 
Other: 1 Alcaligenes sp, 1 Eikenella corrodens,2 
Enterococcus sp (1 faecium, 1 faecalis ), 6 Staphy-
lococcus aureus ( 1 MRSA ),1 Staphylococcus 
epidermidis, 2 Streptococcus milleri,1 group A 
Streptococcus 
Table 2. Lab DOSS reports of blood isolates for the reporting period 11 to 24 March 1993 
Clinical fnformation •· Risk Faders 
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>, (IJ / Ul ... Ul .B '° (IJ ... '° C: u 0. ... rr, - 0.. '° - 0. - Ul ... ::, C: VJ "'O ~ t'""' Ul ·s (IJ ... C: 0 '° .s ... >, >, -- ~ ·s C: -... ... ... ::, (IJ ca «s (IJ ... ca (IJ C: C: C: (IJ 
~ - i:: C: 00 E 0 C: "'O Ul ·c :..i2 ... - .i: (IJ c8 ..3 C: «s :::s E ~ Qi • Organism Total1 UJ c., ::) rJ) rJ) - p_. z 
Stadittlococcus aureu.s 392 4 2 2 3 5 4 5 1 
Sta;intloaxx:us coagulase negative 33 1 3 4 2 14 1 
Enteroccxx:us sp 103 2 4 2 2 1 3 3 
Escherichia ccli 38 4 6 16 2 5 4 2 1 
Klebsiella sp 124 1 2 2 1 3 1 
Entercbacter sp 105 1 1 1 1 1 2 
Pseudomanas aeru~nasa 7 1 1 1 1 1 3 
Candida albicans 6 1 1 3 1 
1. Only organisms with 5 or more reports are included in this table. 
2. 7MRSA 
3. 4 Enterococcus faecalis 
4. 4 Klebseilla oxytoca, 5 Klebsiella pneumaniae 
5. 2 Enterobocter aerogenes, 6 Enterobocter cloocae 
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Sterile Sites Surveillance 
(LabDOSS) 
Data for this fortnight have been provided 
by 5 laboratories. A total of 131 reports has 
been included: 32, ICPMR Westmead; 79, 
Liverpool Hospital; 13, Northern Tasmanian 
Pathology Service; 5, Nambour Hospital; 2, 
Central Queensland Pathology Service. 
Oganisms reported 5 or more times from 
blood are detailed in Table 4. Other blood 
isolates not included in Table 4 were: 
Gram positive: 1 Streptococcus Group B, 1 
Streptococcus Group G, 1 Streptococcus milleri, 
2 Streptococcus sanguis 1 Streptococcus mitis, 1 
Streptococcus intermedius, 2 Corynebacterium 
species, 3 Enterococcus species (2 E. faecalis), 
2 Bacillus species. 
Gram negative: 4 Acinetobacter species (1 A 
baumanni), 2 Enterobacter cloacae, 1 Serratia 
marcescens, 1 Pseudomonas putida, 3 Haemophi-
lus injluenzae (all aged 1 to 11 months, 2 type b), 
1 Salmonella Bredeney, 2Morganella morganii, 
Table 4. Lab DOSS reports of blood isolates 
-C: ·s -. -(lj C: 
Organism Total1 ~ 
St (ll)m/1 ooxcus au reus 1?2 1 
St(ll)ht/looxcus coagulase negative 83 
Streptococcus pneumonitle 6 
Escherichia roli 29 
Klebsiella species i'4 
Pseudooionas aeru~nosa 16 
2 Proteus mirabilis, 1 Chromobacterium vio-
laceum 
Anaerobes: 1 Eubacterium species, 4 Bac-
teroides species, (1 B. fragilis, 1 B. 
thetaiciomicron), 1 Clostridium perfringens, 2 
Peptostreptococcus species. 
CSF Isolates and Meningitis Reports 
2 Haemophilus influenzae type b (female aged 
11 months and a male aged 2 years), Pseudo-
monas aeruginosa and E. coli in a female aged 
3 months. 
Isolates from Sites other than Blood or CSF 
Peritoneal dialysate: 1 Pseudomonas aerugi-
nosa, l Staphylococcus aureus. 
Peritoneal fluid: 1 SalmonellaTyphimurium. 
Joint fluid: 1 Streptococcus Group A (female 
aged 2 months), 1 Staphylococcus aureus. 
Clinical Information Risk Factors 
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1 3 1 3 
1 1 1 4 
6 
4 14 2 3 1 
2 3 2 
4 1 1 2 7 
1. Only organisms with 5 or more reports are included in this table. 
2. MRSAS. 
3. Staphylaxxx:us epidermidis 1. 
4. KldJsiella arytoca 3, K. pneumonitle 4. 
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Sterile Sites Surveillance 
(Lab DOSS) 
Data for this fortnight have been provided 
by 7 laboratories. A total of 136 reports have 
been included: IMVS Adelaide 50, Gosford 
Hospital 10, Royal North Shore Hospital 42, 
Northern Tasmanian Pathology Service 23, 
Nambour Hospital 5, TB Lynch Rock.hamp-
ton 3, Central Queensland Pathology Service 
3. 
Gosford Hospital also provided 36 reports 
for December 1992 and 84 reports for Janu-
ary and February 1993. These records have 
been merged with the total LabOOSS files for 
the respective years. 
Organisms reported 5 or more times from 
blood are detailed in Table 4. Other blood 
isolates not included in Table 4 were: 
Gram positive: 2 Streptococcus sanguis, l 
Streptococcus "viridans ", l Streptococcus bavis 
(endocarditis), 4 Streptococcus pneumoniae, l 
Cmynebacterium jekeium, 4 Enterococcus fae-
calis, l Enterococcus faecium, l Enterococcus 
species. 
Gram negative: 2 Aeromonas species (1 A. 
hydrophila, l A. schria), 3Acinetobacterspecies, 
2 Klebsiella oxytoca, 3 Serratia marcescens, l 
Pseudomonas species, 1 Haemophilus influenzae 
(lower respiratory tract infection in a 29 year 
Table 4. LabDOSS reports of blood isolates 
C: ·o -.. ......_ 
Ill 
C: : 
0 
Organism Total1 co 
Star;ht(loca::cus aureus 232 
Sta,:hylococcus coagulase negative 8 
Escherichia coli 29 
Klebsiella pneumonia 8 
Enterchader species 83 
Pseudomonas aeruginosa 6 
3 
1 
old patient), 1 Salmonella Typhi (from a New 
South Wales laboratory, history of overseas 
travel), 2 Morganella morganii, l Proteus 
mirabilis, l Proteus vulgaris, l Xanthomonas 
maltophilia. 
Anaerobes: 1 Bacteroides fragilis, 2 Clostridium 
-perfringens, l Peptostreptococcus species. 
Fungi: 1 Cryptococcus neoformans (HIV posi-
tive patient). 
CSF isolates and meningitis reports 
l Haemophilus influenzae type b (6 month old 
female), 1 Neisseria meningitidis group B 
(Tasmanian laboratory, 3 month old female), 
l Enterchacter aerogenes (surgery). 
Isolates from sites other than blood or CSF 
Peritoneal dialysate: 1 Escherichia coli, 2 
Staphylococcus aureus, l Pseudomonas aerugi-
nosa, 2 Staphylococcus epidermidis. 
Joint fluid: 2 Staphylococcus aureus, l Proteus 
mirabilis, l Group G Streptococcus (joint re-
placement). 
Other: 1 Escherichia coli, 1 Proteus mirabilis, l 
Citrchacter freundii. 
Clinical Information Risk Factors 
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1 1 6 3 7 2 
1 1 1 1 
11 9 1 7 
3 1 5 1 
1 1 1 
2 1 1 1 2 
1. Only organisms with 5 or more reports are included in this table. 
2. MRSA 1. 
3. Entercbacter cloocae 4. 
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Sterile Sites Surveillance 
(LabDOSS) 
Data for this fortnight have been provided 
by 5 laboratories. A total of 43 reports have 
been included: Northern Tasmanian Pathol-
ogy Service 9, Nambour General Hospital 7, 
TB Lynch Pathologists, Rockhampton 4, 
Toowoomba General Hospital 10, New Eng-
land Pathology Tamworth 13. 
Organisms reported 5 or more times from 
blood are detailed in Table 4. Other blood 
isolates not included in Table 4 were: 
Gram positive: 1 Streptococcus Group A, 2 
Streptococcus Group B (1 male neonate), 1 
Streptococcus Group G, 1 Streptococcus pneu-
moniae (1 year old female), 2 Staphylococcus 
epidermidis, 1 Staphylococcus hominis. 
Gram negative: 1 Acinetchacter baumannii, 4 
Klebsiella pneumoniae, 1 Serratia marcescens, 1 
Haemophilus injluenzae type b (8 month old 
Table 4. LabDOSS reports of blood isolates 
... 
c:: 
·5 
--------QI C: 
On?anism Total1 c8 
Stadlvlococcus aureus 82 1 
Escherichia coli 8 
male), 2 Pseudomonas aeruginosa, 1 Pseud<>-
monas species. 
Anaerobes: 1 Peptostreptococcus species, 1 
Propionchacterium species. 
Fungi: 1 Candida tropicalis. 
CSF Isolates and meningitis reports 
1 Haemophilus injluenzae type b (2 year old 
male), 1 Neisse,·ia meningitidis (group pend-
ing, 6 year old female). 
Isolates from sites other than blood or CSF 
Joint fluid: 2 Staphylococcus aureus, 1 Strept<>-
coccus Group A. 
Other: 1 Klebsiella oxytoca. 
Clinical Information Risk Factors 
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l. Only organisms with 5 or more reports are included in this table. 
2. MRSA 1. 
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COMMUNICABLE DISEASES INTELLIGENCE 
Volume 17, Number 11 - 31 May 1993 
Sterile Sites Surveillance 
(LabDOSS) 
Data for this fortnight have been provided 
by 8 laboratories. A total of 245 reports have 
been included: ICPMR Westmead 75, Liver-
pool Hospital 79, Tamworth Pathology 13, 
Royal North Shore Hospital 36, Nambour 
Hospital 3, Central Queensland Pathology 
Service 4, Northern Tasmanian Pathology 
Service 9, Royal Hobart Hospital 26. 
Organisms reported 5 or more times from 
blood are detailed in Table 6. Other blood 
isolates not included in Table 6 were: 
Gram positive: 3 Streptococcus Group A, 2 
Streptococcus Group B, 2 Streptococcus Group 
G, 2 Streptococcus pneumoniae 1 Streptococcus 
mitis, 1 Streptococcus sanguis, 1 Streptococcus 
'viridans', 2 Streptococcus species, 2 Corynebac-
terium species, 1 Corynebacterium xerosis, 3 
Enterococcus faecalis, 1 Enterococcus species. 
Gram negative: 4 Proteus mirabilis, 1 Serratia 
species, 1 Citrchacter diversus, 1 Citrchacter 
freundii, 1 Citrchacter species, 1 Pseudomonas 
paucimobilis, 2 Pseudomonas species, 2 Haemo-
philus injluenz.ae type b (an 8 month old male 
and a 61 year old female), 1 Morganella mor-
ganii, 1 Campylobacter jejuni, 1 Aeromonas 
hydrophila, 1 Xanthomonas maltophilia. 
Anaerobes: 3 Propionchacterium species (1 P. 
acnes), 1 Prevatella species. 
Mycobacteria: 1 Mycchacterium avium-in-
tracellulare complex, 1 Mycchacterium species. 
CSF isolates and meningitis reports 
Eleven reports of meningitis were received 
(Table 7). Four cases of meningococcal 
group C meningitis were reported by the 
South West Area Pathology Service, Liver-
pool. All cases were investigated by the 
South West Sydney Public Health Unit. 
There was no link between the patients, and 
all recovered from the illness. 
Table 7. Lab DOSS reports of blood isolates, by organism and clinical information 
Clinical Information Risk Factors 
-0 
>- Q) VJ ... ti) 
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Stapht;la:ocrus aureus 36 2 1 1 1 8 8 10 1 
MRSA 9 1 2 
Stapht;lococc:us evidermidis 62 
Stapht;lococc:us coagulase negative 23 1 5 13 1 
Escherichia coli 52 1 6 27 2 1 10 2 1 
Klebsiella species 3 10 1 1 1 2 
Acinetobader spedes4 8 2 2 1 
Enterobacter species5 13 3 1 2 
Pseudcmonas aeru~nosa 8 1 1 1 2 1 
Candida species6 9 2 1 
1. Only organisms with 5 or more reports are included in this table. 
2. Staphylococcus hominis 1. 
3. Klthsiella pneumoniae 5, K. oxytoca 1. 
4. Acinetcbader calcau:eticus 7 (var l woffi 2, var anitratus 1). 
5. Enterobader doacae 7, E. aerogenes 2, E. agglomerans 2. 
6. Candida albicans 5, C. tropicalis l, C. plrapsilosis 1, C. krusei 1. 
Iii t I 
\ ·olwne 17, Nwnber 11 
Isolates from sites other than blood or CSF 
Peritoneal dialysate: 1 Staphylococcus aureus, 
l Staphylococcus epidermidis. 
Joint fluid: 5 Staphylococcus aureus, l Enter~ 
bacter species. 
Other: 1 Haemophilus influenzae group b (55 
yearold female), 1 Klebsiellaoxytoca, l Pseud~ 
monas aeruginosa, 2 coagulase negative 
Staphylococcus, l Streptococcus group A, 1 
Streptococcus 'milleri', l Mycchacterium tuber-
culosis. 
Table 8. LabDOSS reports of meningitis, by organism and age group 
<1 1-4 5-14 15-24 25-34 75 + 
On!anism month years years years years vears Total 
Neisseria menin;?itidis group C I 2 I 4 
Neisseria menin;?itidis group B I I 
Crt{Plococcus neoformans 1 I 2 
Haemovhilus influenzae type b 2 2 
Strevtococcus group B 1 1 
Strevtococcus vneumoniae 1 1 
Total 2· 3 2 2 1 1 11 
COMMUNICABLE DISEASES INTELLIGENCE 
Volume 17, Number 12 - 14 June 1993 
Sterile Sites Surveillance 
(LabDOSS) 
Data for this fortnight have been provided 
by 4 laboratories. The CD/ welcomes Sulli-
van Nicolaides Pathologists, Queensland to 
the laboratory surveillance schemes. A total 
of 124 reports have been included: Sullivan 
Nicolaides Queensland 91, Royal Hobart 
Hospital 28, Northern Tasmanian Pathology 
Service 3, TB Lynch Pathologists, Rock-
harnpton 2. 
Organisms reported 5 or more times from 
blood are detailed in Table 3. Other blood 
isolates not included in Table 3 were: 
Gram positive: 1 Streptococcus Group B, 2 
Streptococcus 'milleri' /group F, 2 Streptococ-
cus sanguis, 2 Streptococcus 'viridans', 2 
Streptococcus mitis, 1 Streptococcus hominis, 1 
Streptococcus pneumoniae, 2 Corynebacterium 
species, 3 Enterococcus faecalis, 1 Bacillus spe-
cies, 1 Arcanchacterium haemolyticum, 1 
Micrococcus species. 
Gram negative: 1 SalmonellaTyphi (Queens-
land report, 13 yearold male, recent travel to 
Indonesia), 1 Enterchacter aerogenes, 1 Serratia 
marcescens, 1 Pseudomonas aeruginosa, 1 
Haemophilus infl.uenzae type b (10 month old 
male), 1 Vibrio species, 2 Prot.eus mirabilis. 
Y ersinia enterocolilica, Branham.el/a species 
and Acinetchacter species were all isolated 
from a 42 year old male with endocarditis 
and HIV. 
Anaerobes: 3 Bacteroides fragilis, I Clostrid-
ium species, 2 Fusobacterium species, 1 
Peptostreptococcus species. 
Fungi: 1 Candida albicans, 1 Candida species. 
Isolates from Sites other than Blood or CSF 
Peritoneal dialysate: 1 Staphylococcus epider-
midis. 
Joint fluid: 2 Staphylococcus aureus. 
Other: 2 Staphylococcus aureus, 1 Staphylococ-
cus epidermidis. 
Reports of meningitis/ CSF isolates are 
summarised in Table 4. Also provided was 
a report of isolation of Bordetella pertussis 
from a nasopharyngeal aspirate in a female 
2 months of age (Tasmania). 
Table 3. Lab DOSS reports of blood isolates, by organism and clinical information 
Clinical Information Risk Factors 
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Stariiuloaxr:us aureus 202 2 1 1 1 2 
Stadt uloaxr:us evidermidis 9 1 1 1 1 2 
Stariiuloaxr:us coaS?Ulase negative 123 2 1 1 1 
Escherichia cdi 20 1 2 
Acincbader species 6 3 2 
Klebsiella species 84 2 1 1 
1. Only organisms with 5 or more reports are included in this table. 
2. MRSA 1. 
3. Stapiylococcus haemdyficus 1, S. warneri 1. 
4. Klrosiella pneumoniae 5, K. oxytoca 3. 
Volume 17, Nwnber 12 
Table 4. LabDOSS reports of meningitis, by organism and age group 
1-11 1-4 5-14 15-24 65-74 
Organism month years years years years Total 
s 
H~,ru...1vhilus influenme type b 1 1 2 
Stavh11lococcus aureus 1 1 
Staph11lococcus coagulase negative 1 1 
Strevtococcus group A 1 2 
Total 1 1 1 1 1 5 
I 
1u: 
COMMUNICABLE DISEASES INTELLIGENCE 
Volmne 17, Nmnber 13 - 28 June 1993 
Sterile Sites Surveillance 
(LabDOSS) 
Data for this fortnight have been provided 
by 9 laboratories. A total of 243 reports has 
been included (146 males, 96 females); 
ICPMR, Westmead 57, Royal Prince Alfred 
Sydney 67, Sullivan Nicolaides, Queensland 
13, IMVS, Adelaide 50, Royal North Shore 
Hospital, Sydney 35, Northern Tasmanian 
Pathology Service 8, Nambour Hospital, 
Queensland 5, Towoomba Pathology 6, Cen-
tral Queensland Pathology Service 2. 
Only reports of isolates collected after the 
first day of the previous month are included 
in the fortnightly CDI report. Additional 
data prior to this period have been included 
in the 1993 total LabOOSS file (Royal Prince 
Alfred 112 reports, IMVS 39 reports). 
Organisms reported 5 or more times from 
blood are detailed in Table 5. Other blood 
isolates were: 
Gram positive: 3 Streptococcus Group A, 4 
Streptococcus Group B (ages 2 months, 34 
years, 40 years, 66 years, 84 years), 1 Strepto-
coccus Group G, 4 Streptococcus 'milleri ', 2 
Streptococcus sanguis, 3 Streptococcus mitis, 1 
Streptococcus salivarius, 1 Streptococcus 'viri-
dans', 1 Streptococcus species, 1 
Arcanooacterium species, 1 Micrococcus spe-
cies. 
Gram negative: 3 Acinetooacter sp, 1 Citrooac-
ter diversus, 2 Pseudomonas cepacia, 1 
Pseudomonas pseudomallei (56 year old dia-
betic male), 4 Haemophilus influenzae (3 type 
b; 5 month old female with periorbi tal celluli-
tis, 13 month old female with epiglottitis, 71 
year old female), 1 Neisseria meningitidis 
group B (patient aged less than 1 year), 1 
Morganella morganii, 3 Proteus mirabilis, 1 Fla-
vobacterium species, 2 Xanthomonas 
maltophilia, 1 Pravidenciaalcalifaciens, 1 Cardio-
bacterium hominis (endocarditis, 22 year old). 
Anaerobes: 2 Bacteroides fragilis species, 1 
Peptostreptococcus species. 
Fungi: 4 Candida species (1 C. albicans,1 C. 
krusei). 
Most of the blood isolates of bacteria were 
from patients aged 55 and over (Figure 2). 
CSF isolates and meningitis reports 
There were 7 reports of CSF isolates and/ or 
meningitis (fable 6). 
Table 6. LabDOSS meningitis reports, by organism and age group 
Total 
1-11 1-4 35-44 55-64 75 + reporte 
d 
month years years years years Total this 
s year 
Haemovhilus influenzae type b 1 2 3 20 
Streptociccus pneumoniae 1 1 2 9 -
Vohnne 17. Number 13 
Figure 2. LabDOSS reports of blood 
isolates of bacteria, by age group 
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Isolates from Sites other than Blood or CSF 
Peritoneal dialysate: 1 Enterooacter cloocae, 2 
Staphylococcus aureus, 7 Staphylococcus epider-
midis, 2 Staphylococcus coagulase negative, 1 
Streptococcus species, 1 Streptococcus group D 
(non enterococcal). 
Joint fluid: 4 Staphylococcus aureus, I Staphy-
lococcus coagulase negative, 1 Streptococcus 
Group G. 
Other: 1 Aspergillus species, 1 Bacillus spe-
cies, 1 Carynebacteriumspecies, 1 Enterococcus 
species, 2 Escherichia col.i, 1 Kingella kingae, 1 
Serratia marcescens, 1 Staphylococcus aureus, I 
Candida species. 
Hospital acquired infections 
Accurate case definitions of hospital ac-
quired infection are complex. The LabOOSS 
scheme arbitrarily accepts 'hospital ac-
quired' as a risk factor if the infection was 
acquired greater than 48 hours after admis-
sion. This risk factor was reported for 42 of 
the 206 reports of bacteraemia. IV lines were 
listed as a risk factor in 22, 10 patients were 
immunocompromised and 7 had undergone 
surgery. 
The organisms implicated were: 1 Acineter 
bacter species, 2 Enterooacter cloacae, 2 
Enterococcus faecalis, 8 Escherichia col.i, 2 
Klebsiella oxytoca., 3 Klebsiella pneumoniae, I 
Prcieus mirabilis, 2 Pseudomonas aeruginosa, 2 
Serratia marcescens, 8 Staphylococcus aureus, I 
Staphylococcus coagulase negative, 7 Staphy-
lococcus epidermidis, 1 Streptococcus group B, 
I Streptococcus 'milleri', 1 Xanthomonas mal-
tophilia. 
COMMUNICABLE DISEASES INTELLIGENCE 
Volume 17, Number 14 - 12 July 1993 
Sterile Sites Surveillance 
(LabDOSS) 
Data for this fortnight have been provided 
by 5 laboratories. A total of 111 reports have 
been included: 
Royal Hobart Hospital 30, Liverpool Hospi-
tal 68, Northern Tasmanian Pathology 
Service 7, TB Lynch Pathologists - Rock-
hampton2, Toowoomba General Hospital 4. 
Organisms reported 5 or more times from 
blood are detailed in Table 5. Other blood 
isolates not included in Table 5 were: 
Gram positive: 2 Streptococcus Group B (1 
neonate), 1 Streptococcus Group G, 1 Strepto-
coccus Group F, 1 Streptococcus milleri, 1 
Streptococcus sanguis, 1 Corynebacterium 
jeikeium (I-ITV), 1 Enterococcus faecalis, 1 En-
terococcus faecium, Lactooacillus leichmannii. 
Gram negative: 1 Flavimonas oryzihabitans (4 
year old male), 3 Acinetooacter species, 3 
Klebsiella species, 1 Klebsiella oxytoca, 1 Entero-
bacter cloacae, 1 Enterooader species, 1 Serratia 
liquefaciens, 3 Pseudomonas aeruginosa l 
Pseudomonas paucimobilis, 1 Neisseria meningi-
tidis (group Y in a 53 year old male), 1 
Salmonella Typhimurium species, 1 Xantho-
monas maltophilia, 1 Providencia species, 1 
Pasteurella multocida. 
Anaerobes: 1 Bacteroides fragilis, l Clostrid-
ium tertium, 2 Fusobacterium species, 1 
Peptostreptococcus species. 
Fungi 1: Candida parapsilosis. 
Ages of patients with bacterial blood isoaltes 
ranged from less than one month to over 75 
years (Table 6). 
Peritoneal dialysate: 1 Fusarium species, 2 
Staphylococcus epidermidis. 
Joint fluid: 1 Staphylococcus epidermidis, 1 
Streptococcus Group G. 
Other: 1 Staphylococcus aureus, l Escherichia 
coli. 
Figure 5. LabDOSS reports of blood 
isolates, by age group 
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Table 5. Lab DOSS reports of blood isolates, by organism and clinical information 
: 
Clinical Information Risk. Factors 
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Sta.,Jiyloaxrus aureus 2 1 1 2 1 6 15 336 
Sta,:J11;lococcus epidermidis 5 101 
Stawl{lococcus coagulase negative 3 1 1 1 8 142 
Streptococcus pneumoniae 4 7 66 
Escherichia cdi 5 11 3 22 425 
Haemophilus influenz.ae4 3 1 5 34 
1. Only organisms with 5 or more reports are included in this table. 
2. MR5A 1. 
3. S. warneri 1, S. hcminis 1. 
4. Type b 3 (18 months, 4 years, 26 years). 
Voh.nne 17, Nwnber 14 
Table 6. Lab DOSS meningitis reports, by organism and age group 
Total 
1-4 5-14 15-24 25-34 35-44 75+ reported 
years vears vears vears years years Total this year 
Propionibacterium species 1 1 1 
Haemcn;t1ilus influenzae 1 (type b) 1 (no tvoe) 2 22 
Streptocoa::us ,meumoniae 1 1 10 
Cryplococcus neoformans 20 
var neoformans 1 (HIV) 
var !<aiti 1 (HIV) 
COMMUNICABLE DISEASES INTELLIGENCE 
Volume 17, Number 15 - 26 July 1993 
Sterile Sites Surveillance 
(LabDOSS) 
Data for this fortnight have been provided 
by 11 laboratories. CDI welcomes Woden 
Valley Hospital, ACT to the LabOOSS 
scheme. 
A total of 272 reports have been included: 
Liverpool Hospital 27, Royal North Shore 
Hospital 27, Northern Tasmanian Pathology 
Service 8, Nambour Hospital 9, Gosford 
Central Coast Hospital Services 28, 
Toowoomba General Hospital 16, West-
mead 60, Woden Valley Hospital 22, 
Tamworth Laboratory, New England Pa-
thology 8, Sullivan and Nicolaides Partners, 
Brisbane 18, Institute of Medical and Veteri-
nary Science, Adelaide 49. 
The LabOOSS scheme received 3 reports of 
Listeria monocytogenes this fortnight from 3 
laboratories (2 NSW, 1 ACT). Risk factors 
were identified in two patients. One was a 70 
year old male with meningitis and a history 
of renal failure and the second was a 22 year 
old male with a history of injecting drug use. 
The third case was a 65 year old female with 
meningitis. The three isolates have been for-
warded to the Microbiological Diagnostic 
Unit, University of Melbourne, for typing. 
Organisms reported 5 or more times from 
lood are detailed in Table 2. Other blood 
isolates were: 
Gram positive: 3 Streptococcus Group B (1 
neonate, 73 year old female, 71 year old 
male), 1 Streptococcus Group F, 2 Streptococcus 
Group G, 3 Streptococcus 'milleri', 4 Strepter-
coccus sanguis, 1 Streptococcus mitis, 3 
Streptococcus species, 3 Corynebacteriumspe-
cies, 2 Corynebacterium jeikeium 
(immunocompromised females, 28 years 
and 31 years), 3 Enterococcus species, 3 Enterer-
coccus faecalis, 2 Enterococcus faecium, 1 
Listeria monocytogenes, 1 Bacillus species. 
Gram negative: 1 Acinetooader species, 3 
Klebsiella species, 1 Klebsiella oxytoca, 1 En-
terooacter aerogenes, 4 Enterooacter cloocae, 2 
Serratia marcescens, 1 Citrooacter species, 4 
Haemophilus in fiuenz.ae type b (2 years, 3 
years, 6 years, 59 years), 1 Haemophi /us parain-
fl uenz.ae, l Proteus mirabilis, 1 Flavobacterium 
species, 1 Aeromonas species, 2 Xanthomonas 
maltophilia, 1 Eikenella corrcxlens. 
Anaerobes: 1 Bacteroides species, 1 Bacteroides 
thetaiotaomicron, 1 Bacteroides avatus, 2 Clos-
tridium species, 1 Peptostreptococcus species, 1 
Propionooacterium species, 1 Propionooac-
terium acnes. 
Fungi: 1 Candida species, 2 Candida albicans. 
Table 2. LabDOSS reports of blood isolates, by organism and clinical information 
Clinical Information 
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Most isolates were from patients aged over 
15 years (Figure 1). 
CSF isolates and meningitis reports 
Eighteen reports of CSF isolates and/ or 
meningitis were received this fortnight (Ta-
ble 3). 
Isolates from sites other than blood or CSF 
Peritoneal dialysate: 1 Candida species, 1 
Acinetobacter species, 1 Klebsiella oxytoca, 1 
Escherichia coli, l Streptococcus 'viridans', 1 
Staphylococcus aureus, l Bacteroides fragilis. 
Pleural fluid: 1 Corynebacterium species, 1 
Enterococcus species, 1 Peptostreptococcus spe-
cies. 
Other: 1 Leuconostoc species, 1 Bran1zamella 
catarrhalis, l Cryptococcus neoformans, l En-
terococcus faecalis, l Escherichia coli, 1 
Staphylococcus aureus. 
Figure 1. Lab DOSS reports of isolates from 
blood, by age group 
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Table 3. Lab DOSS meningitis reports, by organism and age group 
Total 
<1 1-11 1-4 5-14 25-34 35-44 65-74 reported 
: 
month months years Total' this vear years years years years 
Listeria monocvf o~es 2 2 3 
Haemorliilus in{luenzae 2 (type b) 1 3 22 
Streptococcus pneumoniae 2 2 10 
Crypfococcus neoformans 1 1 
var neoformans 1 1 19 
var ~atti 1 1 
Enterococcus faecalis 1 1 1 
Serratia marcescens 1 1 2 
Stavht/lcx:occus aureus 1 1 4 
Streptcx:occus 'viridans' 1 1 1 
Neisseria meningitidis group B 2 2 
group Z 1 1 16 
ungrouped 1 1 
COMMUNICABLE DISEASES INTELLIGENCE 
Volume 17, Number 16 - 9 August 1993 
Sterile Sites Surveillance 
(LabDOSS) 
Data for this fortnight have been provided 
by 8 laboratories. CDI welcomes Sir Charles 
Gairdner Hospital, Western Australia to the 
LabDOSS scheme. 
A total of 108 reports have been included: Sir 
Charles Gairdner WA 30, Liverpool Hospital 
NSW 16, Woden Valley Hospital ACT 31, 
Sullivan Nicolaides Qld 8, Northern Tasma-
nian Pathology Service 8, Nambour Hospital 
Qld 6, TB Lynch Pathologists, Rockhampton 
QLD 7, Central Queensland Pathology Serv-
ice 2. Woden Valley Hospital supplied 
additional data for the period April to June 
1993. These data have been merged into the 
total 1993 file. 
Organisms reported 5 or more times from 
blood are detailed in Table 5. 
Other blood isolates not included in Table 5 
were: 
Gram positive: 1 Streptococcus Group B , 1 
Streptococcus sanguis, 3 Streptococcus 'viri-
dans' , 1 Streptococcus species, 1 
Corynebacterium JK species, 1 Lactococcus ere-
marts 
Gram negative:l Salmonella species (age 2 
years, failure to thrive), 1 Acinetobacter spe-
cies, 3 Klebsiella pneumoniae, 1 Klebsiella 
oxytoca, 1 Enterooacter doocae, 1 Enterooacter 
species, 1 Pseudomonas aeruginosa, 1 Pseudo-
monas species, 1 Neisseria meningitidis group 
B (1 year old female, QLD), 1 Providencia 
species, 3 Proteus mirabilis, 1 Xanthomonas 
maltophilia. 
Anaerobes: 1 Bacteroides species, 1 Bac-
teroides thetaiotomicron, 1 Propionobacterium 
acnes. 
Fungi: 3 Candida species (2 C. albicans). 
Most isolates were from patients over the age 
of 45 years (Figure 4). 
Figure 4. LabDOSS reports of isolates from 
blood, by age group 
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Table 5. LabDOSS reports of blood isolates, by organism and clinical information 
Clinical Information Risk Factors 
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S tar}i t/lococcus au reus 2 4 1 2 1 10 343 
S tar}i t/lococcus eui derm id is 1 8 108 
Stadit,'lococcus coaeulase negat-ive3 1 6 160 
Enterococcus species 4 5 71 
Strerioca::cus 17T1eumoniae 2 5 73 
Escherichia coli 2 1 1 16 434 
l. Only organisms with 5 or more reports are included in this table. 
2. MRSA l. 
3. Stap1ylococcus capitis 2, S. haemolyticus 1, S. hominis 1, S. saprq:l1yloticus 1. 
4. Enterococrus faeailis 3, E. faecium 1. 
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Table 6. LabDOSS meningitis reports, by organism and age group 
1-4 5-14 
years years 
Haemophilus influen:uze type b 1 
H aemovhilus varaintluenzae 1 
Klebsiella pneumaniae 
Neisseria menin~tis group B 
Streptococcus pneumaniae 1 
CSF Isolates and meningitis reports 
There were 46 reports of CSF isolates 
and/ or meningitis (fable 6). 
Isolates from sites other than blood or CSF 
Peritoneal dialysate: 1 Staphylococcus aureus, 
I Streptococcus 'milleri', 1 coagulase negative 
Staphylococcus. 
Joint fluid: 3 Staphylococcus aureus, 1 Group 
G Streptococcus. 
Total 
25-34 35-44 55-64 reported 
years years years Total this year 
1 2 24 
1 1 
1 1 2 
1 1 8 
1 11 
Other: 3 Escherichia coli, 4 Corynebacterium 
species, 1 Enterococcus faecalis, I Haemophilus 
influenzae (no type provided), 2 Pseudomonas 
aeruginosa, I Serratia marcescens, I Staphylococ-
cus aureus, I coagulase negative 
Staphylococcus, I Staphylococcus epidermidis. 
COMMUNICABLE DISEASES INTELLIGENCE 
Volume 17, Number 17 - 23 August 1993 
Sterile Sites Surveillance 
(Lab DOSS) 
Data for this fortnight have been provided 
by6 laboratories. A total of 119 reports have 
been included: IMVS Adelaide 57, Woden 
Valley Hospital ACT 16, Northern Tasma-
nian Pathology Service 24, Royal Hobart 
Hospital 7, Central Queensland Pathology 
Service Mackay 4, Sullivan Nicolaides 
Queensland 11. 
Organisms reported 5 or more times from 
blood are detailed in Table 2. Other blood 
isolates not included in Table 2 were: 
Gram positive: 2 Streptococcus sanguis, 2 
Streptococcus 'viridans', 2 Group B Streptococ-
cus, 2 Group A Streptococcus (1 year old 
female and 55 year old female), 1 Streptococ-
cus species, 1 coagulase negative 
Staphylococcus, 3 Enterococcus faecalis, 1 En-
terococcus species. 
Gram negative: 2Haemophilus injluenzae type 
b (both epiglottitis, 4 year old female and 5 
year old male), 1 Haemophilus influenzae (no 
type, 22 year old male), 1 Acinetooacter spe-
cies, 1 Serratia marcescens, 1 Proteus mirabilis, 
1 Enterooacter species, 2 Enterooacter aero-
genes, 1 Enterooacter cloacae. 
Anaerobes: 1 Fusooacterium species, 1 Bac-
teroides thetaiotomicron, 1 Clostridium 
perfringens. 
Fungi: 1 Candida albicans, 2 Candida species. 
Most isolates were from patients over the age 
of 55 years (Figure 4). 
CSF isolates and meningitis reports 
One report of meningitis was received, Cryp-
tococcus neofarmans var neoformans in a 40 
year old male with HIV. 
Isolates from sites other than blood or CSF 
Peritoneal dialysate: 1 Flavimonas oryzihabi-
tans, 1 Staphylococcus epidermidis, 1 coagulase 
nega~ve Staphylococcus, 1 Pseudomonas 
aerugmosa. 
Joint fluid: 1 Haemophilus injluenzae type b, 6 
Staphylococcus aureus, 1 Escherichia coli. 
Other: 1 Candida albicans, 1 Enterooacter cloo-
cae, 1 Escherichia coli, 1 Klebsiella oxytoca, 3 
Staphylococcus aureus. 
Figure 4. LabDOSS reports of blood 
isolates by age group 
<Im 1-4y 15-24y 35-44y 55-o4y 7&-j+ 
1-llm 5-14y 25-34y 45-54y 65-74y 
AGE GROUP 
Table 2. LabDOSS reports of blood isolates, by organism and clinical information 
Clinical Information Risk Factors 
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: ltl C: :-·.:.u g :, . ... -~ 8' ·5 - :-:- 11:1 .. : .... - 2 · . ... -::, C: <.O -c .·: f-, <n ltl : 
~ 
(l/ --... ... C: -- > t 0 .!S a, a, ·s C: -: ... ~ . I- -::, . (l,I ·5. ltl Total (l,I I- ltl (l/ C: c:; : (l,I 
~ - C: C: ~ .E : o C: ",:j <.O - ~ reported ~ 0 C: ltl ·.: ~ :, E > (l/ .. Organism ...J {JJ 0 ;:::> (J) (J) .... - ::r: z Total1 this year 
Star:J-rvloca::cus aureus 3 1 1 1 3 3 7 232 365 
S ta,11 yloca::cus epi derm id is 2 1 2 8 116 
Stre,ioca::cus pneumoniae 4 5 78 
Escherichia cdi 1 6 5 1 5 1 20 454 
Klebsiella species 1 3 1 1 1 i3 130 
Pseudomonas aeruKinosa 1 1 3 1 1 6 98 
1. Only organisms with 5 or more reports are included in this table. 
2. MRSA 1. 
3. Klebsiella pneumoniae 5, K. oxytoca l. 
COMMUNICABLE DISEASES INTELLIGENCE 
Volume 17, Number 18 - 6 September 1993 
Sterile Sites Surveillance 
(Lab DOSS) 
Data for this fortnight have been provided 
by 8 laboratories. A total of 235 reports have 
been included: Gosford Central Coast Hos-
pital Services 25, Liverpool Hospital 62, 
Nambour Hospital 5, Royal Hobart Hospital 
14, Royal North Shore Hospital 30, Royal 
Prince Alfred Hospital 58, Sullivan and Ni-
colaides Partners, Brisbane 13, Woden 
Valley Hospital, ACT 28. 
Organisms reported 5 or more times from 
blood are detailed in Table 3. Other blood 
isolates not included in Table 3 were: 
Gram positive: Bacillus species 1, Corynebac-
terium species 1, Enterococcus faecalis 3, 
Enterococcus faecium l, Streptococcus bavis l, 
Streptococcus group A 3, Streptococcus group 
B 4 (2 neonates), Streptococcus group G 1, 
Streptococcus sanguis 3, Streptococcus viridans 
3, Streptococcus salivarius l, Streptococcus mitis 
2, Streptococcus species 3, Ladococcus lactis l, 
Micrococcus species 1. 
Gram negative: Acinetcbacter species 2, Ac-
inetcbacter calcoaceticus var lwoffii l, 
Branhamellacatarrhalis l, Citrcbader freundii l, 
Citrobacter species 1, Entercbacter aerogenes l, 
Entercbacter species 1, Flavobacterium mul-
tivorum l, Haemophilus influenz.ae 3 (one type 
b epiglottitis age 2, 2 no type ages 5 and 36), 
Klebsiella species 2, Morganella morganii l, Pro-
teus mirabilis 1, Providencia species 1, 
Pseudomonas fluorescens l, Pseudomonas pauci-
mobilis 2, Pseudomonas stutz.eri l, Pseudomonas 
pseudomallei l (diabetic recent travel to Bor-
neo), Pseudomonasspecies 1, SalmonellaTyphi 
l, Serratia marcescens l. 
Anaerobes: Bacteroides fragilis 3, Clostridium 
perfringens 2, Clostridium species 2, Fuscbac-
terium species 1, Propionibacterium acnes l. 
Fungi: Candida albicans 2. 
Most patients were over the age of 55 years 
(Figure 4). 
CSF isolates and meningitis reports 
There were 9 reports of CSF isolates and/ or 
meningitis (Table 4). 
Isolates from sites other than blood or CSF 
Joint fluid: Escherichia coli 2, Staphylococcus 
aureus l. 
Peritoneal dialysate: Enterococcus faecalis l, 
Pseudomonas fluorescens l, Staphylococcus 
epidermidis l. 
Other: Bacteroides fragilis l, Peptostreptococ-
cus species 1, Staphylococcus aureus l, 
Propionibacterium acnes l, Proteus 
mirabilis l, Staphylococcus aureus l, Streptococ-
cus group A 1. 
Table 3. LabDOSS reports of blood isolates, by organism and clinical information 
Clinical Information Risk Factors 
-0 
c (2) -0 <ll 
"' (l,I 0 «: QI ... : - g «: c:: ..... ::, ... f1l u 
8 ... ·o ·..::: "' (!I ... :, c:: "' -0 (2) E- f1l llJ ·5 (l,I 0 ... ... C: c c ~ llJ ::::::: (!I ·5 c:: ..... ..... ... ~ (l,I llJ Total (2) .t: ff:! (2) :, c:: ·o. C: Q> 
~ c:: ~ E C "'O "' C: - "' 0 reported 0 0 C: ff:! ·c :Q ::, E > 0 Q> Organism i:i::i ...J w . c., ~ C./) C./) - ...... ::c z Total1 this year 
Star:tilliococcus aureus 5 1 7 5 7 10 492 4593 
Sta-,:;nlliococcus euidennidis 1 1 3 7 135 
Stad1t!lococcus coagulase negative 1 1 1 2 1 9 171 
Strevlococcus pneumoniae 1 9 2 2 17 100 
Escherichia coli 5 10 2 4 9 1 1 36 518 
Entercbader cloacae 1 1 2 1 5 53 
Klebsiella oxvtoca 1 1 1 5 31 
Klebsiella rmeumoniae 3 4 8 92 
Pseudomonas aeruginosa 1 2 1 2 7 12 118 
1. Only organisms with 5 or more reports are included in this table. 
2. MRSA 5. 
3. MRSA 24. 
Yolwne 17. Nwnbcr 18 
Table 4. Lab DOSS meningitis reports, by organism and age group 
1-4 5-14 
years years 
Neisseria meningitidis group B 1 
Stam vloaxrus aureus 
Stawv/ococcus epidermidis 
Stre,ioax:cus group A 
Haemophilus influenzae tvpe b 2 
Cryptoccx:cus neoformans 
var neoformans 
• includes all Neisseria meningitidis serogroups. 
Total 
15-2A 25-34 35-44 75+ reported 
years years years years Total this year 
1 2 20· 
1 1 5 
1 1 2 
1 1 3 
2 26 
1 HIV 1 HIV 2 22 
Figure 4. Lab DOSS reports of blood 
isolates by age group 
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COMMUNICABLE DISEASES INTELLIGENCE 
Volume 17, Number 19 - 20 September 1993 
Sterile Sites Surveillance 
(Lab DOSS) 
Data for this fortnight has been provided by 
9 laboratories. CDI welcomes Ipswich Hos-
pital, Queensland to the LabOOSS Scheme. 
Their 87 records have been merged into the 
total 1993 file. 
A total of 249 reports have been included: 
ICPMR, Westmead 25, Institute of Medical 
and Veterinary Science, Adelaide 76, North-
ern Tasmanian Pathology Service 21, Royal 
North Shore Hospital, Sydney 41, Sir Char-
les Gairdner Hospital, Western Australia 24, 
Sullivan and Nicolaides Partners, Queens-
land 10, Tamworth Laboratory 3, 
Toowoomba Pathology Laboratory 8, 
Woden Valley Hospital, ACT 41. 
Organisms reported 5 or more times from 
blood are detailed in Table 5. Other blood 
isolates not included in Table 5 were: 
Gram positive: Corynebacterium jeikeium 2 
(associated with IV lines), Enterococcus fae-
calis 4, Enterococcus faecium 1, Enterococcus 
species 2, Streptococcus group A 4, Streptococ-
cus group B 2 (74 year old female, 23 year old 
male), Streptococcus group D non-€nterococci 
1, Streptococcus group G 2, Streptococcus 
'milleri' 1, Streptococcus sanguis 2, Streptococ-
cus viridans 1, Streptococcus species 2, Nocardia 
asteroides 1. 
Gram negative: Acinetobacter species 1, En-
terchacter aerogenes 2, Enterchacter cloacae 2, 
Enterchacter species 1, Klebsiella oxytoca 4, 
Klebsiella species 4, Neisseria meningitidis 
Group C 1 (14 year old female), Pseudomonas 
species 1, Serratia species 2. 
Figure 6. LabDOSS reports of blood 
isolates, by age group 
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Table 5. Lab DOSS reports of blood isolates, by organism and clinical information 
Clinical Information Risk Factors 
"O 
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rJl QI _g 11:1 Q/ ... ... 
11:1 C: u g ff ... <I) := .... ·5. ·.;::: <I) 11:1 
C: <I) Q/ ~ ::s a:s "O .... rJl 2 QI ... C: t t: 0 - ~ ... 11:1 ·o C: .2 --- ... ~ ::s QI . 'a. .· ~ Total QI QI ... a:s ~ C: C: ~ .... C: C: E 0 C: "O rJl ·.: ... - ~ reported 0 0 C: 11:1 32 ::s E > QI Ors!anism ~ ....l ~ C.J ~ rJJ rJJ .... - .:c z Total1 •·• this vear 
Sta,Jiyloroa::us aureus 1 4 3 1 11 8 9 5 5 1 502 5363 
Stam vloroa::us evidermidis 2 4 2 5 15 160 
Stadivloax:cus coagulase negative 1 1 1 3 1 10 183 
Streploroa::us pneumoniae 11 2 15 118 
Escherichia cdi 13 1 9 2 1 34 557 
Haemophilus influenzae 1 2 54 45 
Klebsiella rmeumoniae 2 1 2 1 9 102 
Prdeus mircvilis 4 2 1 5 49 
Pseudomonas aeru~na;a 3 1 1 2 6 3 12 134 
1. Only organisms with 5 or more reports are included in this table. 
2. MRSA6. 
3. MRSA 51. 
4. 2 type b. 
Vohnne 17, Number 19 
Table 6. LabDOSS meningitis reports, by organism and age group 
: 
: 1-4 5-14 
years years 
Neisseria meningitidis group B 
Neisseria menin~tidis group C 
Streptococcus pneumoniae 1 
1. All Neisseria meningitidis serogroups. 
Anaerobes: Bacteroides fragilis 3, Bacteroides 
species 1, Bacteroides thetaiotaomicron 1, Clos-
tridium septicum 1, Propionibacterium acnes 2. 
Fungi: Candida species 2, Candida albicans 2. 
Most patients were over the age of 55 years 
(Figure 6). 
CSF isolates and meningitis reports 
There were 4 reports of CSF isolates and/ or 
meningitis (Table 6). 
Isolates from sites other than blood or CSF 
Joint fluid: Enterobacter species 1, Pseudo-
monas aeruginosa 1, Staphylococcus aureus 6, 
Streptococcus Group B 1, Streptococcus pneu-
moniae 1, Streptococcus species 1. 
Peritoneal dialysate: Staphylococcus aureus 3, 
Staphylococcus epidermidis 4, Streptococcus 
sanguis 2. 
Other: Clostridium perfringens 1, Corynebac-
terium xerosis 1, EnterdJacter cloa.cae 1, 
Enterococcus species 1, Escherichia coli 4, 
Staphylococcus aureus 3, Staphylococcus epider-
midis 3, Pseudomonas aeruginosa 1. 
Total 
15-24 25-34 55~64 75+ reported 
years years years years Total this year 
1 1 
1 1 231 
1 2 13 
Figure 7. La bDOSS Streptococcus 
pneumoniae isolates 1992 to 1993 
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The winter seasonal trend of Streptococcus 
pneumoniae reports is shown in Figure 7. 
COMMUNICABLE DISEASES INTELLIGENCE 
Volume 17, Number 20- 4 October 1993 
Sterile Sites Surveillance 
(Lab DOSS) 
Data for this fortnight has been provided by 
5 laboratories. 
A total of 51 reports have been included: 
Central Queensland Pathology Laboratory, 
Mackay 4, Nambour General Hospital 10, 
Northern Tasmanian Pathology Service 8, 
Sullivan and Nirolaides Partners, Queens-
land 11 and Woden Valley Hospital, ACTIS. 
Organisms reported 5 or more times from 
blood are detailed in Table 2. Other blood 
isolates not included in Table 2 were: 
Gram positive: Staphylococcus epidermidis l, 
Streptococcus group A 1, Streptococcus group 
G 1, Streptococcus pneumoniae 3, Streptococcus 
viridans l. 
Gram negative: Campylchacter jejuni l, 
Haemophilus influen7.ae type b 1 (61 year old 
female with acute epiglottitis), Klebsiella oxy-
toca l, Klebsiella pneumoniae 3, Neisseria 
meningitidis group B 1 (11 month old female), 
Pseudomonas aeruginosa 2. 
Anaerobes: Bacteroides fragilis 1, Fuschac-
terium species 1. 
Fungi: Torulopsis glabrata 1, Candida albicans 
1. 
Most patients were over the age of 55 years 
(Figure 4). 
CSF isolates and meningitis reports 
One report of meningitis was received, 
Haemophilus influenzae type bin an 11 month 
old female. 
Isolates from sites other than blood or CSF 
Joint fluid= Pseudomonas aeruginosa 1, Staphy-
lococcus aureus 3. 
Peritoneal dialysate: Staphylococcus epider-
midis l, Streptococcus viridans l. 
Other: Enterococcus species 1, Enterchacter 
species l, Escherichia ooli l, Staphylococcus 
aureus l, Staphylococcus coagulase negative 1, 
Streptococcus group A 1, Streptococcus sanguis 
1. 
Figure 4. LabDOSS reports of blood 
isolates, by age group 
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Table 2. Lab DOSS reports of blood isolates, by organism and clinical information 
1 I I 1 I 1 I I 6 I 5642 
2 I I I 5 I 198 
Escherichia coli 3 1 6 590 
1. Only organisms with 5 or more reports are included in this table. 
2. MRSA65. 
COMMUNICABLE DISEASES INTELLIGENCE 
Volume 17, Number 21 - 18 October 1993 
Sterile Sites Surveillance 
(Lab DOSS) 
Data for this fortnight have been provided 
by 6 laboratories. A total of 233 reports have 
been included - ICPMR, Westmead 143, 
Nambour General Hospital 3, Royal Hobart 
Hospital 18, Royal North Shore Hospital 39, 
Sullivan and Nicolaides Partners, Queens-
land 14, Woden Valley Hospital, ACT 16. 
Organis~ reported 5 or more times from 
blood are detailed in Table 4. 
Uncommon isolates reported this fortnight 
were: coryneform (CDC group AS l,Group 
F2 1, Oerskovia-like organism 1), Rothia den-
tocariosa 1, Brevibacterium species 1, CIX 
E0-3 group gram negative rod 1. 
Other blood isolates not included in Table 4 
were: 
Gram positive: Bacillus species 1, Corynebac-
terium jeikeium 1, Corynebacterium xerosis 1, 
Enterococcus faecalis 4, Staphylococcus epider-
midis 4, Streptotoccus group A 1, 
Streptotoccus group B 1 (term neonate), 
Streptococcus group G 1, Streptococcus 
'milleri' 2, Streptococcus sanguis 1, Streptococ-
cus salivarius 1, Lactobacillus casei 1. 
Gram negative: Acinetchader phnsonii 1, Ac-
inetchacter species 1, Aeromonas hydrophila 1, 
Enterchacter cloacae 3, Enterchacter agglomerans 
1, Enterchacter species 1, Flavchacterium in-
dologenes 1, Flavobacterium oryzihabitans 1), 
Gemella haemolysans 1, Haemophilus influenzae 
type b 3 (epiglottitis in a 6 year old female, 
pneumonia in a 75 year old male), Kingella 
kingae 1, Klebsiella oxytoca 1, Moraxella oslren-
sis 1, Prcieus mirabilis 2, Proteus vulgaris 1, 
Pseudomonas species 1, Serratia marcescens 4, 
Xanthomonas maltophilia 1. 
Anaerobes: Actinomyces israelii 1, Bacteroides 
fragilis 3, Bacteroides species 1, Bacteroides 
thetaiomicron 1, Clostridium tertium 1, Clostrid-
ium septicum 1, Clostridium species 1), 
Peptostreptococcus species 1, Prevotella buccalis 
1. 
Figure 7. LabDOSS blood isolates, by 
age group 
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Table 4. Lab DOSS reports of blood isolates, by organism and clinical information 
s tam vloaxcus aureus 3 3 3 1 8 5 7 6 372 6013 
Stadivloaxcus a:>a2t1lase nee:ative 2 2 5 1 3 29 I 1 1 42 240 
Strevtoaxcus rmeumoniae 4 1 
I 
6 13.5 
Escherichia cdi 3 10 1 2 6 3 26 616 
Klebsiella rmeumonia 2 2 1 2 3 2 9 98 
Pseudomonas aeru!l'inasa 1 1 3 2 3 8 146 
1. Only organisms with 5 or more reports are included in this table. 
2. lOMRSA. 
3. 75 MRSA. 
Vohnne 17, Nwnber 21 
Table 5. Lab DOSS meningitis reports, by organism and age group 
Enterchacter aero~es 1 1 3 
Eschericia coli 
Neisseria menin~tidis 31 
Provionibacterium acnes 
H aemOrJhilus in fluenzae type b 1 
Cryptoca:rus neeformans 
var neoformans 
Stariitiloroccus aureus 1 
Sta-,Ji,.j[oaxx:u.s coagulase negative 1 
1. Group C 2. 
2. l-IlV positive. 
3. Group C 8. 
Fungi: Candida parapsilosis l, Candida albicans 
4. 
Mycobacteria: Mycooacterium avium l, Myca-
bacterium intracellulare l. 
There were 20 blood isolates from patients 
aged less than one year and 74 from patients 
aged over 65 years (Figure 7). 
CSF isolates and meningitis reports 
There were 11 reports of CSF isolates and/ or 
meningitis this fortnight (Table 5). 
Isolates from sites other than blood or CSF 
12 
1 1 1 
3 'lf,3 
1 1 1 
1 28 
1 
14 
1 2 7 
1 4 
Peritoneal dialysate: Moraxella species l, 
Staphylococcus epidermidis l, Bacillus species l, 
Staphylococcus coagulase negative 3, Strepto-
toccus viridans 2, MRSA 1. 
Joint fluid: Staphylococcus aureus 4. 
Other: Staphylococcus aureus 4, Streptococcus 
viridans l, Candida parapsilosis 1, Acinetobacter 
species l, Escherichia coli l, Neisseria sicca l, 
Pseudomonas aeruginosa l, Serratia species 1, 
Staphylococcus coagulase negative 2. 
COMMUNICABLE DISEASES INTELLIGENCE 
Volume 17, Number 22 - 1 November 1993 
Sterile Sites Surveillance 
(LabDOSS) 
Data for this fortnight have been provided 
by 6 laboratories. A total of 124 reports have 
been included for this report: Institute of 
Medical and Veterinary Science, Adelaide 
53, Nambour General Hospital 5, Northern 
Tasmanian Pathology Service 7, Sir Charles 
Gairdner Hospital, Western Australia 30, 
Sullivan and Nicolaides Partners, Queens-
land 9, Woden Valley Hospital, ACT 20. 
Organisms reported 5 or more times from 
blood are detailed in Table 3. Other blood 
isolates not included in Table 3 were: 
Gram positive: Enterococcus faecalis 3, Enterer 
coccus species 1, Staphylococcus coagulase 
negative 4, Streptococcus Group A 1, Strepter 
coccus 'milleri' 2, Streptococcus sanguis l, 
Streptococcus 'viridans' 3. 
Gram negative: Enterchacter species 1, Flaver 
bacterium species 1, Haemophilus influenz.ae 
type b 1 (4 year old male), Klebsiella oxytcxa 2, 
Serratia marcescens 3. 
Anaerobes: Bacteroides fragilis 2, Bacteroides 
thetaiotaomicron 1, Clostridium species 1, Clos-
tridium perfringens l. 
Fungi: Candida species 3, Candida albicans 1. 
Most reports were for patients over the age 
of 44 years (Figure 9). 
CSF isolates and meningitis reports 
Neisseria meningitidis untypeable 1 (14 year 
old male), Staphylococcus aureus 1 (51 year 
old female). 
Isolates from sites other than blood or CSF 
Peritoneal dialysate: Staphylococcus epider-
midis 2, Streptococcus species 1. 
Joint fluid: Staphyloroccus aureus l, Es-
cherichia coli l. 
Pleural fluid: Staphylococcus aureus 2. 
Figure 9. LabDOSS reports by blood 
isolates, by age group 
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Table 3. Lab DOSS reports of blood isolates, by organism and clinical information 
St lcxxx:.cus aureus 3 1 1 6 4 8 2 11 24 6252 
Staphylcxxx:.cus epidermidis 1 1 1 2 6 10 15 185 
S trept cxxx:.cus pneumoniae 6 1 1 8 143 
Escherichia roli 4 I 5 1 3 3 19 635 
Klebsiella pneumoniae 2 1 4 2 3 11 130 
Pseudcmonas aeruKinosa 1 1 2 1 2 5 151 
1. Only organisms with 5 or more reports are included in this table. 
2. 75 MRSA. 
COMMUNICABLE DISEASES INTELLIGENCE 
Volume 17, Number 23 -15 November 1993 
Sterile Sites Surveillance 
(Lab DOSS) 
Data for this fortnight have been provided 
by seven laboratories. 
A total of 157 reports have been included: 
Royal Hobart Hospital 17, Liverpool Hospi-
tal 25, Royal North Shore Hospital 41, 
Northern Tasmania Pathology Service 4, Sul-
livan and Nicolaides Partners, Queensland 
16, Toowoomba Pathology Laboratory 25, 
Woden Valley Hospital ACT 29. 
A further 65 reports were received from Liv-
erpool Hospital with onset date of illness 
prior to the 1st of October. These records 
have been merged with 1993 data. 
Organisms reported 5 or more times from 
blood are detailed in Table 3. 
Other blood isolates not included in Table 3 
were: 
Gram positive: 1 Listeriamoncx:ytogenes (lym-
phoma) ,2 Streptococcus Group A, 2 
Streptococcus Group B (1 post partum), 2 
Streptococcus Group G, 1 Streptococcus 
'milleri', 1 Streptococcus sanguis, 2_ Streptococ-
cus mitis, I Streptococcus species, 2 
Corynebacterium species, 2 Enterococcus fae-
calis, I Enterococcus durans, 2 coagulase 
negative staphylococci, 1 Staphylococcus 
auricularis, 1 Staphylococcus lugdunensis (en-
docarditis). 
Gram negative: 1 Salmonella Typhi (from In-
donesia), 2 Acinetooacter species (1 
calcoaceticus ), 1 Serratia marcescens, 4 
Pseudomonas aeruginosa, I Pseudomonas pauci-
mobilis, 2 Haemophilus injluenzae (1 type b 
age 56, 1 not type b), 1 Aeromonas hydrophila, 
I Campylooacter jejuni, I Pasteurella multocida, 
2 Proteus mirabilis, l Xanthomonas maltophilia. 
Anaerobes: 1 Bacteroides fragilis, l Clostrid-
ium perfringens (neonate), 1 Fusobacterium 
mortiferum 
Figure 1. Lab DOSS reports of blood 
isolates, by age group 
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Table 3. Lab DOSS reports of blood isolates, by organism and clinical information 
S ta-,}i i/lococcus aureus 1 I I 2 I 1 I 2 I 5 I 5 I 3 I 7 I I I 252 I 6625 
S tadii/lococcus epidermidis 1 I 2 I I I I 1 I I I I 7 I 192 
Str~ococcus pneumoniae 4 5 156 
Escherichia cdi 1 6 4 7 32 683 
En tercbacter species 1 2 53 114 
Klebsiella species 1 1 2 3 1 1 94 217 
1. Only organisms with 5 or more reports are included in this table. 
2. MRSA 2. 
3. Enterchacter aerogenes 1, cloacae 3, agglomerens 1. 
4. Klebser1la pneumoniae 4, oxytoca 2. 
5. MRSA 75. 
Volwne 17, Nwnber 23 
Fungi: Candida albicans 4. 
Most reports were for patients over the age 
of 24 years (Figure 1). 
CSF isolates and meningitis reports 
Three cases of Neisseria meningitidis sero-
group C were reported in children in 
Sydney. The children were from the same 
family and developed illness on 15 October 
(Table 4). All three children survived. 
Chemoprophylaxis was administered to 
close contacts. The remaining two family 
members were Neisseria meningitidis group C 
nasopharyngeal carriers. No other carriers 
were identified in close contacts. No further 
cases occurred. 
(Liverpool Hospital and South West Area 
Pathology Service, NSW). 
Isolates from sites other than blood or CSF 
Joint fluid: 1 Enterococcus faecalis, 5 Staphylo-
coccus aureus, l Streptococccus group B. 
Peritoneal dialysate: 2 Escherichia roli, 1 Bac-
teroides fragilis, l Staphylococcus aureus, 4 
coagulase negative staphylococci. 
Other: 1 Enterococcus faecalis, l coagulase 
negative Staphylococcus, l Staphylococcus 
aureus, l Streptococcus group A. 
Table 4. Lab DOSS meningitis reports, by organism and age group 
Neisseria meninx-itidis 1 21 12 4 32 
Streptococcus Group A 1 1 4 
Enterobacter cloocae 14 1 1 
Haemodiilus influenzae 13 1 2 30 
Streptococcus pneumoniae 1 1 15 
l. Neisseria meningitidis group A. 
2. Neisseria meningitidis group C. 
3. Haemopiilus injluenme type b. 
4. Preterm neonate. 
COMMUNICABLE DISEASES INTELLIGENCE 
Volume 17, Number 24- 29 November 1993 
Sterile Sites Surveillance 
(LabDOSS) 
Data for this fortnight have been provided 
by 7 laboratories. A total of 138 reports was 
received this fortnight Sir Charles Gairdner 
Hospital, Western Australia 40, Liverpool 
Hospital, New South Wales 9, Sullivan Ni-
colaides, Queensland 9, IMVS Adelaide 46, 
Central Queensland Pathology Laboratory, 
Mackay 7, Nambour General Hospital 9, 
Northern Tasmanian Pathology Service 18. 
Organisms reported 5 or more times from 
blood are detailed in Table 4. Other blood 
isolates not included in Table 4 were: 
Gram positive: 1 Bacillus species,! Coryne-
bacterium jeikeium, 1 Corynebacterium species, 
2 Enterococcus species (1 E. faecalis), 4 Strepto-
coccus group B (3 adult females, 2 of whom 
died, 1 male aged 2 months), 1 Streptococcus 
group A, 1 Streptococcus group G, 1 Strepto-
coccus group D nonenterococci, 1 
Streptococcus equinus, 3 Streptococcus sanguis, 
1 Streptococcus 'milleri', 2 Streptococcus pneu-
moniae, l Streptococcus salivarius, 2 
Streptococcus mitis, 2 Streptococcus 'viridans' 
, 2 Streptococcus species. 
Gram negative: 1 Neisseria meningitidis (19 
year old male, Tasmania, awaiting sero-
group identification), 3 Acinetchacter 
species, 3 Klebsiella pneumoniae, 2 Klebsiella 
oxytoca, 3 Pseudomonas aeruginosa, l Proteus 
mirabilis, l Xanthomonas maltophilia, 2 Serratia 
marcescens, l Serratia species, 1 Citrchacter fre-
undii. 
Anaerobes: 3 Bacteroides fragilis, 2 Clostrid-
ium perfringens, l Peptostreptococcus species, 1 
Propionibacterium species. 
Fungi: 6 Candida species (3 C. albicans, l C. 
glabrata). 
Most patients were over the age of 55 years 
(Figure 10). 
CSF isolates and meningitis reports 
There were two reports of meningitis, 
Haemophilus influenz.ae type bin a 2 year old 
male, and Staphylococcus aureus in a 7 4 year 
old male. 
Isolates from sites other than blood or CSF 
Peritoneal dialysate: 1 Bacillus species, 1 
Pseudomonas aeruginosa, l Enterchader cloacae, 
1 Enterococcus faecalis. 
Joint fluid: 4 Staphylococcus aureus, 1 
Klebsiella species. 
~er: 1 Escherichia coli, 1 Streptomyces 
grzseus. 
Figure 10. Lab DOSS blood isolates, by 
age group 
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Table 4. Lab DOSS reports of blood isolates, by organism and clinical information 
Staphylococcus aureu.s 313111 121214131211 232 7853 
Staphylococcus epidennidis 1 I I I I 1 15 206 
Staphylococcus c:oagulase negative 1 I 2 I 1 6 256 
Escherichia roli 2 111 1 I 5 I I 1 24 707 
1. Only organisms with 5 or more reports are included in this table. 
2. 2MRSA. 
3. 175MRSA. 
COMMUNICABLE DISEASES INTELLIGENCE 
Volume 17, Number 25 -13 December 1993 
Sterile Sites Surveillance 
(Lab DOSS) 
Data for this fortnight have been provided 
by 3 laboratories. A total of 27 reports has 
been included: Sir Charles Gairdner Hospi-
tal, Western Australia 13, Sullivan 
Nicolaides Partners, Queensland 9, Woden 
Valley Hospital, ACT 5. 
Other blood isolates not included in Table 3 
were: 
Gram positive: 3 Staphylococcus aureus,1 
Staphylococcus haemolyticus, 2 Staphylococcus 
epidenmdis, 2 coagulase negative Staphylo-
cocci, 2 Streptococcus group G, 1 
Streptococcus' milleri', 1 Streptococcus pneunur 
niae l, Streptococcus mitis (endocarditis), 1 
Streptococcus mutans (endocarditis), 1 Strepto-
coccus species (endocarditis), 1 Enterococcus 
faecalis (endocarditis), 1 Listeria moncx:yt.o-
genes (neutropaenic 75 year old female). 
Gram negative: 3 Pseudonumoos aeruginasa. 
Anaerobes: Bacterades fragilis. 
CSF isolates and meningitis reports 
1 Haemophilus injluenzae type b (2 year old 
male), 1 Neisseria meningitidis group B (32 
year old male). 
Isolates from sites other than blood or CSF 
Joint fluid: 1 Staphylococcus aureus. 
Other : 1 Serratia marcescens, 1 group F Stre,r 
tococcus, 1 Enterococcus species. 
1.2 The LabDOSS Scheme : Analysis of data from January 1992 to September 1993 
A condensed form of the following article is to be submitted for publication in a 
refereed journal. I have prepared the article to a stage for comment by co-authors Dr 
Robert Hall and Dr Mahomed Patel. 
1.2.1 Introduction 
1.2.2 Methods 
1.2.3 Results 
• Overview of Reports, Patterns of Contributing Laboratories, Age 
and Sex Distribution 
• Common Organisms, Proportion of Sepsis by Age Group and Sex 
Distribution 
• Cases of Sepsis by Clinical Category; Endocarditis, Meningitis, 
Osteomyelitis and Septic Arthritis, Recent Surgery, 
Imm unocompromised 
1.2.4 Discussion 
1.2.1 Introduction 
A new laboratory based surveillance scheme for sepsis from invasive organisms was 
established in 1992. The purpose of the routine surveillance of organisms isolated in 
normally sterile sites was to : 
• Improve our understanding of epidemiology of disease caused by 
invasive organisms in Australia, 
• Monitor trends of disease caused by invasive organisms over time, e.g. seasonal 
or annual, 
• Identify emerging pathogens causing invasive disease, 
• Identify outbreaks, 
• Monitor geographic distribution of diseases across Australia, 
• Identify risk groups for disease e.g. sex, age, underlying disease, 
• Guide direction for further research and 
• To use the knowledge gained from surveillance to develop and evaluate public 
health policy e.g. vaccination for Haemophilus influenzae type b disease. 
(Refer Section 1 A New Surveillance Scheme Part 1 Development of LabDOSS) 
The scheme is operated by the Commonwealth Department of Human Services and 
Health and results are published in the Communicable Diseases Intelligence (CDI). 
The surveillance system is titled LabDOSS, an acronym for Laboratory Database of 
Organisms from Sterile Sites. LabDOSS is a passive surveillance scheme with 
voluntary contributions from microbiology laboratories across Australia. Contributing 
laboratories provide reports of organisms isolated from normally sterile sites. 
My role in establishing the scheme is outlined in Section 1.1 A New Surveillance 
Scheme, Development of LabDOSS. The vast majority of collation of laboratory 
reports, processing , sorting , screening for errors and duplicates and analysis of data 
for this report is my own work. 
1.2.2 Methods 
The definition of a normally sterile site is a site in the body that does not under 
normal healthy conditions contain any micro-organisms. Examples of samples of 
normally sterile sites are blood, cerebrospinal fluid, joint fluid, tissue samples such as 
spleen, liver, muscle. To be sterile the site must not have any connection out of the 
body. Access to a normally sterile site must be via an invasive instrument, needle or 
surgical implement. 
LabDOSS software for personal computers is provided to laboratories by the 
Commonwealth Department of Human Services and Health. The system is written in 
Epilnfo. Laboratories transfer data to the CDI by floppy disc, or telephone modem, 
on a fortnightly basis. Details of development of the scheme are outlined in the 
Section 1; A New Surveillance Scheme, Part 1 Development of LabDOSS. Data from 
the commencement of the scheme, 1st January 1992 through to the end of September 
1993 have been analysed. Reports of Haemophilus influenzae have been considered 
separately and analysed from January 1992 to December 1993 (refer section 1.3). 
Analysis of LabDOSS data has been performed using Epilnfo and Excel. There has 
been a progressive increase in the number of contributing laboratories over the 21 
month period. Proportions of reports per ten "contributing laboratory months " have 
been quoted to compare periods with a varying number of participating laboratories. 
One "contributing laboratory month" is defined as one laboratory providing reports for 
a period of one month. 
1.2.3 Results 
Total Number of Reports and Patterns of Contributing Laboratories 
There were 7,033 reports of organisms from normally sterile sites from January 1992 
to September 1993. Nineteen laboratories contributed to the scheme. The mean 
number of contributing laboratories per month was 13. Laboratories from 5 states and 
the ACT contributed; 73 percent of laboratories were from NSW and Queensland 
(Figure 1). Reports from contributing laboratories have increased slowly over time 
(Figure 2). There is little difference between the total numbers of reports for the 
periods of January to September 1992 ( n = 2901) and 1993 ( n= 3003). However, 
the number of contributing laboratories has changed over this period . The mean 
number of reports per contributing laboratory month was 30.9 for Jan to Sep 1992 
and 18.7 for the same period in 1993. This difference in the mean number of reports 
per contributing laboratory month in 1992 and 1993 is restricted to the months 
January to March (Figure 3). The distribution of laboratories contributing in this early 
phase of the scheme was skewed as 3 of the 4 contributing laboratories were 
servicing metropolitan teaching hospitals. Metropolitan hospital laboratories provide 
more reports of sepsis from sterile sites than country hospital or private laboratories 
(Figure 4). There was little difference in the number of reports per contributing 
laboratory month and a more even proportion of type of laboratory over the 
subsequent period April 1992 to September 1993 (Figures 3 and 5). One large 
teaching hospital laboratory provided data in 1992 but has not provided reports in 
1993. 
Figure 1: State Location of Contributing Laboratories, LabDOSS January 1992 to September 1993 
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Figure 2: Number of Reports in Each Sex per Month, LabDOSS January 1992 to September 1993 
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Figure 3: Number of Reports per Contributing Laboratory Month, LabDOSS January 
1992 to September 1993 
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Figure 5: Contributing Laboratoires by Month of Commencement and Hospital or Laboratory Type, LabDOSS 
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1.2.3 Results 
Age and Sex Distribution 
Reports of sepsis were more common in the young and elderly (Figure 6). There 
was a high proportion of reports in neonates compared with all children under 5 years 
of age (Figure 7). There was a slight predominance in males, the male to female 
ratio being 13: 10. 
Source of Isolate 
Eighty eight percent of reports were isolates cultured from blood, 3 percent from 
cerebrospinal fluid, 2 percent from peritoneal dialysate, 2 percent from joint fluid and 
5 percent from another normally sterile site e.g. fine needle aspirate specimen. 
Clinical information was not consistently provided as the data were supplied by 
laboratory staff who do not have direct contact with the patient. 
Figure 6: Number of Reports by Age Group, LabDOSS January 1992 to September 1993 
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Figure 7: Proportion of Reports by Age Group in Children under 5 Years of Age, LabDOSS January 1992 
to September 1993 
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1.2.3. Results, Common Organisms 
Common Organisms and Proportion of Sepsis by Age Group and Gender 
Thirteen organism species, or genera, accounted for 74 percent of reports (Table 1). 
Ninety genera were reported in total. Sepsis in males exceeds females in all age 
groups with the male to female ratio ranging from 11:10 in the elderly to 15:10 in 
infants under 1 year. Gram positive aerobic bacteria were reported more frequently 
than gram negative aerobic bacteria, anaerobes or fungi in all age groups except the 
elderly. The ratio of gram positive to gram negative organisms was highest in 
neonates and young adults aged 15 to 24 years; staphylococci, coagulase positive and 
negative, accounted mainly for this trend in these age groups. 
Staphylococcus species 
Staphylococci are presented in two groups , Staphylococcus aureus (coagulase positive 
Staphylococcus) and coagulase negative staphylococci (Table 1). Staphylococcus 
aureus is a well recognised significant invasive pathogen. The clinical significance of 
coagulase negative staphylococci is often difficult to assess. Coagulase negative 
staphylococci are common contaminating and non significant cultures from blood. 
Reports considered by laboratory staff as probable contaminants are not included in 
LabDOSS analysis. The large numbers of coagulase negative staphylococci in the 
remammg data suggests that some are contaminating organisms. Settings where 
coagulase negative Staphylococci have been shown to have a significant role are in 
immunocompromised patients, in patients with a prosthetic device such as a prosthetic 
joint or intravenous line and in neonates. 
Table 1: Percentage of Reports for Common Organisms Stratified by Age Group with Ratio of Males to Females for Each Isolate 
Total Number of Re orts 
Organisms 
Gram Positive 
Staphylococcus aureus 
Coagulase negative Staphylococci 
Streptococcus pneumoniae 
Group B Streptococcus 
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Group A Streptococcus 
Gram N ative 
Eschericia coli 
Haemophilus influenzae 
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Klebsiella pneumoniae 
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1.2.3 Results, Common Organisms 
Staphylococcus aureus 
Between 6 and 29 percent of reports in each age group were Staphylococcus aureus 
(Table 1). Sepsis in males exceeded females in all age groups except 1 to 4 years. 
The male to female ratio ranged from 11:10 ( 1 to 4 year age group) to 20:10 ( 45 
to 64 year age group). Reports of Staphylococcus aureus were the highest proportion 
of all reported organisms in all agegroups over 5 years of age. The proportion of 
bacteraemia attributable to Staphylococcus aureus was highest in the age group 5 to 
14 years. 
Clinical information was provided for 58 percent (29/50) of the reports of 
Staphylococcus aureus sepsis in children aged 5 - 14. Septic arthritis was reported in 
30 percent of cases and osteomyelitis in 18 percent of cases. Cases of septic arthritis 
were more common in males, the male to female ratio being 24: 10. In contrast, 
osteomyelitis was more common in females, the male to female ratio being 6: 10 . 
Initial analysis of reports by month of illness suggests a Winter peak (Figure 8). 
When adjusted by contributing laboratory month this Winter peak is less dramatic 
,' 
(Figure 9). 
Coagulase negative Staphylococci 
Coagulase negative Staphylococci ranged between 9 and 28 percent of all reports of 
invasive disease (Table 1 ). The proportion was highest in neonates, being 28 percent 
of all reports. There was a predominance of males in all age groups. The male to 
female ratio ranged from 11:10 (age groups 35 - 44 and 75+) to 28:10 (agegroup 1 
to 11 months ). There was no seasonal pattern in the reports. 
i 
Figure 8: Numbers of Staphylococcus aureus Reports by Month of Illness, LabDOSS January 1992 
to September 1993 
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Figure 9 : Numbers of Staphylococcus aureus Reports per 10 Contributing Laboratory Months by Month of 
Onset of Illness, LabDOSS January 1992 to September 1993 
1.2.3 Results 
Streptococcus pneumoniae 
The proportion of Streptococcus pneumoniae reports was between 3 and 21 percent 
for each age group (Table 1 ). The highest proportion was in children aged 1 - 4 years. 
Sepsis occurred unevenly between the sexes with males predominant in some age 
groups and females in others. There was a strong predominance of males in the 35 to 
44 year age group, the male to female ratio being 43:10. Clinical information 
provided for males in this age group was: 61 percent lower respiratory tract infection, 
6 percent meningitis and 46 percent compromised immune status. 
The number of reports was greatest in two age groups, children aged under 5 years 
of age and adults over 75 years (Figure 10). Sixty four percent of cases in children 
under 5 were between 1 and 4 years of age (Figure 11).Lower respiratory tract 
infection was reported more frequently in the elderly than in children (Table 2). 
The surveillance reports show a definite seasonal pattern with peaks in Winter 1992 
and 1993 (Figure 12). Compared with 1993, 1992 appears to be an epidemic year for 
invasive pneumococcal infections. (Figure 13). 
Agel to 4 Years Over 75 Years All Ages 
Clinical Information n = 105 n = 73 n = 337 
Lower Respiratory Tract Infection 50% 86% 70% 
Meningitis 10% 6% 100k 
Septic Arthritis 5% - 0.7% 
Skin Infection 5% - 1% 
Endocarditis 2.5% - 0.3% 
Gastrointestinal Disease 2.5% - 3% 
No Clinical Information 25% 8% 15% 
Total 100% 100% 100% 
Table 2: Clinical Diagnosis in Cases of Streptococcus pneumoniae Sepsis, Comparison 
between Selected Age Groups, LabDOSS January 1992 to September 1993 
Figure 10: Numbers of Streptococcus pneumoniae Reports by Age Group, LabDOSS January 
1992 to September 1993 
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Figure 12: Numbers of Streptococcus pneumoniae Reports by Month of Illness, LabDOSS 
January 1992 to September 1993. 
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Figure 13: Numbers of Streptococcus pneumoniae reports by Months of Illness, per 10 
Contributing Laboratory Months , labDOSS January 1992 to September 1993 
1.2.3 Results, Common Organisms 
Group B Streptococcus 
Group B Streptococcus was reported between 2 and 10 percent of all reports in three 
age groups: neonates, infants 1 to 11 months and adults 25 to 34 years (Table 1). The 
sexes were equally represented in children under 1 year. In adults, females 
predominated in the 25 to 34 year age group, the male to female ratio being 3:10. 
Fifty seven percent ( 4n) women in this age group with Group B Streptococcal sepsis 
were pregnant or postnatal. This predominance of sepsis in females of reproductive 
age is supported by other studies which have shown that of Group B streptococcus 
septicaemia is associated with pregnancy. There was no seasonal pattern in the 
reports. 
Twenty six cases of neonatal group B streptococcal disease were reported, two cases 
had meningitis. Eighty four percent of reports were of early onset disease ( onset 
within the first 5 days after birth). Fifty four percent of cases of early onset disease 
listed pre-term delivery as a risk factor. Three neonates died. Ten cases of late onset 
group B streptococcal septicaemia (5 days to 3 months) were reported, four were 
neonates. No cases of meningitis in late onset disease were reported. Group B 
streptococcal disease in the first year of life was not reported after 8 weeks of age. 
1.2.3 Results, Common Organisms 
Enterococcus species 
Enterococci featured in neonates and adults over 15 years, accounting for an 
increasing proportion of sepsis with age (Table 1 ). Neonatal disease was predominant 
in females, while disease in the elderly was predominant in males. There was no 
seasonal trend in the reports. 
Group A Streptococcus 
The proportion of Group A Streptococcus was 2 to 3 percent of reports in three age 
groups : infants 1 to 11 months, children 5 to 14 and young adults 15 to 24 (Table 
1). There appears to be a predominance in females in the 5 to 14 year age group and 
males aged 15 to 24. However, the number of reports are low in these groups. There 
was no seasonal trend. There were more reports in 1993 than in 1992 for the periods 
January to September (Figure 14). However, when adjusted for the number of 
contributing laboratories, there was no difference between the two years (Figure 15). 
Figure 14: Number of Reports of Group A Streptococcus by Month of Illness, LabDOSS January 1992 to 
September 1993 
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Figure 15: Numbers of Reports of Group A Streptococcus per 10 Contributing Laboratory 
Months, LabDOSS January 1992 to September 1993 
1.2.3 Results, Common Organisms 
Eschericia coli 
Eschericia coli was the most frequently reported gram negative organism. i.e. between 
7 and 25 percent of reports (Table 1). The proportion of sepsis due to E coli was 
highest in the elderly. Sepsis in adults was predominantly in females over 14 years. 
A clinical history of urinary tract infection was reported in 45 % of Eschericia coli 
sepsis in women over 14 years. There was a predominance of males in children 
under 5 years. There was no seasonal trend . 
1.2.3 Results, Common Organisms 
Haemophilus influenzae 
Haemophilus influenzae accounted for between 12 and 27 percent of reports in 
children between 1 month and 5 years (Table 1 ). The proportion was highest in 1 to 4 
year olds where Haemophilus influenzae comprised 27 percent of repons. The was a 
predominance of males, the male to female ratio being 15: 10 
Haemophilus influenzae data have been analysed separately for an extended period to 
December 1993 ( Section 1. 3). 
Pseudomonas aeruginosa 
Pseudomonas aeruginosa comprised between 1 and 5 percent of reports in all age 
groups (Table 1). There was a predominance of males in adult and infant (1 to 11 
month) age groups. In contrast, females were predominant in neonates and children 1 
to 14 years. There was no seasonal distribution. Twenty seven percent of all 
Pseudomonas aeruginosa reports listed iatrogenic risk factors: hospital acquired, 
intravenous line or recent surgery. 
Enterobacter species 
Enterobacter species accounted for 2 to 5 percent of reports in neonates and all ages 
over 5 years (Table 1). The number of cases in each age group are too small to 
include a meaningful interpretation of male to female ratio. There was no seasonal 
trend. 
1.2.3 Results, Common Organisms 
Klebsiella pnewnoni.ae 
K lebsiella pneumoniae accounted for 3 to 5 percent of all reports of sepsis in adults 
aged over 35 years and in children 5 to 14 years (Table 1). There was a strong 
predominance of males in these children, however the total nu~ber of reports is 
small. There was a predominance of females in the ages 35 to 44. There was little 
difference between the sexes in the ages 55 to 64. Males were predominant in cases 
aged over 55. There was no seasonal trend. 
Proteus mirabilis 
Proteus mirabilis sepsis was more common in the elderly (Table 1) . There was a 
predominance of males over 55 years. In contrast, there was a predominance of 
females in the age group 45 to 54 years. 
Neisseria meni.ngitidis 
There were 75 reports of sepsis with N eisseria meningitidis. Meningococcal disease 
reports were between 4 and 8 percent of all reports in ages 1 month to 24 years 
(Table 1). Seventy six percent of cases were under 24 years of age, 43 percent under 
5 years of age. There was a predominance of males in the 1 to 4 year age group. All 
other age groups depict a predominance of infection in females. There was no 
seasonal trend 
Serogroup information was provided for 58 percent of reports: 30 percent serogroup 
B, 27 percent serogroup C, 1 percent serogroup Z. Serogroup B reports peaked in the 
agegroup 15 to 24 years, serogroup C reports were more frequent in the 1 to 14 year 
agegroups (Figure 16). Serogroup preferences by agegroup must be interpreted with 
caution as 42 percent of reports did not include serogroup data. 
Figure 16: Numbers of Neisseria meningitidis Reports by Serogroup and Agegroup, LabDOSS January 1992 to 
September 1993 
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1.2.3 Results, Clinical Category 
Endocarditis 
There were 132 cases of endocarditis reported, 101 involving a native valve and 30 
cases a prosthetic valve. The number of reports was highest in the age group of 65 to 
7 4 years (Figure 17). Sixty precent of cases were over 50 years of age, with a mean 
age of 55 years. Endocarditis was more common in males , the male to female ratio 
being 16: 10. However, the male predominance was not present in the elderly 
(Figure 17, Table 3) . Gram positive organisms were responsible for 90 percent of 
reports of endocarditis. Seventy three percent of reports were attributed to 5 
organisms or organism groups (Table 3 ). Other "viridans " Streptococci included 2 S 
mitis, 2 S mutans, l S mitior. Enterococcal endocarditis was not reported under the 
age of 55 years, the mean age for enterococcal endocarditis was 69 years. Prosthetic 
valve endocarditis was more frequently reported due to coagulase negative 
Staphylococci, and Enterococci than native valve infection ( Table 4 ). 
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Figure 17: Number of Reports of Endocarditis by Age Group and Sex, LabDOSS January 1992 
to September 1993 
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Table 3: Endocarditis; Percentage of reports for Common Organisms Stratified by Age Group with Ratio of Males to Females for 
Each Isolate 
< 5 Years 15- 24 25 - 34 35 - 44 45 - 54 55 - 64 65 -74 75+ Total 
. M:lOF M:lOF 
:: 
M:lOF M:lOF 
Total Number of Reports 2 7 12 15 :::;:; 28 15 20 ·• 30 35 266 
Organisms 
Staphylococcus aureus 33% 20% 20% 
Coagulase negative Staphylococci 7% 30% 20% 
Enterococcus sp 10% 8'l, 
Streptococcus sanguis 
. ::: ··::::,: :: 
13% 2 Males 33% 10% 13% 
;:. ::: . 
Other streptococcus "viridans" 33% · Ao 20% 15% 9% 
. . )n 
Streptococcus "milleri" 8% \.1 Male ; 7% Male · 3% 
Other 100% 25% 7% ,,:, - 20% 15% 27% 
Total Percenta e 100% 100% 100% 100% 100% 100% 100% 100% 100% 
1 . Age Unknown for 8 cases 
Table 4: Percentage of Common Organisms reported in Cases of Prosthetic Valve and 
Native Valve Endocarditis 
Native Valve Prosthetic Valve Total 
n = 102 n = 30 n = 132 
Organisms 
Staphylococcus aureus 22% 10% 20% 
Coagulase negative Staphylococci 18% 30% 20% 
Enterococcus sp 5% 2D°k 8% 
Srreptococcussangu~ 13% 10% 13% 
Other ·viridans· Streptococci 11% 7% 9% 
Streptococcus ·milleriM 2% 7% 3% 
Other 29% 16% 27% 
Total 100% 100% 100% 
1.2.3 Results, Clinical Category 
Meningitis 
There were 280 reports of meningitis. A slight predominance in males was present, 
the male to female ratio being 13:10. There was a predominance of females in the 
elderly , the male to female ratio being 2: 10 (Table 5). Six organisms, or organism 
groups were responsible for 75 percent of meningitis reports (Table 5). 
The greatest number of cases was in the 1 to 4 year old agegroup (Figure 18). Forty 
three percent of these cases were Haemophilus influenzae, 30 percent N eisseria 
m eningitidis (Table 5). 
Staphylococcus aureus was responsible for 23 percent of cases of meningitis in the 
agegroup 65 to 74 years. There was a predominance of females in this age group , the 
male to female ratio being 5: 10. 
Coagulase negative Staphylococci were not reported in cases of meningitis in the very 
young and the very elderly. These organisms were responsible for 21 percent of cases 
of meningitis in young adults aged 15 to 24 years. Clinical risk factors for sepsis were 
provided in all cases: 57 percent recent neurological surgery, 14 percent recent 
vascular surgery, 14 percent recent surgery type unstated and 14 percent with a 
prosthetic device type unstated. 
Streptococcus pneumoniae was responsible for 36 percent of reports of meningitis in 
the elderly . There was a female predominance in this age group. 
Neisseria meningitidis was responsible for between 27 and 40 percent of cases of 
meningitis in the ages 1 month to 24 years. 
Table 5 : Bacterial and Fungal Meningitis; Percentage of Reports for Common Organisms Stratified by Age Groups with Ratio of Males to Females for Each 
Isolate 
Total Number of Reports 
Organisms 
Gram Positive 
Staphylococcus aureus 
Coagulase negative Staphylococ ci 
Streptococcus pneumonlae 
Gram Ne five 
HaemophRus lnfluenzae 
Ne/sser/a menln ff/dis 
Fun I 
Cryptococcus neoformans 
Crypto neof var gaff/I 
C pto neof var neof 
Other 
Total Percenta e 
< lmth 
,, 
12 ' 16 
8% 
8% 
8% 
75% 
100% 
l -llmth l -4 yr 
····fl=•':.1::;;:, 
il'~'1:10F 
h 
. M:lOF 
56 16 
7% 5% 
100% 100% 
5 - 14 15 - 24 25 - 34 35 - 44 45-54 55-64 
''l: 
M:lOF ''M:lOF ·· M:lOF M:10F 
15 8 34 16 35 12 21 25 16 22 14 
7% 1 Ferne 9% '" · 20 / 6% 
7% i Mole 21% 13 11% 10 14% 13% )f'fo'. 21% 
20% 5 6% l O 9% 3 Females 5% 1 Mai~ .. . , 21% 
35% 
20% 26% 
100% 100% 
3% 
3% 
10% 6% 
6% 
23% '. 9 Moles 43% . Q Moles 19% 
34% 19% 44% 
100% 100% 100% 
36% 
100% 
65- 74 75+ 
@M:lOF 
13 '" 23 l l 2 
36% J 
46% 36% 
100% 100% 
Total 
280 
5% 
9% 
10% 
21% 
18% 
4% 
<1% 
8% 
24% 
100% 
1.2.3 Results, Clinical Category 
Meningitis 
Cryptococcus neof ormans was not seen under the age of 15 years. Sixty six percent 
of cases of Cryptococcus neoformans meningitis were patients with AIDS. Variant 
neoformans was responsible for the greatest proportion of cases. 
There were less reports of meningitis from all bacterial and fungal causes in 1993 for 
the period January to September than for the same period in 1992: 107 in 1993 and 
124 in 1992 (Figure 19). 
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Figure 18: Numbers of Reports of Meningitis by Age Group, LabDOSS January 1992 to 
September 1993 
< 1 mth 1 - 1 - 4 yr 5 - 14 15 - 25 - 35 - 45 - 55 - 65 - 75+ 
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1992 
1993 ----~ ---~ 
0 -t----t---+--t----+---+-----+--+----+-------1----~----J 
J F M A M J J A s 0 N D 
Month 
Figure 19: Numbers of Reports of Meningitis per 10 Contributing Laboratory Months, LabDOSS 
January 1992 to September 1993 
1.2.3 Results, Clinical Category 
Septic Arthritis and Osteomyelitis 
There were 165 cases of septic arthritis and 31 cases of osteomyelitis. Staphylococci, 
coagulase negative and positive, and group G Streptococci were the most frequently 
reported organisms in both osteomyelitis and septic arthritis (Table 6). 
Eighty three percent of cases were due to 7 organisms (Table 7). Cases of septic 
arthritis were predominant in males , the male to female ratio being 23:10. The 
male to female ratio for osteomyelitis was 12: 10. 
Staphylococci were responsible for most cases of infection of bone and joints. 
Staphylococcus aureus was the most common organism in all age groups except age 1 
to 11 months. Haemophilus influenzae was the most common organism reported in 
infants between 1 and 11 months. 
Group G Streptococcus was the third most frequently reported organism. Bone and 
joint sepsis from this organism was only present in adults over 35 years of age. There 
were 10 cases of Group G streptococcal bone or joint disease, 1 patient had a 
prosthetic joint. 
Septic Arthritis Osteomyelitis 
Organisms n = 165 n = 31 
Staphylococcus aureus 68.0% 50.0% 
Coagulase negative Staphylococci 5.4% 13.0% 
Group G Streptococcus 4.2% 9.6% 
Group A Streptococcus 3.6°k l.4°/4 
Haemophilus influenzae 1.2% 2.8% 
Eschericia coli 3.0% -
Pseudomonas aeruginosa 1.8% 1.4% 
Table 6: Septic Arthritis and Osteomyelitis; Percentage of Reports for Common 
Organisms, LabDOSS January 1992 to September 1993 
Table 7: Septic Arthritis and Osteomyelitls; Percentage of Reports for Common Organisms Stratified by Age Group with Ratios of Males to Females for 
Each Isolate 
Total Number of Reports 
Organisms 
Gram Positive 
Staphylococcus aureus 
Coagulase negative Staphylococci 
Group G Streptococcus 
Gram Ne ative 
Haemoph/Jus lnf/uenzae 
Escherlcia coli 
Pseudomonas aeru /nosa 
Other 
Total Percenta e 
1 -1 lmth 
·; M:foF 
4 ,, 10 
75% 
100% 
l - 4 r 5 - 14 
1UJi%F M:lOF 
10 23 26 12 
!ll!!!Wll!;i11i~i(in:: 
20% :2 Mote 85% . 14 
30% !1!i1!i!:
1~'i':,; 4% 1 Femal 
8% 10· 
40% 4% 
lOO°k lOO°k 
15 - 24 25- 34 
·1: 
M:lOF M:lOF 
17 32 20 56 
18% : 5 ; 15% 3 Moles 
-i. 
6% 
, 
Male 
18% 25% 
lOO°k lOO°k 
35 - 44 45- 54 55 - 64 
:::: ::- .. ;. '.!><J .. ', 
M:lOF ' M:lOF MilOF 
19 85 15 20 27 15 
::, 
1 Mate 7% 
5% J tv,ale 7% 1 Male 
.; ::: 
5% '1 Maie - :i::: :;~ 
5% 
17% 7% 11% 
101% lOO°k 100% 
65 - 74 
J Mi10F 
;:: 
33 ,; ., 15 
18% 
100% 
75+ 
:\'1:10F 
52 :;, · 11 
25% 
100% 
Total 
237 
63% 
8% 
4% 
3% 
2% 
2% 
2% 
17% 
1.2.3 Results, Clinical Category 
Surgery 
There were 736 reports of organisms from sterile sites in patients with a risk factor of 
recent surgery. This represents 10.2 percent of all reports. Abdominal surgery was 
most frequently reported , being 4.1 percent of all reports, followed by Thoracic (1.2 
percent), Neurological (1.2 percent), Orthopaedic (0.9 percent), Urinary Tract and 
Vascular surgery (0.8 percent each). Surgery type unspecified represented 1.2 percent. 
Nine organisms, or organism groups were responsible for 73 percent of reports of 
sepsis (Table 8). 
All Surgery Abdominal Thoracic Neurological Orthopaedic Urinary Tract Voscula Total 
Total Number of Reports 738 292 88 83 70 59 56 1386 
Organisms 
Gmm Positive 
Staphylococcus aureus 22% 14% 49% 16% 36% 2% 23"k 21% 
Coagulase negative Staphylococci 1()% 7o/o 7o/o 3(R l ?o/o - 11% 10% 
Enterococcus sp 6% 8% 7o/o 2% 1% 8% 5% 6% 
Gram Negative 
Eschericia coli 13% 15% - 4% 9% 42% 5% 13% 
Enterobacter sp 7o/o 11% 13% 1% 4% - 9% 8% 
Pseudomonos aeruginosa 6% 8% 2% 4% 4% 10% 9% 6% 
K/ebs/ella pneumoniae 4% 5% 1% 5% 1% 7o/o 4% 4% 
Anaerobe 
Bacteroldes sp 3% 5% 1% 1% 4% 3% - 3% 
Fungi 
Candida a/bicans 2% 3% 1% - 1% 3% 2% 2% 
other Orgcrilsms 27o/o 25% 19% 37o/o 21% 24% 32% 27o/o 
Total Percentage 100% 100% 100% 100% 100% 100% 100% 100% 
1. MRSA2.2% 
Table 8: Recent Surgery; Percentage of Reports for Common Organisms by Class of Surgery 
j 
I 
1.2.3 Results, Clinical Category 
Compromised Immune Status 
Twenty four percent (n = 1670) of all reports listed immunocompromised status as a 
risk factor for sepsis. Reports increased with age up to 7 4 years. The sexes were 
equally represented. Further details of immune susceptibility were 32 percent 
malignancy, 23 percent renal failure, 16 percent neutropaenia, 7 percent diabetes, 6 
percent transplant, 5 percent HIV/AIDS and 2 percent intravenous drug user. Nine 
organisms were responsible for sixty seven percent of the reports (Table 9). 
Table 9: Compromised Immune Status; Percentage of Reports for Common Organisms Stratified by Description of lmmunosuppression , 
LabDOSS January 1992 to September 1993 
HIV /AIDS Neutropaenia Diabetes IDU Renal Failure Transplant Malignancy Other 
Total Number of Reports 85 267 122 25 379 94 154 544 
Organisms 
Gram Positive 
Staphylococcus aureus 11% 8% 16% 56% 22% 15% 12% 16% 
Coagulase negative Staphylococci 11% 12% 7% 4% 10% 7% 11% 10% 
Enterococcus sp - 1% 1% - 4% 6% 4% 2% 
Streptococcus pneumonlae 6% 1% 2% - - 2% 3% 7% 
Gram Negative 
Eschericia coli 4% 19% 32% 4% 9% 12% 18% 17% 
Pseudomonas aeruginosa 6% 13% 4% - 3% 5% 6% 6% 
Klebsiella pneumoniae 1% 6% 2% 4% 2% 4% 6% 3% 
Enterobacter species - 4% 2% - 2% 10% 5% 4% 
Fungi 
Candida sp - 1% - - 1% 3% 1% 1% 
Other 62% 33% 34% 32% 46% 35% 34% 34% 
Total percentage 100% 100% 100% 100% 100% 100% 100% 100% 
l. Intravenous Drug User 
Total 
1670 
16% 
14% 
3% 
2% 
16% 
6% 
4% 
4% 
2% 
33% 
100% 
1.2.4 Discussion 
• Valid Data 
• Trends over Ti me 
• An Emerging Pathogen 
• Limitations of the LabDOSS Scheme 
• Value of LabDOSS 
1.2.4 Discussion 
Valid Data 
Known Patterns of Sepsis 
Known patterns of infectious diseases are echoed in the LabDOSS data. The greatest 
number of cases of sepsis from invasive organisms are in the young and the elderly. 
Gram negative organisms play a larger role with increasing age. H aemophilus 
influenzae , Streptococcus pneumoniae and N eisseria meningitidis are well known as 
the three common causative organisms of meningitis. Reproduction of these and 
other known trends of infection is an encouraging feature of a new surveillance 
system. 
Clinical Information 
The reliability of clinical information from contributing laboratories is controversial. 
The clinical data are provided by laboratory staff who have no direct contact with 
patient. Laboratory staff suggest that the completeness of ascertainment of cases will 
differ with the condition. The ascertainment rate of cases of meningitis, endocarditis, 
or patients with recent surgery is likely to be high whilst the ascertainment of all 
patients with diabetes will be low. 
The LabDOSS data for endocarditis are validated by overseas studies. It has been 
shown that males are more commonly affected with the mean male to female ratio of 
1.7: 1 with a range of 1.2 to 3.0: 1 in 17 large series1• The male to female ratio in the 
LabDOSS data was 1.6: 1. Other studies show over 50 percent of cases are over 50 
years, 60 percent of patients were over 50 years in Lab DOSS data with a mean age 
55 years. The mean age of patients with enterococcal endocarditis has been shown to 
be higher than other organisms, with a range of 61 to 67 years in other studies. The 
mean age for enterococcal endocarditis in LabDOSS was 69 years. Thus, the clinical 
data are reliable when the rate of ascertainment of all cases is high. 
1.2.4 Discussion 
Trends over Ti me 
Seasonal Trend and an Epidemic 
LabDOSS surveillance showed pneumococcal sepsis in Australians to be more 
common in Winter. The Winter increases in pneumococcal disease are also found in 
overseas studies. In the first year of operation, LabDOSS surveillance detected an 
epidemic of pneumococcal disease in comparison with the subsequent year. 
Pneumococcal data in future years may show patterns of disease that may be useful 
for developing and monitoring effects of public health policy for use of pneumococcal 
. 
vaccme . 
Trends Resulting From Other Diseases or Public Health Intervention 
Cryptococcus neoformans is the fourth most frequently reported organism causing 
meningitis, an effect of AIDS. 
There is a decrease in reports of Haemophilus influenzae disease following 
introduction of Hib vaccine. Ongoing Haemophilus influenzae disease, type b and 
other serotypes, will be monitored through LabDOSS 
An Emerging Pathogen 
Group G Streptococcus may be an emerging pathogen in bone and joint disease. The 
patterns of known common organisms in cases of bone and joint sepsis are present in 
the LabDOSS data. Group G Streptococcus has not previously been described as a 
frequent agent in bone and joint disease. All Streptococci accounted for 10 percent of 
bone or joint sepsis in LabDOSS data, 4.2 percent of this being group G Streptococci. 
The role of group G Streptococci in bone and joint sepsis will be further investigated. 
Emerging pathogens may be detected through the LabDOSS scheme. 
"111111 
1.2.4 Discussion 
Limitations of the LabDOSS Scheme 
Small Sentinel Scheme 
LabDOSS surveillance is a scheme in its infancy. It consists of a small number of 
contributing laboratories with a geographical bias. Growth of the scheme has been 
limited by the resources of the section producing the CDI rather than lack of offers 
to provide contributions. 
The Need for a Semi-Active Scheme 
Incomplete serogroup information highlights the need for LabDOSS to be a 
semiactive scheme. Considering N eisseria meningitidis, there is a suggestion of a 
difference of serogroup reports for differing agegroups, serogoup B being more 
common in the 15 to 24 year age group. However, the incomplete serogroup 
information restricts a confident conclusion. A semiactive scheme would allow 
telephone follow up to complete missing data. 
Appropriate or Inappropriate Denominator Data 
Appropriate denominators for current LabDOSS data are difficult to define. 
Admission data, or numbers of currently occupied beds, may be used as 
denominators for numbers of reports of sepsis. However, comparison between hospital 
laboratories encompasses a referral pattern bias. Sepsis reported by one hospital may 
only be a reflection of the type of patient managed. For example , hospitals with 
oncology or burns facilities will generate a different spectrum of blood culture results 
than hospitals without these units. Similarly, use of the total number of blood cultures 
processed by any laboratory is affected by likelihood of admission of a patient with 
sepsis and the hospital policy of numbers of blood samples referred for culture. 
Appropriate denominators with growth of the scheme may be total population for 
States or other geographical areas 
1.2.4 Discussion 
Value of LabDOSS 
The LabDOSS surveillance system provides valuable information on cases of 
diseases from invasive organisms. The scheme has detected an epidemic of 
pneumococcal disease, monitored a seasonal trend and disease prevention by 
vaccination. Unusual reports are able to be accepted as worthy of further investigation 
because of the strong reproduction of known trends in infectious diseases. Seasonal 
patterns, outbreaks, emerging pathogens hitherto not identified will become apparent 
with subsequent years of reporting. Prevention of disease may be enabled by 
intervention arising from improved understanding. 
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1.3 Haemophilus influenzae, LabDOSS 1992 and 1993 and National Notifiable 
Diseases Surveillance System, Communicable Diseases Network Australia 
I have prepared the following section with the assistance of Dr Robert Hall and Dr 
Mahomed Patel. 
1.3 Haemophilus influenzae, LabDOSS 1992 and 1993 and National Notifiable 
Diseases Surveillance System, Communicable Diseases Network Australia 
National notifications and microbiological surveillance of invasive Haemophilus 
influenzae type b (Hib) disease before and immediately after the introduction of 
conjugated Hib vaccines in Australian children. 
Introduction 
Invasive Haem ophilus influenz ae type b (Hib) disease is estimated to have affected 
between 550 and 700 Australian children under 5 years of age per year ( 1). The 
incidence in this age group varies from 20 to 30 per 100,000 in non Aboriginal 
children to 500 per 100,000 in Aboriginal children (2,3,4). 
The first available conjugate Haemophilus influenzae type b vaccine in Australia was 
PRP - D (ProHIBit Pasteur Merieux) licensed in February 1992. This vaccine was 
recommended for use in children over 18 months of age. Vaccines suitable for infants 
were licensed from September 1992 and marketed from February 1993. All Hib 
vaccines were government funded from April 1993 by reimbursement of vaccine cost 
to parents. HbOC vaccine (HibTITER Lederle) for non Aboriginal children and PRP-
OMP (Pedvax HIB, Merck Sharp & Dahme CSL) for Aboriginal children, were 
included in the immunisation schedule from July 1992. This enabled vaccination of 
babies aged 8 weeks of age at no outlaying cost to the parent. 
Surveillance of Hib disease is required to assess the impact of the vaccination 
program. 
1.3 Haemophilus influenzae, LabDOSS 1992 and 1993 and National Notifiable 
Diseases Surveillance System, Communicable Diseases Network Australia 
Methods 
We analysed reports of Haemophilus influenzae from two routine, autonomous, 
surveillance systems. Hib disease was included as a notifiable disease in state and 
territories from 1991. In 1992 a new sentinel laboratory based surveillance scheme 
commenced; Laboratory Database of Organisms from Sterile Sites (LabDOSS). 
LabDOSS is operated by the Commonwealth Department of Humans Services and 
Health and data are published in the Communicable Diseases Intelligence (CD/). The 
two schemes differ in rates of ascertainment of cases and coverage of the population . 
Statutory notifications of Hib cases are made to each state or territory health 
department who forward data to the Commonwealth Department of Health, Housing 
Local Government and Community Services. The definition of a case of Hib 
infection is; 
a) An invasive clinically compatible illness 
(meningitis,epiglottitis, cellulitis, septic arthritis, osteomyelitis, 
pneumonia, pericarditis or septicaemia). 
OR 
AND either: 
the isolation of Haemophilus influenzae type b ( Hib) from 
blood 
or 
detection of Haemophilus influenzae type b antigen 
( in a clinical case) 
or 
detection of gram negative bacteria where the organism fails to 
grow in a clinical case 
b) A confident diagnosis of epiglottitis by direct vision, laryngoscope or X -
ray 
1.3 Hae,nophilus influenzae, LabDOSS 1992 and 1993 and National Notifiable 
Diseases Surveillance System, Communicable Diseases Network Australia 
Notification of Hib disease commenced in 1991. The source of notification differs 
between states and territories. Notifications are made by physicians, microbiology 
laboratory staff or a combination of both sources. The proportion of cases notified is 
not known. Case ascertainment is not considered complete, however data are 
provided from across the entire country. Cases are identified as Aboriginal or non 
Aboriginal. 
LabDOSS is a voluntary sentinel surveillance system rece1v1ng reports from 
microbiology laboratories. The scheme commenced operation in 1992 with 4 
participating laboratories increasing to 17 participating laboratories at the end of 1993. 
Reporting of meningitis and septicaemia by each contributing laboratory is considered 
complete, however the ascertainment can be expected to be low for cases of 
epiglottitis. All reports of Haemophilus influenzae in children under 5 were analysed. 
The data in LabDOSS are currently from mainly two geographic areas; NSW and 
Queensland. Ethnicity data are not collected. To allow for comparison of numbers of 
reports per month in an expanding surveillance scheme , the mean number of 
Haemophilus influenzae reports per 10 contributing laboratories for one month has 
been used. 
"'!'Ill 
1.3 Haemophilus influenzae, LabDOSS 1992 and 1993 and National Notifiable 
Diseases Surveillance System, Communicable Diseases Network Australia 
Results 
National Notifiable Dis eases Surveillance System 
Nationwide there were 1,186 cases of Hib disease in children under 5 years of age 
notified to State and Territory Health departments from January 1991 to December 
1993. Thirty nine percent of reports were from NSW, 24 percent from Victoria .. 
There were 16 cases of Hib disease in aboriginal children ( 1.4 percent) , however 
aboriginality was not reported in 72 percent of cases. There was a male 
predominance, the male to female ratio being 1.3 : 1. Seventy nine percent of cases 
were under 3 years of age . The highest rates of Hib disease per 100,000 children 
under 5 years of age were in children under 1 year of age in spring of 1991 . 
LabDOSS Reports 
All reports of Haemophilus influenzae in children under 5 were analysed; 92 percent 
were serotype b, serotype data were not provided in 8 percent. There were 129 reports 
of invasive Hib disease in children under 5 years of age to LabDOSS scheme 
between January 1992 and December 1993. Eighty five percent of cases were under 
3 years of age . There was a predominance of males, the male to female ratio being 
1.4 : 1. Forty three percent of reports were from NSW/ACT , 48 percent from 
Queensland and 8 percent from Tasmania. 
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1.3 Haemophilus influenzae, LabDOSS 1992 and 1993 and National Notifiable 
Diseases Surveillance System, Communicable Diseases Network Australia 
Children Less Than 1 year of a2e 
Notifiable Disease 
After reporting began in 1991 a peak of Hib disease was present in spring of 1991 
(Figure 1 ). A similar but less dramatic increase in spring was also evident the 
following year. The rate of Hib disease in children under 1 year of age in spring 
1993 are lower than the previous two years. Rates for 1993 fall below those of 
previous years from June 1993 onward. 
LabDOSS 
A peak in reports of disease was present in spring 1992 (Figure 2). The 1993 reports, 
adjusted for number of contributing laboratories, fall below levels for 1992 after 
August 1993. 
Children A2ed 1 to 4 years 
Notifiable Dis eases 
The rate of Hib disease in children aged 1 to 4 years has decreased since 1991. A 
peak of reports occurred in winter 1992 (Figure 3). In contrast a slow decline 
occurred in reports in winter 1993. 
LabDOSS 
There were fewer reports of Haemophilus influenzae in 1993 than in 1992. The 
comparative decrease is seen beginning September 1993 (Figure 4 ). 
Figure 1: Two Month Moving Average of Nofication Rate of Hib Disease in Children Under 1 Year per 100,000 
Children Under 1 Year of Age, 1991 to 1993 
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Figure 2: Two Month Moving Average of Number of Reports of Invasive Haemophilus influenzae Disease in 
Children Under 1 Year of Age, LabDOSS 1992 and 1993 
Figure 3: Two Month Moving Average of Notification rates of Hib Disease in Children Aged 1 to 4 years per 
100,000 children aged 1 to 4 years, 1991 to 1993 
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Figure 4: Two Month Moving Average of Number of reports of Invasive Haemophilus lnfleunzae Disease in 
Children Aged 1 to 4 Years, per 10 Contributing Laboratory Months, LabDOSS 1992 and 1993 
1.3 Haemophilus inf[uenzae, LabDOSS 1992 and 1993 and National Notifiable 
Diseases Surveillance System, Communicable Diseases Network Australia 
Discussion 
Reports of cases of Hib disease have decreased since 1991. The decrease in reports to 
the notifiable diseases scheme in from 1991 to 1992 preceded the use of vaccine 
indicating a natural decrease occurred. We anticipated fewer cases in 1993 in children 
over 18 months of age because of the availability of PRP-D vaccine in early 1992. It 
is surprising however to see a decrease in Hib disease in children under 1 year of age 
soon after the introduction of infant Hib vaccines. The trend of a recent decrease in 
Hib disease in children under 1 year of age is starting to appear in two autonomous 
surveillance systems. Introduction of government funded Hib vaccine in April 1993 
appears to have successfully prevented cases of Hib in children under the age of 5 
years in 1993. Ongoing surveillance is needed to continue to assess effect of 
vaccination in future years. 
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1.4 Evaluation of LabDOSS 
My evaluation of the system is provided and acknowledges the shortcomings of any 
evaluation that is conducted by the person who developed the project. I have used the 
CDC Guidelines for Evaluating Surveillance Systems 1 to improve objectivity. 
Public Health Importance of the Health Event 
LabDOSS receives reports of significant invasive organisms. Septicaemia , meningitis 
and sepsis in other normally sterile sites represent significant morbidity, mortality, 
health care costs. The total number of cases , incidence and prevalence of septicaemia 
and meningitis in Australia is unknown. Some reports in LabDOSS may have a high 
case fatality ratio, for example cases of meningococcal septicaemia. In contrast the 
case fatality ratio for sepsis from other organisms reported may be low , for example 
cases of septicaemia with coagulase negative Staphylococci. The morbidity of 
septicaemia and meningitis is high. Nosocomial septicaemia results in extended 
hospitalisation. The preventability of sepsis varies widely and includes factors of 
general health of the population , public health policy toward vaccine, development of 
immunosuppression by therapy for other disease, awareness and prevention of 
nosocomial infection. 
Description of the System 
The objectives of the LabDOSS system are outlined in section 1.1.1. The case 
definition for reports in the scheme is the isolation of a bacterial or fungal organism 
from a site that is normally sterile. Organisms that are considered as probably 
contaminating the specimen may be reported to the scheme however, are analysed 
separately from reports of significant organisms. 
Data generated from sentinel, voluntary microbiology laboratories are forwarded to the 
CDI ( Figure 1 ). 
1.4 Evaluation of LabDOSS 
Figure 1 Flow Chart of the LabDOSS Surveillance Scheme, Contributing 
Laboratories from 1992 to September 1993. 
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1.4 Evaluation of LabDOSS 
The population under surveillance is; the group at risk of developing infection in a 
normally sterile site whose pathology tests will be performed by one of the 
contributing laboratories. This includes a referral pattern bias as for example 
individuals with meningitis or severe burns may be referred to one of the contributing 
laboratory's hospitals for treatment . 
Details of what information is collected, ~e frequency of collection , transfer of data 
are outlined in section 1.1.2 
The data are stored in Epiinfo in the Surveillance and Evaluation Unit of the 
Commonwealth Department of Human Services and Health. Fortnightly data are 
analysed and printed in the CDI, distributed free of charge to approximately 5,000 
Australian and International Readers. 
Usefulness 
Initial observation of the scheme suggests limited use as there has been no action 
taken as a result of the data. The priority thus far has been for the process of 
establishing the system and in determining a baseline for future comparisons. 
However, the system does improve understanding of the epidemiology of invasive 
organisms in the Australian population. The system has detected seasonal trends, age 
and sex patterns of disease and risk factors for sepsis. It is able to detect epidemics 
and has shown periods of increased reports of pneumococci and decreasing reports of 
Haemophilius influenzae. Evaluation of vaccination for Hib disease is able to be 
preformed. 
( Refer Section 1.2 Analysis of Data January 1992 to September 1993 and Section 1.3 
Haemophilus influenzae LabDOSS 1992 and 1993) 
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1.4 Evaluation of LabDOSS 
Usefulness , Stimulation of Epidemiological Research 
As knowledge about the system grows it is likely to stimulate epidemiological 
research to control or prevent illness. For example, there are few reports of early 
onset neonatal group B streptococcus infection in the 1992 and 1993 LabDOSS data. 
However, some centres in Australia actively screen all women for vaginal carriage of 
the organisms and use intrapartum chemoprophylaxis to prevent neonatal disease. The 
incidence of this diseases has been shown to vary geographically within countries2· 
The incidence of the disease in neonates across Australia is unknown. One Melbourne 
study showed the incidence one area to be 2.0 per 1,000 live births3. Screening for 
any disease should only occur if there is effective intervention. Controversy persists 
about chemoprophylaxis to prevent disease and work continues on development of 
group B streptococcal vaccine. Expansion of LabDOSS scheme may allow a more 
representative determination of the incidence of this disease. LabDOSS may enable 
evaluation of current screening programs and any future programs of intrapartum 
chemoprophylaxis or vaccination. 
Usefulness, Prevention of N osocomial Sepsis 
The constituents of the surveillance system each use Labdoss for their own purposes. 
One of these purposes may be improvement of nosocomial infection surveillance. The 
system currently collects data on intravenous line risk factors and hospital acquired 
(defined as infection acquired greater than 48 hours after admission) origin of sepsis. 
With improved hospital access to data on sepsis, treatment of infections and 
prevention of nosocomial sepsis may be improved . 
1.4 Evaluation of LabDOSS 
Attributes 
Simplicity The system has been designed to be easy for the laboratory to provide 
and send data. The means of providing data can be tailored to each laboratory's 
needs. This has been a major factor in the slow development of the scheme as 
considerable time is spent to individualise each system . However, it will be a 
significant factor in ensuring the scheme will continue. 
Flexibility LabDOSS flexibility has been shown with copying of the scheme to 
create LabVISE. Fifty percent of the virus reports are now provided on floppy disc. 
Any organism may be included , data may requested from other sites, for example 
genital specimens , wound swabs . 
Acceptability The acceptance of LabDOSS has been shown by the request of 
laboratories to join the scheme and the support displayed at the Australian Society for 
Microbiology Meetings. 
Sensitivity The sensitivity of the scheme is high if the condition is detected by 
culture of an organism from sterile sites. An example of lack of sensitivity is cases of 
Hib epiglottitis which are unlikely to be detected. 
Positive Predictive Value The positive predictive value of a report of an isolate from 
sterile sites is high for known pathogens and may be low for less aggressive 
organisms such as coagulase negative staphylococci. False positive case reports have 
been minimised by including the option of coding the organisms as "probable 
contaminant". At times it will be difficult for the laboratory scientist to assess the 
significance and therefore the positive predictive value of an isolate. 
1.4 Evaluation of LabDOSS 
Attributes 
Representativeness The scheme appears to be representative, as initial analysis of 
early data support known trends in infectious diseases. Where the scheme lacks 
accuracy is in incomplete data provided such as serogroup information. This is a 
considerable shortcoming of the scheme for surveillance of meningococcal sepsis. This 
highlights the need for the scheme to be semiactive, allowing for telephone call back 
to correct or correct and complete reports. 
Timeliness The data are reported in a timely manner to CDI and reports are printed 
no later than one month after onset of illness. On occasions, data are provided 
retrospectively by laboratories, this occurs when their staffing levels are low or the 
computer entry person is on leave. On such occasions the data are acknowledged in 
the CDI and merged into the main file for the year. All data printed in the CDI are of 
recent isolates. 
1.4 Evaluation of LabDOSS 
The Resources for the System 
The direct costs in establishing the scheme have been high, largely the cost of staff 
time. Costs of the LabDOSS scheme to the Department of Human Services and 
Health are outlined below. Cost of production and distribution of CDI and attendance 
at conferences are not included. The individual laboratory cost is approximately 1 
hour of data entry per fortnight, estimated between $ 260 and $ 780 per year 
depending on staff qualification. 
1991 
70% of Medical Officer grade 1 
20 % Computer Systems Officer 
Telephone, stationary ,travel 
Total 
1992 
30 % Medical officer grade 1 
20 % Senior Professional Officer 
30 % Computer systems officer 
Kits for 14 laboratories 
Travel 
Total 
1993 
10 % Medical Officer grade 1 
20 % Computer systems Officer 
20 % Clerical Officer 
Kits for 5 Laboratories 
Total 
Projected for 1994 Including Scheme 
Expansion 
40 % Computer systems Officer 
10 % Medical office 
70 % Clerical Officer 
Kits for 20 Laboratories 
Travel 
Annual Report Medical Officer 
1994 Projected Total 
$ 35,000 
$ 10,000 
$ 1,000 
$ 46,000 
$ 15,000 
$ 9,000 
$ 15,000 
$ 280 
$ 2,000 
$ 41,280 
$ 5,000 
$ 10,000 
$ 6,000 
$ 100 
$ 21,100 
$ 20,000 
$ 5,000 
$ 21,000 
$ 400 
$ 2,000 
$ 5,000 
$53,400 
Ongoing Maintenance 
10 % Systems operator 
70% Clerical Officer 
Analysis 
Fortnightly 20 % 
Medical /Science Officer 
Annual report 
Medical /Science Officer 
Annual Total 
$ 5,000 
$21,000 
$10,000 
$ 5,000 
$ 41,000 
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1.4 Evaluation of LabDOSS 
Conclusions and Recommendations 
The LabDOSS system is meeting its objectives. The understanding of the 
epidemiology of disease caused by invasive organisms in Australia such as 
Streptococcus pneumoniae has been improved. Trends of disease caused by invasive 
organisms over time have been monitored. Emerging pathogens causing invasive 
disease may be identified. Outbreaks are able to be identified. The knowledge gained 
from LabDOSS surveillance is able to be used to develop public health policy. 
The LabDOSS system is in an early stage of development. Fully meeting the objective 
and providing full value of the scheme will only be attained if expansion is enabled to 
occur. 
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1. THE LABDOSS SYSTEM 
1.1 Overview of the LabDOSS System 
LabDOSS is a national scheme for surveillance of significant isolates from normally 
sterile sites. 
The computerised LabDOSS surveillance system presented here has been prcxluced in 
Epilnfo 5.0la, a text editor (word processing), database and statistics system for 
epidemiology on microcomputers. This program is public domain software from the 
Centers for Disease Control (CDC) in Atlanta, Georgia, USA. An Epilnfo manual is 
provided with these instructions for use in more general operations. 
For LabDOSS, a series of Epilnfo and DOS programs have been prcxluced to allow for 
DATA ENTRY, STORAGE, ANALYSIS, and REPORTING TO CDI. 
The LabDOSS system is two tiered, as follows:-
i) An interim file (LDCDI.REC) is created for entry of data and for reporting via a file 
(LD###.REC) on diskette to the Communicable Diseases Intelligence bulletin 
(CDI). (The### refers to the laboratory number.) 
ii) A main file (LABooss2.REC) is created for your own laboratory, in which you may 
do your own analysis, by incorporating the interim file into it. 
Data Entry 
Interim File 
WCDI.REC 
Main File 
LABDOSS2REC 
Note: WCDI REC is used for entering all records. 
January, 1992 
LABDOSS2REC is the main file that is used to analyse data. 
LD### .REC is copied to diskette for CDI. 
Reporting File 
W117REC 
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1.2 Data in LabDOSS 
Data related to each isolate and entered in LabDOSS are divided into 3 types: 
i) Clerical data 
ii) Clinical data 
iii) Microbiological data. 
Details on the data for each type are provided in Section 2 of this manual. 
1.3 Tailoring LabDOSS for your Laboratory 
LabDOSS can be tailored for your own needs, adding extra fields (e.g. patient outcome, 
antimicrobial susceptibility) where appropriate. The data sent to CDI are only the core 
data that have been included in the files mentioned above. 
If you would like your database to store additional information it is important that you 
contact the personnel indicated on the front page. Adding additional fields may cause 
unintended consequences to the LabDOSS files. For example, the look-up tables (or pop-
up screens) may not function properly, thereby seriously affecting your data entry. 
Alterations may be readily arranged by contacting the CDI personnel. 
1.4 Installation of Epilnfo System. 
Refer to chapter 4 of the Epilnfo manual for installation of the Epilnfo system. 
If you already have Epilnfo 5.0la installed, skip this procedure and move to the 
"Installation of LabDOSS System" procedure, Section 1.5. 
January, 1992 
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1.5 Installation of LabDOSS System. 
Insert LabDOSS2 installation diskette into drive A: (or B:) 
At the DOS prompt (i.e. C:\:> or A:\> or B:\:>) 
Type A:INSTALL (or B:INSTALL B:) & press <Enter> 
A series of instructions will lead you through the installation process, as follows:-
This installation procedure assumes Epilnfo has been installed 
in the directory "C:\EPIS" and copies the LABDOSS2 system files 
to it-
If this is so and you wish to proceed with the installation, press 
<Enter>, 
otherwise press "<Ctrl> C". 
LabDOSS2 system files have been copied to "C: \EPIS" 
and the current path has been set to include "C:\EPIS". 
This next procedure will use the ''SET PA TH=" to add "C: \EPIS" 
to your "AUTOEXEC.BAT' file and save your current 
"AUTOEXEC.BAT" file to "AUTOEXEC.OLD". 
•-THIS IS NECESSARY TO ENABLE THE "BAT(ch)" FILES 10 RUN• 
next time you reboot your PC. 
rocl'ed, press <Enter>, otherwise press <Crtl> C. 
Installation is now complete! 
Thankyou, Bye, DE. 
FIGURE 1. INSTALLATION PROCEDURES FOR LABOOSS. 
NOTE: If the message "Invalid directory" appears on the screen during installation, you will need to install 
the EPIINFO system to the C:\EPI5 directory before proceeding with the installation of Lab00SS2. 
At the end of the installation of LabDOSS2 a menu (shown next page) will appear. 
January, 1992 
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1.6 LabDOSS2 Menu 
To bring up the LabDOSS2 Menu, type LDMENU at the DOS prompt (C:\.> or A:\>) 
WELCOME TO THE LABDOSS2 SYSTEM 
------------------------------LabDOSS2 data files include: 
1. interim file LDCDI.rec into which data is entered; 
2. main file LABDOSS2.rec into which all data is stored and analysed. 
Select the appropriate options by typing against the C:\> prompt:-
LDENTER to enter data into the interim file LDCDI.rec. 
LDSORT to sort records in the interim file LDCDI.rec. 
LDDEL to delete records in the interim file LDCDI.rec. 
LDPOST to run the program which writes LDCDI.rec data to the A: drive 
diskette Cfor posting to CDI> and to LABDOSS2.rec on hard disk. 
LOAN to analyse the LABDOSS2.rec file under ANALYSIS option of Epilnfo. 
LDBK to run the Backup/Restore Menu. 
LDMENU to run this menu again. 
C:\> 
FIGURE 2. ENfER DAT A, POST ( OR SEND) DAT A and SORT RECORDS. 
This menu is not required to run the following options but is provided as a reminder of 
the options available. 
1.7 Entering Data 
To enter data into the interim file LOCDI.REC: 
Type LDENTER at the DOS prompt (i.e. at C:\.> or A:\>). 
For more details on entering data, refer to "/ nstructions for Entering Data ... " - Section 2. 
1.8 Sorting & Deleting Data 
To sort records (in LOCDI.REc) to check for duplicates: 
(The records will be sorted by Organism and Surname) 
Type LDSORT at the DOS prompt (i.e. at C:\.> or A:\>). 
Press <F5>, then <up arrow> twice, then <Enter> to print out the data for 
checking of duplicates OR scan the records on the screen to enable checking of 
duplicates. 
To delete records (in Loco1.REc): 
January, 1992 
(The UPDATE procedure will be invoked under AN AL YSIS - refer to page 359 "UPDATE" 
command ofEpilnfo manual for more detail.) 
Type LDDEL at the DOS prompt (i.e. at C:\.> or A:\>). 
Position cursor on the duplicate record. 
Press <F6> to mark records for deletion. 
Press <Fl0> twice to quit ANALYSIS and Epilnfo. 
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1.9 Posting (or Sending) data to CDI 
To send data to the CDI (as file LD###.REc): 
Type LDPOST at the DOS prompt (i.e. at C:\> or A:\>). 
A programme will run that will ask you to insert a formatted diskette into the A: drive. 
The data from LOCDI.REC - excluding the patients whole name and any extra fields included in 
your tailored system - is copied onto the diskette as file LD###.REC. 
All of the data in LDCDI.REC is merged into the main file LABDOSS2.REC, and LOCDI.REC is emptied 
ready for you to start over again. 
Mail the diskette to CDI/LABDOSS, Communicable Diseases Section, Department of HH&CS, 
GPO Box 9848, Canberra, ACT 2601. 
1.10 Analysing your Laboratory Data 
Analysing your data may be performed using the Epilnfo ANALYSIS option, and can be 
accessed from the LabDOSS2 menu, as follows: 
Type LDAN at the DOS prompt (i.e. at C:\> or A:\>). 
(This is equivalent to typing CD'-EP15 at the DOS prompt, then EP1 to activate the program, then selecting ANALYSIS.) 
You should now be in the browse mcxle looking at the LABDOSS2.REC file. 
To look at options for ANALYSIS, escape from the BROWSE screen by pressing <Escape> or 
<Fl0>, then press <F2>, and for field names. press <F3>. 
If at any time you need to look at another file, type READ <path><filename>, then press 
<F4> to browse. 
Refer to the ANALYSIS section of the Epilnfo Manual for further details. 
For examples of LabDOSS2 data analysis refer to "Analysis Report Examples" 1n 
Section 6. 
1.11 Backing up and Restoring Data 
To bring up the Backup/Restore Menu: 
Type LDBK at the DOS prompt (i.e. at C:\> or A:\>). 
For more details on backing up and restoring files, refer to "BACKUP and RESTORE 
Procedures" - Section 3. 
January, 1992 
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2. INSTRUCTIONS FOR ENTERING DATA INTO THE LABDOSS SYSTEM 
From "LabDOSS2 System" menu (see figure 2), to enter data: 
Type LDENTER at the DOS prompt (i.e. C:\> or A:\>). 
(This can also be accessed from the Epilnfo menu by selecting ENTER then at the data file prompt, type 
LDCDI and press <Enter>) 
To enter data into each field (or entry location) type the appropriate data and the cursor 
will jump to the next field, or pre~ <Enter> if the cursor remains. The following sets out 
the procedures and requirements for each field. 
CLERICAL DATA - SCREENl 
Communicable Diseases Intelligence LabOOSS 
Laboratory Database of Organisms from Sterile Sites 
Phone enquiries Dr Leslee Roberts 06 2897217 
***************************************************************************** 
CLERICAL 
Laboratory Code,,, Specimen Labnumber 
Specimen Collection Date 
PATIENT IDENTIFICATION 
Sumame Firstname 
Sex DOB If No DOB •• Age 
Post Code of patient 
Press Return to Continue •.•• 
LABCODE: All entries allowed 
<Ctrl-N>-Nev <Ctrl-F>-Find FS-Print F6-Delete F9-Choices Fl0-Done Rec= 
FIGURE 3. 
' 
Laboratory Code: Automatically entered 
Specimen Number: Either numbers or characters up to 8 in length, e.g. B000231. 
Date of Collection 
of Specimen: Format is dd/mm/yy. If this is not available enter the date the 
specimen was received by the laboratory. Compulsory field - if 
nothing is entered you cannot move to the next field. 
Surname: Enter the whole name - when the LDPOST program is executed, 
only the first 2 letters of the name will be sent to CDI. 
Firstname: 
Sex: 
DOB: 
January, 1992 
Enter the whole name, only the first 2 letters will be sent to CDI 
M = male F = female U = unknown 
Format is dd/mm/yy. The patient's age will automatically be calculated (as 
"Collection date" - "DOB") and presented in years. If the DOB is not 
entered the cursor will move to the age field where the age can be 
manually entered. The age field may be left blank. 
8 
Postcode of Residence 
of Patient: If this is not available please leave blank. If the specimen 
has been referred from interstate, but full postcode is 
unknown, please place first digit of state followed by 999, 
e.g. NSW is 2999. 
Press Return to Continue: Press <Enter> and cursor will move to the next screen 
CLINICAL INFORMATION - SCREEN 2 
**********************************************************************•******* 
CLINICAL 
Clinical Diagnosis 1 
Clinical Diagnosis 2 
Risk Factor 
Press return to continue ••• 
****************************************************************************** 
DIAGl: Valid values: 95, 02, 07, 20, 21, 03, 89, 88, 31, 30, 16, 99, A2, 09 
<~trl-R>-New <Ctrl-F>-F1na F)-Pr1nt Fti-Delete F~-cno1ces FlU-Done Rec= 
F!GURE4. 
D iag nos is 1: Press the <F9> Key . This will bring up all the options for this field. The 
appropriate number can be entered by typing it directly OR by highlighting 
it (using the <arrow> keys) and pressing the <Enter> key. Your choice will 
appear in words on the screen. If you want to leave the screen without 
making a selection use the <Escape> key. 
Diagnosis 2: Press the <F9> Key - contains the same options as diagnosis 1. 
Risk Factor: Press the <F9> Key . This will bring up all options for this field. Either 
enter in the number or highlighted choice. Other clinical information may 
be entered in the comments field. 
Press Return to Continue: Press <Enter> and cursor will move to the next screen 
Note: To move to previous screen use <up arrow>. 
January, 1992 
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MICROBIOLOGY - SCREEN3 
MICROBIOLOGY 
Source Tissue 1 Optional Source Tissue 2 
Isolated by Culture? 
If Antigen Detection •••••••• Method 
Organism Code 
serogroup 
Further Identification of organism 
Comments 
SOURCEl: Valid values: BL, CS, PF, PD, JF, OT You must enter data 
<Ctrl-N>-New cCtrl-F>-Find FS-Print F6-Delete F9-Choices Fl0-Done Rec= 
FIGURE 5. 
Source Tissue l: Is compulsory. The <F9> Key will bring up the options. Enter the 
code or press <Enter> on the highlighted choice. 
Source Tissue 2: May be used when two sources are present e.g. Blood and CSF. 
Press <F9> Key for options. 
Isolated by culture: Defaults to YES. To change to No, press "N". 
Antigen detection: Press <F9> Key for options. 
Organism: Press <F9> Key for a list of organisms in alphabetical order. To quickly 
arrive at a group of organisms, press the first letter, e.g. Y for Yersinia, OR 
use the <Page down> or <down arrow> key to work through this field. 
The appropriate organism code can be entered by typing it directly, e.g. 
ESO 1 for Ecoli OR by pressing <Enter> when the organism is 
highlighted. The name of the organism will appear on the screen. 
If there is no code for the organism, type the correct name in full in the 
Further Identification of Organism field. If you have chosen the wrong 
organism use the <up arrow> key to return to the field, press <F9> Key 
and select again. 
Serogroup: If applicable, e.g. enter B for Neisseria meningitidis type B, organism code 
NE02. 
Funher Identification of 
Organism: Use this for organisms that are not included in the code list (e.g. 
Staphylococcus warnerii) or where the identification is insufficient (e.g. 
Acinetobacter calcoaceticus var lwoffii). 
Comments: If applicable, e.g. resistance pattern, patient history, travel, occupation. 
To complete the record, the message "Write data to disk? YIN' will appear. Type "Y" to 
complete or, if there is an error in any field, type "N" to return to the beginning of that 
record. (The <FlO> Key will also enable "Write data to disk" but will end the "DITER" session if pressed 
while the cursor is on the last field). 
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3. BACKUP & RESTORE PROCEDURES 
Data backup is a most important part of any successful system. You can use either your existing 
backup procedures or the backup facility provided with the LabDOSS system as shown in the 
menu below: 
THIS IS THE LABDOSS2 SYSTEM BACKUP/RESTORE MENU 
-----------------------------------------------
BACKUP is a most important part of any successful system. The following 
options provide for backup or restore of all LABDOSS2.• & LDCDI.• files 
from the \EPIS directory on your C: drive. 
~ 
•• - .----- -~------ -4 -~,.-----~ -~---·-- ---- -- ·---··c---
LOBACKA to backup LABDOSS2.• & LDCDI.• files to A: drive. 
LDBACKB to backup LABOOSS2.• & LDCDI.• files to B: drive. 
LORESTA to restore LABDOSS2.• & LDCDI.• files from A: drive. 
LDRESTB to restore LABOOSS2.• & LDCDI.• files from B: drive. 
LDBK to run this Menu again • 
LDMENU to run the main LABDOSS2 Menu. 
C:\> 
FIGURE 6. BACKUP & RESTORE PROCEDURES FOR A: & B: DRIVES. 
To access this menu: 
Type LDBK at the DOS prompt (i.e. at C:\> or A:\>). 
i) The LabDOSS Backup facility uses the DOS BACKUP command. If it is necessary to 
Restore the data to your system, refer to the procedure in ii) below. 
To backup the LabDOSS data to the A: drive: 
Type LDBACKA at the DOS prompt (i.e. at C:\> or A:\>). 
The DOS BACKUP procedure will run and ask you to insert a diskette into the A: drive. 
(NOTE: It will then ask you to "Insert the last backup diskette ... " to enable backup or further files. If 
you have used only one diskette re-insert that diskette, or if you used more than one, insert the last 
diskette used.) 
Ensure each backup diskette is numbered in order and labelled. 
The diskette can either be formatted or unformatted - if unformatted, ensure the diskette is compatible with 
the default size of the drive (e.g. do not use a double density (or 360Kb) diskette in a 1.2Mb drive because 
the FORMAT command uses the default size of 1.2Mb). 
If the diskette is formatted, any size that can be operated in the diskette drive is acceptable. 
Files that are backed up using this procedure are LABOOSS2.* and LOCDI.*, where"*" means all extensions 
of those files. 
To backup the LabDOSS data to the B: drive: 
Type LDBACKB at the DOS prompt (i.e. at C:\> or A:\>). 
The DOS BACKUP procedure will run and ask you to insert a diskette into the B: drive. 
Freguency of backup, 
It is important that the backup be performed at the end of each day, Monday to Friday, and that 
diskettes are set aside for this purpose, QR, if only a small amount of data is entered, then at less 
frequent intervals (however, BACKUP should occur not less than weekly). 
January, 1992 
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Where you operate a daily backup procedure, the earliest backup diskette/s can be used on the 
first day of the following week. For example, use the Monday diskette/s on Monday of the 
following week, and the Tuesday diskettels on Tuesday of the following week, etc. 
Where you operate a less-than-daily backup procedure, keep at least three backups at any one 
time. The earliest backup diskettels can be used for the current backup. 
ii) The LabDOSS Restore facility uses the DOS RESTORE command using files that were 
backed up on your system from the BACKUP command. 
Ensure that the same version of DOS (e.g. 3.3) is used as was used in the BACKUP - this should not normally 
be a concern, however, because you would normally RESTORE to the same computer as you backed up 
from.) 
To restore the LabDOSS files to the A: drive: 
Type LDRESTA at the DOS prompt (i.e. at C:\> or A:\>). 
The DOS RESTORE procedure will run and ask you to insert a diskette into the A: drive. 
To restore the LabDOSS files to the B: drive: 
Type LDRESTB at the DOS prompt (i.e. at C:\> or A:\>). 
The DOS RESTORE procedure will run and ask you to insert a diskette into the B: drive. 
iii) LabDOSS files can also be backed up using the DOS COPY command by typing the 
following at the DOS prompt: 
COPY C:\EPI5\ filename A: (where filename is e.g. LABooss2.REC for one file or 
LABOOSS2. * for all files with the name LABOOSS2) 
In the COPY procedure, the number of files that can be copied to disk is restricted to the size of one 
disk, whereas with BACKUP the whole disk and subsequent disks are used to store files. 
A BACKUP file is different from a COPY file in that a backup file can only be accessed using the 
RESTORE command, whereas a copy file can be accessed directly. 
(Note: BACKUP and RESTORE in versions of DOS earlier than 3.3 are not compatible with version 3.3 or later.) 
January, 1992 
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4. LABORATORY WORKSHEET 
A Laboratory Worksheet (see following page), if required, is provided for data entry 
purposes. The worksheet provides a paper copy of the LabDOSS data and may be useful 
in the laboratory work flow. For example, clinical diagnosis and risk factor options may 
be selected prior to entering the data. 
A Laboratory "LabDOSS2 Worksheet" document file (LDWORK.rxx:) has been included on 
your LabDOSS diskette and may be mcxlified using EPED, the Epilnfo text editor. 
For editing in EPED refer to the EPIINFO Manual provided. 
January, 1992 
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CDI LabDOSS2 Worksheet 
Specimen Labnumber ____ _ 
Surname Firstname 
Collection Date / / 
Sex ------- ------
OOB I I If no OOB, Age__ Postcode of patients residence __ _ 
Diagnosis Attributable to Pathogen (May Select One or Two) 
95 Probable Contaminant 
02 Lower Resp Tract Infection (Pneumonia) 
20 Endocarditis Native Valve 
03 Meningitis 
88 UTI Post catheterisation/instrumentation 
30 Septic Arthritis 
09 Other, please write in comments 
Risk factor (May Select One) 
Surgery 
Immunosuppression 
70 Abdominal 
73 Thoracic 
79 Other surgery 
50HIV 
53 IV Drug use 
58 Malignancy 
99 No Diagnosis Provided 
07 Gastrointestinal disease 
21 Endocarditis Prosthetic 
89UTI 
31 Osteomyelitis 
16 Skin Cellulitis Wound 
A2 Died 
71 Orthopaedic 
74 Vascular 
72 Urinary Tract 
75 Neurological 
51 Neutropaenia 52 Diabetes 
54 Renal Failure 55 Transplant 
57 Other Immunocompromised 
IV Line 81 IV Peripheral 82 IV Central 
84 Other Vascular Prosthesis 
Miscellaneous 61 Pregnant 62 Postnatal 
68 Preterm Neonate 15 Trauma 
96 Hospital Acquired (greater than 48hrs after admission) 
Microbiology 
Source Tissues (May Select One or Two) 
BL= Blood CS= CSF PF= Pleural Fluid JF = Joint Fluid OT= Other 
Isolated by Culture? Y /N 
If antigen detection .... Method: 
LX = Latex Agglutination IF = Immunofluorescence OT = Other 
Organism _________________ _ Serogroup __ _ 
(if applicable) 
Further Identification of organism ____________________ _ 
Comments ________________________________ _ 
January, 1992 
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5. LIST OF ORGANISM CODES USED IN LABDOSS2 
AAOO 
AEOO 
AE0l 
ASOO 
AT0l 
BA0l 
BA02 
BAOO 
BTOO 
BT0l 
BT02 
BT03 
BT04 
BT0S 
BT06 
BT07 
BTOB 
BT09 
BROO 
BR0l 
BR02 
BR03 
BR04 
BH0l 
BHOO 
CAOO 
CA0l 
CB02 
CB03 
CBOO 
CIOl 
CI02 
CIOO 
CL02 
CLOO 
CMOO 
CM0l 
CM02 
CM03 
CR0l 
CR02 
CR03 
EN0l 
EN02 
ENOO 
ER0l 
ER02 
EROO 
ESOl 
FLOO 
FUOO 
GA0l 
GE0l 
"ACINETOBACI'ER SPECIES" 
"AEROMONAS SPECIES" 
"AEROMONAS HYDROPHILA" 
"ASPERGILLUS SPECIES" 
"ACTINOMYCES ISRAELII" 
"BACILLUS CEREUS" 
"BACILLUS SUBTILIS" 
"BACILLUS SPECIES" 
"BACTEROIDES SPECIES" 
"BACTEROIDES CORPORIS" 
"BACTEROIDES FRAGILIS" 
''BACTEROIDES LOESCHII" 
"BACTEROIDES MELANINOGENICUS" 
''BACTEROIDES ORALIS" 
''BACTEROIDES OVA TUS" 
''BACTEROIDES THET AIOTOMICRON" 
"BACTEROIDES BIVIUS" 
"BACTEROIDES DISIENS" 
"BRUCELLA SPECIES" 
"BRUCELLA ABORTUS" 
"BRUCELLA MELITENSIS" 
"BRUCELLA SUIS" 
"BRUCELLA CANIS" 
"BRANHAMELLA CAT ARRHALIS" 
"BRANHAMELLA SPECIES" 
"CANDIDA SPECIES" 
"CANDIDA ALBICANS" 
"CORYNEBACTERIUM JK" 
"CORYNEBACTERIUM XEROSIS" 
"CORYNEBACTERIUM SP" 
"CITROBACTER DIVERSUS" 
"CITROBACTER FREUNDII" 
"CITROBACTER SPECIES" 
"CLOSTRIDIUM PERFRINGENS" 
"CLOSTRIDIUM SPECIES" 
"CAMPYLOBACTER SPECIES" 
"CAMPYLOBACTER JEJUNI" 
"CAMPYLOBACTER COLI" 
"CAMPYLOBACTER FETUS " 
"CRYPTOCOCCUS NEOFORMANS" 
"C NEOFORMANS-GA TTII" 
"C NEOFORMANS-NEOFORMANS" 
"ENTEROBACTER AEROGENES" 
"ENTEROBACTER CLOACAE" 
"ENTEROBACTER SPECIES" 
"ENTEROCOCCUS FAECALIS" 
"ENTEROCOCCUS FAECIUM" 
"ENTEROCOCCUS SPECIES" 
"ESCHERICHIA COLI" 
"FLA VOBACTERIUM SP" 
"FUSOBACTERIUM SP" 
"GARDNERELLA V AGIN ALIS" 
"GEMELLA MORBILLORUM" 
GEOO 
HM02 
HM03 
HP0l 
KI0l 
KL0l 
KL02 
KLOO 
LIOl 
MR0l 
NE02 
NE0l 
PAOO 
PDOO 
PEOO 
PIOO 
PP0l 
PPOO 
PR02 
PR0l 
PROO 
PS0l 
PS02 
PS03 
PS04 
PSOS 
PS06 
PSOO 
SL0l 
SL02 
SLOO 
SS01 
SS02 
ssoo 
SHOO 
SA01 
SA02 
SA03 
SANO 
SE0l 
SE02 
SE04 
SE0S 
SE06 
SE07 
SE08 
SE09 
SE11 
SE12 
SEOO 
VIOO 
YE01 
"GEMELLA SP" 
"HAEMOPHILUS INFLUENZAE" 
"HAEMOPHILUS P ARAINFLAE" 
"HISTOPLASMA CAPSULA TUM" 
"KINGELLA KINGAE" 
"KLEBSIELLA PNEUMONIAE" 
"KLEBSIELLA OXYTOCA" 
"KLEBSIELLA SP" 
"LISTERIA MONOCYfOGENES" 
"MORGANELLA MORGANTI" 
'NEISSERIA MENINGITIDIS" 
'NEISSERIA GONORRHOEA" 
''P ASTEURELLA SP" 
''PROVIDENCIA SP" 
''PEPTOSTREPTCX::OCCUS SP" 
''PLESIOMONAS SP" 
''PROPIONIBACTERIUM ACNES" 
''PROPIONIBACTERIUM SP" 
''PROTEUS VULGARIS" 
''PROTEUS MIRABILIS" 
"PROTEUS SP" 
"PSEUD AERUGINOSA" 
"PSEUD CEP ACIA" 
"PSEUD FLUORESCENS" 
"XANTHOMONAS MAL TOPHILIA" 
"PSEUD PAUCIMOBILIS" 
"PSEUD PICKETTII" 
"PSEUD SP" 
"SALMONELLA TYPHI" 
"SALMONELLA PARA TYPHI" 
"SALMONELLA SP" 
"SERRA TIA LIQUEF ACIENS" 
"SERRA TIA MARCESCENS" 
"SERRA TIA SP" 
"SHIGELLA SP" 
"STAPH AUREUS" 
"STAPH EPIDERMIDIS" 
"STAPH SAPROPHYTICUS" 
"STAPH COAG NEG" 
"STREP PNEUMONIAE" 
"STREP A" 
"STREP B" 
"STREP C" 
"STREP D NONENTERO" 
"STREP F ' 
"STREP G" 
"STREP SANGUIS" 
"STREP VIRIDANS" 
"STREP MILLER! II 
"STREP SP" 
'VIBRIO SP" 
''YERSINIA ENTEROCOLIT A" 
If no code exists for an organism enter the whole name in the "Further Identification of Organism" field. 
If you would like further codes included in the Labdoss lookup table please phone or send a note 
with your CDI diskette report. 
January, 1992 
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6. ANALYSIS REPORT EXAMPLES 
Analysis Reports of LabDOSS data in Epil nfo are provided in the following examples. 
To produce each report: 
Notes: 
Type LOAN at the DOS prompt (i.e. at C:\> or A:\>) 
(or select the ANALYSIS option from the Epilnfo menu) 
then use the commands listed in each section. 
The codes used in the database fields { ORGANISM, DIAGl, DIAG2, RISK} have been decoded 
for the purpose of each report. 
Assistance with decoding may be obtained from the authors. 
The select command alone cancels the selection. 
The reports are provided only as examples of the steps involved in analysing your own 
data. The data shown here has been modified for purposes of illustration. 
January, 1992 
16 
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i) 
Commands 
Read LABDOSS2.REc 
Select ORGANISM= "SAOI" 
List AGE SEX DIAGl RISK 
Select 
Current selection: ORGANISM = "SAOI" 
AGE SEX DIAGl 
M 
M 
F 
M 
M 
M 
M 
u 
M 
M 
M 
M 
M 
M 
M 
M 
16 
20 
16 
89 
SKIN CELLULITIS WOUND 
ENDOCARDITIS NATIVE 
SKIN CELLULITIS WOUND 
UTI 
RISK 
81 
52 
81 
52 
53 
58 
75 
75 
66 
71 
31 
54 
41 
53 
65 
58 
56 
64 
75 
69 
74 
73 
73 
89 . . . 
IV PERIPHERAL 
DIABETES 
IV PERIPHERAL 
DIABETES 
IV DRUG 
MALIGNANCY 
:JJI1:1I1:1IIIII1IIII11Ili:i:J\{tli:1:IIiI1:J)t\J:t:ItIIt1I1IJII1I1\1:JI1)It1:f :1It1II1:JI1:1:1:1I:II1:1I1:1II1:1:1:1I1:1I: 
ii) 
Commands 
Read LABDOSS2.REC 
Select ORGAN1SM = "SAOI" 
Histogram AGE 
Select 
Histov-am of A_{re in Patients with Stavhulococcus aureus isolates 
10 
9 
8 
7 
6 -C 
~ 
5 
CJ 4 
3 
2 
1 
0 
c=;:. I ,.- ~~~~~~:~~~~~~~R~~~~:~ 
AGE 
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B. Infective Endocarditis involving Native Valves 
i) 
Commands 
Read LABDOSS2.REC 
Select (DIAGl = "20") or (DIAG2 = "20") 
List AGE SEX ORGANISM FURlliERIDl 
Select 
AGE SEX ORGANISM 
33 M 
FURTHERIDl 
28 F CBOO CORYNEBACTERIUM SP 
MORAXELLA 
C.DIPHTHERIAE 
41 M SA0l STAPH AUREUS 
C. Neisseria menigjtidis Bacteraemia 
i) 
Commands 
Read LABDOSS2.REC 
Select ORGANISM = "NE02" 
Define MTHS ### 
Set EUROPEAN = ON 
Let Mrns = (COLLECTDAT- DoB)/31 
List SERO AGE Mrns SEX SOURCEl DIAGl 
Select 
Current selection: ORGANISM = "NE02" 
SERO AGE 
NEISSERIA MENINGITID C 2 
NEISSERIA MENINGITID C 14 
NEISSERIA MENINGITID C 0 
NEISSERIA MENINGITID u 3 
NEISSERIA MENINGITID C 6 
NEISSERIA MENINGITID C 4 
NEISSERIA MENINGITID C 9 
January, 1992 
MTHS SEX SOURCEl 
29 F cs 
166 cs 
5 M BL 
42 M BL 
76 F cs 
58 M cs 
116 M BL 
DIAGl 
03 MENINGITIS 
03 MENINGITIS 
03 MENINGITIS 
03 MENINGITIS 
03 MENINGITIS 
03 MENINGITIS 
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D. Patients with Hospital Acquired Infections 
lIIllllillll!lilillIIl!lltFit:\tilf / l/l{]lIJtf ll)lt:tI\llllt::1:1:irrn:1::11:tJIJII]:::i:tt}ltl]::t:11ItI::11:1::irn1t1:1:1:::1::J 
i) 
Commands 
Read LABDOSS2.REC 
Select RISK = "96" 
List AGE SEX ORGANISM FURTHERIDl 
Select 
AGE SEX ORGANISM FURTHERIDl 
0 M. . . ENTEROCOCCUS FAECALIS 
54 M . KLEBSIELLA, CITROBACTER, MRSA 
29 M . . BACTEROIDES FRAGILIS, S.AUREUS 
46 F CBOO CORYNEBACTERIUMSP 
63 M ENDO ENTEROBACTER SPECIES 
24 F ESOl ESCHERICHIA COLI 
78 F ES01 ESCHERICHIA COLI 
83 M ES01 ESCHERICHIA COLI 
22 M FUOO FUSOBACTERIUM SP 
11
1
1 53 M PSOl PSEUD AERUGINOSA 
78 M PS01 PSEUD AERUGINOSA 
74 M PSOl PSEUD AERUGINOSA 
M PS02 PSEUD CEP ACIA 
66 F SAOl STAPH AUREUS 
54 M SA01 STAPH AUREUS 
18 M SANO STAPH COAG NEG 
53 M SANO STAPH COAG NEG 
53 M SANO STAPH COAG NEG 
62 M SANO STAPH COAG NEG 
0 M SANO STAPH COAG NEG 
30 F SANO STAPH COAG NEG 
0 M SEOl STREP PNEUMONIAE 
fl•· 
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D. Patients with Hospital Acquired Infections - cont'd 
ii) 
Commands 
Read LABDOSS2.REC 
Select RISK = "96" 
Pie ORGANISM 
Select 
FUS08ACTERIUM SP C5.3i.) SCHEAIC'HJ A COLI <15. Bi.) 
PSEUD AERUGJNOSA C15.8i.) 
PSEUO CEPACJA <5.3i.) 
STAPH AUREUS C10.5i.) 
ENTER08ACTER SPECIES C5.3i.) 
COR~NEBACTERIUM SP C5.3/.) 
STREP PNEUNONIAE C5.3i.) 
STAPH CMG NEG C31. 6i:) 
Note: The organisms have been decoded for the purpose of demonstration. 
The command Pie ORGANISM will produce the same graph, however the organism names will be in code. 
iii) 
Commands 
Read LABDOSS2.REC 
Select RISK= "96" 
Freq ORGANISM 
Select 
ORGANISM ! Freq Percent Cum. 
I 
CORYNEBACTERIUMSP ! 1 5.3% 5.3% 
ENTEROBACTERSPECIES ! 1 5.3% 10.5% 
ESCHERICHIA COLI !3 15.8% 26.3% 
FUSOBACTERIUM SP ! 1 5.3% 31.6% 
PSEUD AERUGINOSA !3 15.8% 47.4% 
PSEUD CEP ACIA ! 1 5.3% 52.6% 
STAPH AUREUS !2 10.5% 63.2% 
STAPH COAG NEG !6 31.6% 94.7% 
STREP PNEUMONIAE ! 1 5.3% 100.0% 
Total ! 19 100.0% 
January, 1992 
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i) 
Commands 
AGE 
Read LABDOSS2.REC 
Select (DIAGl = "89") OR DIAG2 = "89") 
List AGE SEX ORGANISM FURTHERIDl 
Select 
SEX ORGANISM 
57 F ENDO ENTEROBACTER SPEOES 
55 M 
84 F 
70 F 
76 F 
91 F 
F 
46 M 
39 M 
80 F 
79 F 
78 M 
74 M 
F 
ii) 
Commands 
ESOl 
ES01 
ES01 
ES01 
ES01 
ESOl 
ES01 
ES01 
ESOl 
KLOO 
PS01 
SAOl 
SANO 
Read LABDOSS2.REC 
ESCHERICHIA COLI 
ESCHERICHIA COLI 
ESCHERICHIA COLI 
ESCHERICHIA COLI 
ESCHERICHIA COLI 
ESCHERICHIA COLI 
ESCHERICHIA COLI 
ESCHERICHIA COLI 
ESCHERICHIA COLI 
KLEBSIELLA SP 
PSEUD AERUGINOSA 
STAPH AUREUS 
STAPH COAG NEG 
Select (DIAG1 = "89") or (DIAG2 = "89") 
Tables ORGANISM SEX 
Select 
SEX 
ORGANISM !F M! 
-------!------------!----
ENTEROBACTER SPECIES 
ESCHERICHIA COLI 
KLEBSIELLA SP 
PSEUD AERUGINOSA 
STAPH AUREUS 
STAPH COAG NEG 
iii) 
Commands 
Read LABDOSS2.REC 
! 1 
!6 
! 1 
!O 
!O 
! 1 
---! 
Total ! 9 
Select (DIAG1 = "89") or (DIAG2 = "89") 
Freq SEX 
Select 
SEX ! Freq Percent Cum. 
I 
F ! 9 64.3% 64.3% 
M !5 35.7% 100.0% 
I 
Total ! 14 100.0% 
January, 1992 
0 ! 
3 ! 
0 ! 
1 ! 
1 ! 
0 ! 
-!---
5 ! 
Total 
1 
9 
1 
1 
1 
1 
14 
FURTHERIDl 
MIXED COAG. NEG 
STAPHYLOCOCCI 
111 
I' 
!11 I 
21 
fi:rnirnHl,liiii&TI1!;ii1!1i,Jiii1i1LliiOOi\1tirli11m!l111;i/:!i:ril1l!l1uiz;11nt111i1nt111HMlii@i!wr1111111;;;;;gg;11 
i) 
Commands 
Read LABIX)SS2.REC 
Select ORGANISM = "HM02" 
Define Mrns ### 
Set EUROPEAN= ON 
Let MTI-IS = (COLLECTDAT- DoB)/31 
Sort Mrns 
List ORGANISM SERO AGE MTI-IS SEX SOURCEl DIAGl 
Select 
ORGANISM SERO AGE MTHS SEX SOURCEI 
HM02 
HM02 
HM02 
HM02 
HM02 
HM02 
HM02 
HM02 
HM02 
HM02 
ii) 
Commands 
B 
B 
B 
. 
B 
B 
B 
B 
B 
B 
0 
0 
0 
0 
0 
1 
1 
1 
1 
4 
Read LABDOSS2.REC 
5 
7 
8 
8 
8 
13 
15 
14 
14 
52 
Select ORGANISM = "HM02" 
Define MTHS ### 
Set EUROPEAN = ON 
M 
M 
M 
F 
M 
M 
. 
M 
Let Mrns = (COLLECTDAT- DoB)/31 
Freq DIAGl 
Select 
BL 
BL 
BL 
BL 
BL 
BL 
cs 
BL 
BL 
BL 
DIAGl ! Freq Percent Cum. 
I 
LRTI - PNEUMONIA !2 22.2% 22.2% 
MENINGms !3 33.3% 55.6% 
SKIN CELLULffiS WOUND !4 44.4% 100.0% 
I 
Total ! 9 100.0% 
January, 1992 
16 
02 
16 
16 
16 
03 
03 
03 
02 
DIAGI 
SKIN CELLULITIS WOUND 
LRTI - PNEUMONIA 
SKIN CELLULITIS WOUND 
SKIN CELLULITIS WOUND 
SKIN CELLULITIS WOUND 
MENINGITIS 
MENINGITIS 
MENINGITIS 
LRTI - PNEUMONIA 
Section 1 Appendix B CDI Reporting Forms 
~ vommonwealth l Department of Communicable Diseases Intelligence Pathogen Report . .- ~ Health 
1. 2. 3. 4. 
I I I I I I I I I I I I I I I I I : Laboratory I I 
3 1 3 1 3 1 3 I I, 1 I, ,, 
I I I I I I I I I I I I I I I 
I 
I I I I I I, tpathogen 
i! 4 7 4 7 4 7 4 7 
j 
I I I I ID• I I I I ID• I I I I ID• I I I I ID• Patient l 8 11 12 13 14 8 11 12 13 14 8 11 12 13 14 8 11 12 13 14 
[D[D [D[D [D[D [D[D 
I 
:ol lection date Yr/Mth Yr/Mth Yr/Mth Yr/Mth 
15 16 17 18 15 16 17 18 15 16 17 18 15 16 17 18 
I 
< 1 Mth = 1 < 1 Mth = 1 < 1 Mth = 1 < 1 Mth = 1 
I 1. 
1-12 Mths = 2 1-12 Mths = 2 1-12 Mths = 2 1-12 Mths = 2 
1--4 yrs= 3 1--4 yrs= 3 1--4 yrs= 3 1--4 yrs= 3 I j 
~ge 
5-14 yrs= 4 • 5-14 yrs= 4 • 5-14 yrs= 4 • 5-14 yrs= 4 • 15-24 yrs= 5 15-24 yrs= 5 15-24 yrs= 5 15-24 yrs= 5 25--44 yrs = 6 25-44 yrs= 6 25--44 yrs= 6 25--44 yrs = 6 45-64 yrs= 7 19 45-64 yrs= 7 19 45-64 yrs= 7 19 45-64 yrs= 7 19
65-74 yrs= 8 65-74 yrs= 8 65-74 yrs= 8 65-74 yrs= 8 
> 75 yrs= 9 > 75 yrs= 9 > 75 yrs= 9 > 75 yrs= 9 
I 
--,:,ex Mor F • Mor F • Mor F • Mor F • 20 20 20 20
:ategory of 
Patient= 1 • Patient= 1 • Patient= 1 • Patient= 1 • Survey= 2 Survey= 2 Survey= 2 Survey= 2 nfection Colonisation = 3 Colonisation = 3 Colonisation= 3 Colonisation= 3 Nosocomial = 4 21 Nosocomial = 4 21 Nosocomial = 4 21 Nosocomial = 4 21 
I • • • • Host Living= L Living= L Living= L Living= L condition Dead= D 22 Dead= D 22 Dead= D 22 Dead= D 22 
I :linical [D[D[D [D[D[D [D[D[D [D[D[D nformation 
23 24 25 26 27 28 23 24 25 26 27 28 23 24 25 26 27 28 23 24 25 26 27 28 
Source [D[D[D [D[D[D [D[D[D [D[D[D :issues 
' 29 30 31 32 33 34 29 30 31 32 33 34 29 30 31 32 33 34 29 30 31 32 33 34 I ,. 
Method of [D[D[D [D[D[D [D[D[D [D[D[D .isolation 
~ ~ 35 36 37 38 39 40 35 36 37 38 39 40 35 36 37 38 39 40 35 36 37 38 39 40 
Method of [D[D[D [D[D[D [D[D[D [D[D[D identification 
I 41 42 43 44 45 46 41 42 43 44 45 46 41 42 43 44 45 46 41 42 43 44 45 46 
/1 technique diag. technique diag. technique diag. technique diag. technique diag. technique diag. technique diag. technique diag. 
1' Serology •••• •••• •••• •••• I I 47 48 49 50 51 52 47 48 49 50 51 52 47 48 49 50 51 52 47 48 49 50 51 52 
' 
' [D[D[D [D[D[D [D[D[D [D[D[D 1 l\ntibiotic 
· sensitivity 53 54 55 56 57 58 53 54 55 56 57 58 53 54 55 56 57 58 53 54 55 56 57 58 
'if applicable) [D[D[D [D[D[D [D[D[D [D[D[D I 
J 59 60 61 62 63 64 59 60 61 62 63 64 59 60 61 62 63 64 59 60 61 62 63 64 
1! ' Complete= 1 • Complete= 1 • Complete= 1 • Complete= 1 • ~Yirus typing Pending= 2 Pending= 2 Pending= 2 Pending= 2 ~,I Untypable = 3 65 Untypable = 3 65 Untypable = 3 65 Untypable = 3 65
11 ,o 
lf1 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II 66 72 66 72 66 72 66 72 
'11  
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I Central office use 73 79 73 79 73 79 73 79 
only 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 11 I I 80 86 80 86 80 86 80 86 
) 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I ' \ I 
87 93 87 93 87 93 87 93 
! 
II i I 
Ii 
'1 ·~-
,I I 
,, : Fomments 
I 
I 
I! (  
I ~ l~ 
r 
I 
~ I I •,, H84 {8/11:i) - - -
., -~ 
I Laboratory 
ri Patient 
I 
'J 
I' Sex 
i 
Age I 
I 
, Patient (1) 
. Survey (2) n 
II 
Syndrome 
' Collection date 
Life (1) 
PM (2) 
Source tissues 
' 
I 
/ 1 Isolation method 
,I 
I' r Direct ldent. 
: method 
I 
I 
I 
I 
~ I 
Serology 
Virus 
Typing 
Central 
Office Use 
Only 
Comments 
I 
Communicable Diseases Intelligence - Virus Report 
1 2 3 
1 3 ' 1 3 1 3 
- - -I I 
' 
- - '---
4 78 9 10 4 78 9 10 4 7 8 9 10 
- - -
- - -
11 11 11 
rt < 1 year, If < 1 year, If < 1 year, 
enter months. · enter months. enter months. 
12 13 12 13 12 13 
I 
. If > 1 year, If > . 1 year, 
1 
If > 1 year, 
enter years. ' . enter years. ! enter years. 
14 15 14 15 14 15 
ii - 1 -- ' 
; . L__J 
16 16 : ~ 
' 
mcc I ii I I I I I I I I I I I i I I ' ' 17 1819 20 17 1819 20 17 1819 20 
I : ! i 
I I 
I ! 
I I i I I ; I ' I : I 
I I I I 
: i I I i I I I 
' I I ; I I i ' I I I I I I I ' ' 21 26 l 21 26 21 26 
I ' ----, ,- , I ,~ 
i I I I - - ; -27 ! 27 27 
I 
I I IDJC I '. i I : ! I ' I ;  ' I : . I 1i I I I I I I I ' ' 
28 29 30 31 32 33 I 28 29 30· 31 32 33 28 29 30 31 32 33 
i ' rnmc== ! i ii I I ; 'i ! I ,, I :1 ! I ! I , I I I 
34 35 36 37 38 39 34 35 36 37 38 39 i 34 35 36 37 38 39 
I : I !I I '' i I :i IC 1 I I 11 I I I I ' I ' 'I I I 
40 41 42 43 44 45 I 40 41 42 43 44 45 ! 40 41 42 43 44 45 
' 
I 
! 
technique I 
' ' .-, I I Id. . jl i I ~ ' I i i diagnosis ' 1 technique ! I I I I , 1agnos1s_ technique diagnosis l.__ 
46 47 48 46 47 48 46 47 48 
. 
I I I. I I I I I I I I 
I ' I I I I 
49 52 49 52 I 49 52 
I • • 1• 53 53 53 
l 1·1·1 I I I ~~-- ~--[·Lr 1 ·T l I w LJ 
54 58 54 58 54 58 
I I I - I . I I I I I I I I I I I i I I 
59 63 59 63 59 63 
I I I I I I I I I I I. I I I -1 I I I 
64 68 64 68 · · 64 68 
4 
1 3 
-
-
4 7 8 9 . ,-
-
-
11 
-
If < 1 year, 
enter months. 
12 1 3 
I 
1 
If > 1 year, 
enter years. 
14 1 5 
r-
I 
16 
;L I 
I ' 
i 17 1819 20 
I 
I . 
i I I I . : 
I 
I I 
I I ' 
; 21 26 
I ,,- , 
I I 
L 
27 
'' ' 
, , 
I I 
i I 
28 29 30 31 32 33 
I 
; ~ . I ' ' 
! i 
34 35 36 37 38 39 
i I ' 
'i 
40 41 42 43 44 45 
technique [ 
I ,-
' ' 
1 diagnosis • __ 
46 47 48 
1 
I i I I I 
! 49 52 
I 
!• 
53 
I I I l ·r1 
. 54 58 
! I I I I l 
59 63 
I I I I I I 
·54 68 
l I 
I ~i 
:i I. 
ti 
" 
1, 
I• 
11 
• Communicable Diseases Intelligence - Laboratory Report 1 2 3 
I 1 
Laboratory 11 I 
j I I 
~ J • Clerical 
Lab Patient ID 
Collection date 
' ' ' I ' ' ' I 
I I I I I I I I 
I 11 : II I ii~. -11 ~· ~II ~I ~ ~- :-1-1 ~lc=J~~ 
dd mm yy . dd mm yy_--+-- dd mm~ y~y -------< 
SN FN SN FN SN FN 
Initials I : II~ CJCJ CJ~I .~I 
Sex D 1• • Mor F --+--
Date of birth I dd 11 : w~ 
mm yy 
I 11 : 11 I 
dd !Tlm yy 
I . 11 11 I 
dd mm yy 
if no DOB then 1 ~ 
Age years I I years [:=]years 
Postcode 1 1 I 
• Clinical 
Clinical 
diagnosis 1_ 11 I 
Risk factor Outcome 
l I I 
I II _I I 11 I 
+-
Risk factor Outcome I Risk factor Outcome 
D ~ ~~~~ived I I ~----~----------'--____ U Unknown I~--~-
Risk factor 
and outcome I I D ~ ~~~~1ved 11 I U Unknown D DDied S Survived U Unknown 
,, • Microbiology 
I 
ti 
,iii 
:,1 
111 
I , 
f: ii 
~ :· 
.:,1 
Source tissues 
Method of 
detection 
I 
I II I 11 : 11 : I I . II I 
lsoJation '----------'--- ---t Isolation _:=-~ ~ 
D (YIN) D (Y/N) D (Y/N) 
Antigen ~ Antigen ~ Antigen 
I : II I I II : I I l~I ~I 
Antibody ~ Antibody ~ Antibody 
I . IIJ I ID I . IIJ I ID 4 ID I II J 
I Organism I I I I I I I 
I 
I 
Serogroup 
if applicable 
Further 
identification 
of organism 
Comments 
eg outbreak 
occupation 
CDI Office 
use only 
I 
I 
I I I I I I : I 
--
-
I I 
] I 
I 
_11 
1703 (9203) 
II 
II 
~ 
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********************************************************************* 
* PROGRAM NAME: LDANPRE9.PGM Preliminary Program 
* This program produces two tables: org and furtherid; organism, comments, 
* diag 1, risk 1 and risk2. 
* This allows for updating of the merged data file with more complete 
* codes prior to running the analysis program. 
* 
* The tables are written to a .doc file called vvnnprel.doc and the 
* records are written to a .rec file called vvnnprel.rec. 
* where vv is the volume and nn is the number of the 
* CDI issue in which the data will be published. 
* Sept93 
*********************************************************************** 
** 
SET NOECHO = ON 
SET STATISTICS= OFF 
SET LISTREC = OFF 
SET NOECHO=ON 
READ ?type in name of merged file to read ? 
* Before Processing ensure that adequate codes have been entered for organism 
* Identification. 
ROUTE ? type in text file name eg vvnnprel.doc ? 
set ignore = off 
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********************************************************************** 
* Decoding data and grouping into extra fields 
* 
* 
***The recodings listed below are not literal decodes . These are 
***grouped for the purpose of CDI 
*** Accurate decodes can be found in decode.prg 
*********************************************************************** 
define agegroup <A > 
define m ths ### 
let mths = (collectdat - dob) /31 
recode mths to agegroup O = 11 <lmth11 1-11 = 11 1-1 lmth''\ 
12 = II 1-4 II 
recode age to agegroup 1-4=11 1-411 5-14=11 5-14 11 15-24=11 15-24''\ 
25-34= 11 25-34 11 35-44=11 35-4411 45-54= 1145-54 11 55-64="55-64" \ 
65-74= 11 65-74" 75-110= 1175+" 
** Spaces in recodes gives correct order for Agegroup 
if age = . then age group = 11 u 11 
*if risk = 11 68 11 then agegroup = " <lmth 11 
if mths = . and age = 0 then agegroup = 11 l-l lmth 11 
if mths = . and age = 0 and riskl = "68" then agegroup = " <lmth 11 
if agegroup = . then agegroup = mths 
**** This allows records with no agegroup classification to be listed in 
**** the table under individual months and the record can than be manually 
**** placed in the correct agegroup. 
define clinical _ 
recode diag 1 to clinical \ 
02=LRT 07=Gas 20=End \ 
21=End 03=Men 89=UTI 88= UTI \ 
recode diagl to clinical 3 l="B/J" 30="B/J" 16=Skn \ 
*not needed in table 99="nil" 
* not needed in table A2="Die" 
l I 
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define diagnosis _ 
recode diag2 to diagnosis\ 
02=LRT 07=Gas 20=End \ 
21=End 03=Men 89=UTI 88= UTI \ 
recode diag2 to diagnosis 3 l="B/J" 30="B/J" 16=Skn \ 
* not needed in table 99="nil" A2="Die" 
define risks 
recode risk 1 to risks 70=Surge 7 l=Surge 72=Surge \ 
73=Surge 74=Surge 75=Surge 79=Surge \ 
recode risk 1 to risks\ 
58=Immun/com 50=Immun 5 l=Immun \ 
52=Immun 53=Immuno 
recode riskl to risks\ 
54=Immun 55=Immun 57=Immun 
recode risk 1 to risks\ 
81="IV Ln" 82="IV Ln" 84="IV Ln" 61= "P/P.n''\ 
62="P/P.n" 68= Neona 96="HospAc" 
* not needed in table 15 = trauma 
define risks2 
recode risk2 to risks2 70=Surge 7 l=Surge 72=Surge \ 
73=Surge 74=Surge 75=Surge 79=Surge \ 
recode risk2 to risks2\ 
58=Immun/com 50=lmmun 5 l=lmmun \ 
52=lmmun 53=lmmuno 
recode risk2 to risks2\ 
54=lmmun 55=Immun 57=Immun 
recode risk2 to risks2\ 
8 l="IV Ln" 82="IV Ln" 84="IV Ln" 61= "P/P.n''\ 
62="P/P.n" 68= Neona 96="HospAc" 
if risk 1 = "96" then HospAcq = "y" 
if risk2 = "96" then HospAcq = "y" 
if comments = "risk=96" then HospAcq = "y" 
sort organism 
*****Classification or organisms into gram pos neg 
***** anaerobes and fungi for CDI report 
l 
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define class <A> 
recode organism to class AAOO = "N" AAO3 = "N" AEOO = "N" AEO 1 = "N" ASOO = 
"F'\ 
ATOl = "A" BAOl ="P" BAO2 ="P" BAOO ="P" BTOO = "A" BTOl = "A" BTO2 = 
"A" BTO3 = "A'\ 
BTO4 = "A" BTO5 = "A" BTO6 = "A" BTO7 = "A" BTO8 = "A" 
recode organism to class BTO9 = "A" BROO = "N" BROl = "N" BRO2 = "N'\ 
BRO3 = "N" BRO4 = "N" BHO 1 = "N" BHOO = "N" CAOO = "F" CAO 1 = "F" CBO2 
="P'\ 
CBO3 ="P" CBOO ="P" CIOl = "N" CIO2 = "N" CIOO = "N" CLO2 ="A" CLOS ="A" 
recode organism to class CLOO ="A" CMOO = "N" CMOl = "N" CMO2 = "N'\ 
CMO3 = "N" CRO 1 = "F" CRO2 = "F" CRO3 = "F" ENO 1 = "N" ENO2 = "N" ENOO = 
"N'\ 
EROl = "P" ERO2 = "P" EROO ="P" ESOl = "N" FLOO = "N" FUOO = "A" 
recode organism to class GAOl = "N" GEOl = "N" GEOO = "N" HMO2 = "N'\ 
HMO3 = "N" HPOl = "F" KIOl = "N" KLOl = "N" KLO2 = "N" KLOO = "N" LIOl 
="P'\ 
MRO 1 = "N" MXOO = "N" NEO2 = "N" NEO 1 = "N" NEOO = "N" P AOO = "N" PDOO 
= "N" PEOO = "A" 
recode organism to class PIOO = "N" PPOl = "A" PPOO = "A" PRO2 = "N'\ 
PRO 1 = "N" PROO = "N" PSO 1 = "N" PSO2 = "N" PSO3 = "N" PSO4 = "N" PSO5 = 
"N'\ 
PSO6 = "N" PSOO = "N" SAOl ="P" SAO2 ="P" SAO3 ="P" SANO ="P" SAMR ="P" 
recode organism to class SEO 1 ="P" SEO2 ="P" SEO4 ="P" SEO5 ="P" SEO6 ="P'\ 
SEO7 ="P" SEO8 ="P" SEO9 ="P" SEl 1 ="P" SE12 ="P" SEOO ="P" SHOO = "N'\ 
SLOl = "N'' SLO2 = "N" SLOO = "N" SSOl = "N" SSO2 = "N" SSOO = "N" VIOO = 
"N" YEO 1 = "N" 
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define org _____________ _ 
recode organism to org AAOO="Acinetobacter species" AAO3="Acinetobacter calc 
var lwoffi" \ 
AEOO="Aeromonas species" AIOO = "Alcaligenes sp" AEOl="Aeromonas 
hydrophila" \ 
ASOO="Aspergillus species" ATOl="Actinomyces israelii" BAOl="Bacillus cereus" 
recode organism to org BAO2="Bacillus subtilis" BAOO="Bacillus species" 
recode organism to org BTOO="Bacteroides species" BTO l="Bacteroides corporis" 
\ 
BTO2="Bacteroides fragilis" BTO3="Bacteroides loeschii" BTO4="Bacteroides 
melaninogenicus"\ 
BTO5="Bacteroides oral.is" BTO6="Bacteroides ovatus" BTO7="Bacteroides 
thetaiotaomicron" 
recode organism to org BTO8="Bacteroides bivius" BTO9="Bacteroides disiens" \ 
BROO="Brucella species" BROl="Brucella abortus" BRO2="Brucella melitensis" \ 
BRO3="Brucella suis" 
recode organism to org BRO4="Brucella canis" BHO l="Branhamella catarrhalis"\ 
BHOO="B1'1'1'.1'ranhamella species" CAOO="1'1'Candida species" CAO l="Candida 
albicans"\ 
CAO2 = "Candida parapsilosis" CBO2="Corynebacterium jeikeium" 
CBO3="Corynebacterium xerosis" 
recode organism to org CBOO= "Corynebacterium species" CIOl="Citrobacter 
di versus"\ 
CLOS = "Clostridium septicum" 
recode organism to org CIO2="Citrobacter freundii" CIOO="Citrobacter species" 
CLO2="Clostridium perfringens"\ 
CLOO="Clostridium species" CMOO="Campylobacter species" 
CMO l="Campylobacter jejuni" 
recode organism to org CMO2="Campylobacter coli" CMO3="Campylobacter fetus 
" CROl="Cryptococcus neoformans"\ 
CRO2="Cryptococcus neoformans var gattii" CRO3="Cryptococcus neoformans var 
neoformans" 
I I 
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recode organism to org EI0 l="Eikenella corrodens" ENO l="Enterobacter 
aero genes"\ 
EN02="Enterobacter cloacae" EN00="Enterobacter species" ER0l="Enterococcus 
faecalis"\ 
ER02="Enterococcus faecium" ER00="Enterococcus species" ES0l="Escherichia 
coli" 
recode organism to org FL00="Flavobacterium sp" FU00="Fusobacterium sp''\ 
GA0l _ "Gardnerella vaginalis" GE0l="Gemella morbillorum" GE00="gemella sp''\ 
HM02="Haemophilus influenzae" HM03="Haemophilus parainfluenzae" 
HP0l="Histoplasma capsulatum" 
RECODE ORGANISM TO ORG ki0l="Kingella kingae" kl0l="Klebsiella 
pneumoniae" k.102="Klebsiella oxytoca''\ 
kl00="Klebsiella sp" li0 !="Listeria monocytogenes" mrO l="Morganella morganii''\ 
mc00="Micrococcus species" NE02="Neisseria meningitidis" Ne0l="Neisseria 
gonorrhoeae" 
RECODE ORGANISM TO ORG MX00="Moraxella species" NE00 = "Neisseria 
species" MY00 = "Mycobacterium species" 
RECODE ORGANISM TO ORG pa00="Pasteurella sp" pd00="Providencia sp" 
pe00="Peptostreptococcus sp''\ 
pi00="Plesiomonas sp" pp0 l="Propionibacterium acnes" pp00="Propionibacterium 
sp''\ 
pr02="Proteus vulgaris" pr0l="Proteus mirabilis" pr00="Proteus sp" 
RECODE ORGANISM TO ORG ps0 l="Pseudomonas aeruginosa''\ 
ps02="Pseud cepacia" ps03="Pseud fluorescens" ps04="Xanthomonas maltophilia''\ 
ps05="Pseud paucimobilis" ps06="Pseud pickettii" ps00="Pseudomonas sp" 
RECODE ORGANISM TO ORG sa0l="Staph aureus" sa02="Staph 
epidermidis"\ 
sa03="Staph saprophyticus" san0="Staph coagneg" sano = "staph\ 
coag neg" se0l="Strep pneumoniae" SAMR = "MRSA" 
RECODE ORGANISM TO ORG se02="Strep group A" se04="Strep group B''\ 
se05="Strep group C" se06="Strep group D nonenterococci" 
RECODE ORGANISM TO ORG se07="Strep group F" se08="Strep group G" 
se09="Strep sanguis"\ 
sel l="Strep viridans" se12="Strep milleri" se00="Streptococcus sp" 
sh 00=" S higella sp ''\ 
sl0l="Salmonella typhi" sl02="Salmonella paratyphi" sl00="Salmonella sp" 
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RECODE ORGAi~SM TO ORG ss0l="Serratia liquefaciens" ss02="Serratia 
marcescens"\ 
ss00="Serratia sp" vi00="Vibrio sp" ye0l= "Yersinia enterocolitica" 
IF ORGANISM= . THEN ORG=FURTHERID 
if org= . then org=organism 
********** note only upper case may be achieved when decoding the 
********** data - recode automatically converts to upper case 
********** Using if statments ie.e if diagl = then clinical = 
********** converts to upper case also 
define menin <y> 
if sourcel = "cs" then menin = "y" 
if source2 = "cs" then menin = "y" 
if diagl = "03" then menin = "y" 
if diag2 = "03" then menin = "y" 
define other <y> 
if source 1 = "pd" then other = "y" 
if sourcel = "pf" then other= "y" 
if source 1 = "jf" then other = "y" 
if sourcel = "ot" then other = "y" 
if source2 = "pd" then other = "y" 
if source2 = "pf" then other = "y" 
if source2_ = "jf" then other = "y" 
if source2 = "ot" then other = "y" 
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LabDOSS Analysis Programs LDANPRE9.PGM 
define labname ------------------------
recode labcode to labname 116 ="Woden Valley Hospital, ACT" 112 
="ICPMR,Westmead''\ 
213 ="Prince of Wales, Sydney" 214 ="Royal Alexandra Hospital for Children''\ 
117 ="Liverpool Hospital" 220 ="Royal Prince Alfred Hospital" 
recode labcode to labname 230 = "Concord Hospital" 270 ="Tamworth Laboratory''\ 
275 ="Royal North Shore Hospital" 280 ="Gosford Central Coast Hospital Service''\ 
290 ="Lismore Area Pathology Service" 
recode labcode to labname 400 ="TB Lynch Pathologists, Rockhampton''\ 
410 ="Royal Brisbane Hospital" 411 ="Princess Alexandra Hospital, Queens"\ 
416 ="Prince Charles Hospital, Queens" 418 ="Sullivan and Nicolaides Partners,\ 
Queensland" 
recode labcode to labname 420 = "Nambour General Hospital" 425 ="Central 
Queensland Pathology\ 
Laboratory, Mackay" 430 ="Toowoomba Pathology Laboratory" 435 ="Ipswich 
General Hospital''\ 
426 ="Mackay Base Hospital" 
recode labcode to labname 510 ="Institute of Medical and Veterinary Science,\ 
Adelaide" 511 ="Flinders Medical Centre, SA" 512 ="Gribbles Pathology" 
recode labcode to labname 664 ="Western Diagnostic Pathology, WA" 666 
="Princess\ 
Margaret Hospital for Children, WA" 667 ="Royal Perth Hospital" 668 ="Sir 
Charles\ 
Gairdner Hospital, WA" 669 ="Fremantle Hospital" 
recode labcode to labname RHH = "Royal Hobart Hospital" 710 = "Hobart 
Pathology''\ 
711 ="Royal Hobart Hospital" 730 ="Northern Tasmanian Pathology Service" 
if labname = . then labname = labcode 
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LabDOSS Analysis Programs LDANPRE9.PGM 
Title 1 \cComplete/further Organism identification - ALL SITES 
select furtherid <> . 
so rt source 1 
list org source 1 funherid 
select 
select comments <> . 
Title 1 \cCOMMENTS FOR ALL SITES 
sort source 1 
list organism sourcel comments diagl riskl risk2 
select 
route ? type in data file name eg vvnnprel.rec ? 
***** This file contains significant and contaminant records. 
write recfile 
route screen 
set noecho = off 
type '\7\7" 
quit 
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LabDOSS Analysis Programs LDANFIN9.PGM 
********************************************************************* 
* PROGRAM NAME LDANFIN9.PGM 
* This program analyses data sent from labs to prepare 
* tables for CDI bulletins. 
* The programme prints a table of probable contaminants from the pooled 
* data stored in the merged file. 
* It then selects significant isolates for further processing by excluding 
* those labelled as probable contaminants and then writing the resulting 
* file to ldvvnn.rec where vv is the volume and nn is the number of the 
* CDI issue in which the data will be published. 
* Sept 93 
*********************************************************************** 
** 
READ ? type in file name of screened data eg vvnnprel.rec ? 
ROUTE ? type in text file name eg LDvvnn.doc ? 
SET NOECHO = ON 
SET ST A TISTICS = OFF 
SET LISTREC = OFF 
******************************************************************* 
**************** Preparing reports for CDI 
set ignore missing = off 
* Browsing contaminants for unusual organisms 
SELECT DIAG 1 = "95" OR DIAG2 = "95" 
TITLE 1 'cCONTAMINANTS BY LABORATORY 
freq org 
FREQ LABNAME 
SELECT 
* CODE 95 IS PROBABLE CONTAMINANT. EXCLUDE FROM REGULAR 
ANALYSIS 
SELECT DIAGl <> "95" AND DIAG2 <> "95" 
Title 1 'cLABORATORY CONTRIBUTIONS 
FREQ LABNAME 
111: 
1111 
Section 1 Appendix C 
LabDOSS Analysis Programs LDANFIN9.PGM 
* Report below is covered in the pre program 
**Title 1 \cComplete/further Organism identification - ALL SITES 
* select furtherid <> . 
*list org furtherid 
*select 
*select comments <> . 
*Title 1 \cCOMMENTS FOR ALL SITES 
*sort sourcel 
*list organism comments diagl riskl risk:2 
*select 
******** Blood culture reports 
SELECT DIAG 1 <> "95" AND DIAG2 <> "95" 
SELECT MENIN <> "Y" AND ( SOURCEl="BL" OR SOURCE2="BL") 
Title 1 \cFrequency blood culture organisms 
Freq org 
Title 1 \cBlood Culture Organisms by Agegroup 
Title 2 0.01. .. - 0.1. .. = 0mth 0.1. .. - 0.9 .... = lmth 1.1. ... - 11.9 .... = x mths 
freq agegroup 
**** Blood Culture Organisms by Class 
select class = "P" 
Title 1 \c Blood Culture Gram Positives 
Title 2 
Freq org 
Select 
SELECT DIAG 1 <> "95" AND DIAG2 <> "95" 
SELECT MENIN <> "Y" AND ( SOURCEl="BL" OR SOURCE2="BL") 
select class = "N" 
Title 1 \c Blood Culture Gram Negatives 
Freq org 
Select 
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SELECT DIAG 1 <> "95" AND DIAG2 <> "95" 
SELECT MENIN <> "Y" AND ( SOURCEl="BL" OR SOURCE2="BL") 
select class = "A" 
Title 1 \c Blood Culture Anaerobes 
Freq org 
Select 
SELECT DIAG 1 <> "95" AND DIAG2 <> "95" 
SELECT MENIN <> "Y" AND ( SOURCEl="BL" OR SOURCE2="BL") 
select class = "F" 
Title 1 \c Blood Culture Fungi 
freq org 
select 
**** Blood Culture Organisms by No Class 
SELECT DIAGl <> "95" AND DIAG2 <> "95" 
SELECT MENIN <> "Y" AND ( SOURCEl="BL" OR SOURCE2="BL") 
select class = . 
Title 1 \c Blood Culture No Class 
list organism org furtherid 
Select 
*Title 1 \cBlood Culture ORGANISMS REPORTED 
*FREQ ORG 
*title 1 \c Blood culture organisms reported by code 
*freq organism 
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SELECT DIAG 1 <> "95" AND DIAG2 <> "95" 
SELECT MENIN <> "Y" AND ( SOURCEl="BL" OR SOURCE2="BL") 
Title 1 \cDIAGNOSIS & ORGANISMS REPORTED FOR THIS MONTH - BLOOD 
CULTURE 
TABLES ORG CLINICAL 
tables org diagnosis 
Title 1 \cRISKS & ORGANISMS REPORTED FOR THIS MONTH - BLOOD 
CULTURE 
TABLES ORG RISKS 
TABLES ORG RISKS2 
TABLES ORG HOSP ACQ 
SELECT 
SELECT DIAG 1 <> "95" AND DIAG2 <> "95" 
SELECT MENIN="Y" 
Title 1 \cMENINGITIS 
FREQ ORG 
Title 1 \cMeningitis by age group 
Title 2 0.01. .. - 0.1 ... = 0mth 0.1. .. - 0.9 .... = lmth 1.1. ... - 11.9 .... = x mths 
tables org agegroup 
Title 1 \cMENINGITIS ORGANISM DATA 
Title 2 
sort org 
LIST ORO sero AGE SEX RISKS RISKS2 COMMENTS FURTHERID 
SELECT 
SELECT DIAG 1 <> "95" AND DIAG2 <> "95" 
SELECT SOURCEl <> "BL" AND SOURCE2 <> "BL" AND OTHER="Y" 
select menin <>"Y" 
SORT SOURCE! ORG 
Title 1 \cORGANISMS FROM OTHER STERILE SITES 
FREQ ORG 
Section 1 Appendix C 
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Title 1 'cSOURCE OF ORGANISMS REPORTED FOR THIS MONTH - OTHER 
SITES 
LIST SOURCEl ORG AGE SEX DIAGl COMMENTS 
select 
select sourcel =. 
Title 1 'c Organisms reported with no source 
list org source 1 so urce2 lab code 
select 
route ? name of CDI expanded file, eg LDvvnn.rec ? 
***** This file contains significant and contaminant records. 
write rec file 
ROUTE SCREEN 
SET NOECHO = OFF 
TYPE ''\7 \7" 
QUIT 
Section 1 Appendix C 
LabDOSS Analysis Programs LD2to3.PGM 
************************************************************* 
*LD2to3.pgm 
* Converts data received in LD2 format into LD 3 structure 
************************************************************** 
read ? type in name of file to be modified to LD3 format? 
Define Risk 1 <A > 
Define Furtherid <A 
Define Comments <A 
define risk2 <A > 
define outcome <A> 
define hospacq <A> 
let risk 1 = risk 
let furtherid = furtherid 1 
let comments = commentsl 
route ? type in name of new file in ld3 format? 
> 
> 
write recfile labcode:3 labnumber:9 collectdat:8 surname:2 firstname:2 sex: 1 \ 
dob:8 age:2 pcode:4 diagl:2 diag2:2 hospacq:1 riskl:2 risk2 outcome\ 
sourcel :2 source2:2 cult: 1 ant:2 organism:4 sero:2 furtherid:51 comments:51 
Section 1 Appendix C 
LabDOSS Analysis Programs LDYTDT AB.PGM 
******************************************************************** 
* Program Name YTDTAB.PGM 
* New program to create YTD tables for Blood Culture, Meningitis and 
* other Sites. 
* Sheila Beaton 27 /9/93 
******************************************************************** 
* YTD totals for LabDOSS significant blood and meningitis 
read ? type in name of ytd file ? 
route ? file to store eg ytdsvvnn.doc ? 
select menin <> "y" and (sourcel="bl" or source2="bl") 
set ignore missing = off 
Title 1 \cFrequency of Organisms in Blood Cultures 93 to date 
freq org 
select 
title 1 \cFrequency of Organisms in Meningitis 93 to date 
select menin = "y" 
freq org 
select 
select other = "y" 
title 1 \cFrequency of organisms in Other Sterile Sites 93 to date 
freq org 
I 
I 
I, 
II 
I 
lill 
11 
Ii 
Ji 
•l 
~'. 
~-- ri 
!1 
j 
g,1 
I 
I 
l 
l1 
li: 
m 
I 
~ 
I.' 
mli 
~ r II
I 
,i 
IJ" 
I i .I 
Section 2 Outbreak Investigation 
2.1 Introduction Winter Rubella Outbreak in the ACT: Investigation of One Primary 
School 
In 1991 I investigated an outbreak of Rubella in the Australian Capital Territory 
ACT. The outbreak was reported in the CDI, article attached. At the time, the policy 
of the CD/ editor was that staff who routinely worked on the CDI did not have their 
name heading an article. Because of my work with the pathogen scheme and 
LabDOSS, my name was not included on the article. The work performed in this 
outbreak was entirely my own. The outbreak report was reprinted by the Weekly 
Epidemiological Record, one of the first CD/ articles to be reproduced. 
How I became aware of the outbreak 
In May 1991, I was notified of a case of measles in a three year old child who 
attended child care. The diagnosis of measles was not confirmed by pathology 
testing. A school aged sibling of the child had been unwell two weeks previously 
with symptoms of fever and rash. The three year old child attended a family day care 
home. The family day care mother had taken the child to a play group meeting of 20 
children on the two days preceding the onset of her rash. I reviewed the immunisation 
records of all children who had attended the play group and contacted by telephone 
parents of children who had not received MMR vaccine. All parents were informed of 
their child's contact with a case of presumed measles by letter. 
JIIIIIIII 
2.1 Introduction Winter Rubella Outbreak in the ACT: Investigation of One Primary 
School 
Cases at the local school 
The co-ordinator of the family day care scheme and a parent of the index case told 
me of numerous cases of "measles both sorts" at the local primary school. I 
contacted the school and found more than 40 children had been absent in the previous 
month because of illnesses thought to be either measles or rubella. To make a 
diagnosis, I contacted parents of children who were away with the illness. I obtained 
clinical histories and arranged serological testing of some of the cases. I contacted 
general practitioners in the surrounding suburbs, informing them of the outbreak: and 
requesting any new cases be tested for antibodies to rubella and measles. The first 
serological test confirming rubella was provided by a general practitioner. 
Public Health Action 
When the rubella outbreak was identified , I reviewed possible action with the ACT 
Medical Officer of Health and ACT Child Health Doctors. The greatest concern was 
the risk of rubella to susceptible pregnant women in the ACT. We issued media 
warnings about the outbreak: and provided advice for susceptible women. Community 
newspapers, delivered free to each household, The Canberra Times and local radio 
stations all presented news of the Rubella outbreak:. Immunisation of all children at 
the index school against rubella was not considered manageable. The time of the 
outbreak: was nearing commencement of a two week school holiday period and this 
was considered as a fortuitous and probable conclusion of outbreak. 
2.1 Introduction \Vinter Rubella Outbreak in the ACT: Investigation of One Primary 
School 
Communication between the Department of Education and the Department of Health 
The fortnightly school newsletter had contained a paragraph on the illness for the 
previous two editions. Despite this awareness of large numbers of cases and the 
reported diagnosis of some cases of measles , the school principal had not informed 
the Department of Health of the outbreak. Similarly, the regional co-ordinator for 
schools was unaware of the absenteeism. I discussed with all regional co-ordinators 
the possible role they may play in being aware of absenteeism and alerting the 
Department of Health of suspected outbreaks of disease. Because schools may play an 
important part in surveillance of absenteeism, improved communication between the 
departments of Education and Health in the ACT is desirable. 
I formulated to further areas for potential investigation from this outbreak: 
• A possible hypothesis that open plan classes containing between 
50 and 90 students promote greater mixing between children and may 
promote widespread outbreaks of disease. I did not pursue any further 
investigation of school design/function and spread of communicable diseases. 
• How could we determine serosusceptibility rates of women in the ACT? 
I am undertaking a case control study to determine the reasons for rubella 
serosusceptibility in women in the ACT. I obtained results of all rubella tests 
performed at the central health laboratory ACT in 1992. From this data I established 
that 6.3 % (64/1008) of women routinely tested for rubella serostatus were 
seronegative .. I have obtained ethics committee approval to contact seronegative and 
positive women in writing to determine possible reasons for sero susceptibility, e.g. 
overseas born , not schooled in Australia. The study is at the stage of forwarding 
letters to 64 cases and 192 controls. 
Section 2.2 CDI article 1991: Winter Rubella Outbreak in the A CT: Investigation 
of One Primary School 
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COMMUNICABLE DISEASES INTELLIGENCE 
Volume 15, Number 19- 23 September 1993 
WINTER RUBELLA OUTBREAK 
IN THE ACT: INVFSTIGATION 
OF ONE PRIMARY SCHOOL 
Introduction 
An outbreak of rubella in a Canberra pri-
mary school occurred from 31 May 1991 to 4 
September 1991. Notification of measles in a 
three year old vaccinated child led to the 
investigation. Two siblings of this child at-
tended the primary school where students 
had been absent with assumed rubella and 
measles. The school outbreak occurred dur-
ing widespread rubella activity in the ACT, 
with at least 168 rubella cases from other 
primary schools. The Medical Officer of 
Health issued a statement to the community 
to warn of the risk to susceptible pregnant 
women. 
Methods 
Questionnaires distributed to families of 
children attending the primary school and a 
neighbouring preschool identified the cases 
of rubella. Cases were defined according to 
the Canadian Communicable Disease Sur-
veillance System case definitions1• A 
confirmed case included a child or adult 
with either rubella virus isolation, a 4-fold 
rise in titre of rubella antibodies, or rubella-
specific IgM in the serum. A person was 
considered to have had clinical rubella if 
they had an illness comprised of fever and 
rash, with one or more of arthritis/arthral-
gia, lymphadenopathy, or conjunctivitis and 
they were epidemiologically linked to a con-
firmed case. 
Results 
Eighty-nine cases of rubella were identified 
in this school outbreak. Eleven cases were 
tested for rubella antibodies; eight were con-
firmed rubella. One serologically tested case 
had no detectable antibodies, however the 
serum had been collected on the day of onset 
of the rash. Two cases had IgG but not IgM 
antibodies, but the sera had been collected 
from these two children 44 days after the 
onset of rash. 
Seventy-seven of these 89 cases of rubella 
occurred in children attending the school or 
preschool. The overall attack rate was 
77 I 468 or 16% of the student population. 
Sixty percent of cases were female. The out-
break is continuing. 
The epidemic curve (Figure 1) ,is difficult to 
interpret until separated into class groups. 
Eighty-seven cases are presented; parents 
could not recall the date of onset of illness for 
two school children. The almost flat curve 
shows this outbreak is of long duration , with 
sporadic low level incidence. The largest 
Figure 1. Day of onset of 87 cases of rubella associated with a school, Canberra, May through 
September 1991. 
~ I I I I I I ,~ I I I I I I "'\ 11 I I~ I fl 1 1 I I 11 I I I 11 I 
0 10 20 30 40 
I 111111111 
50 60 
,.:m I I 11 
Tl I ITTTl 
70 
1m1111111111111 1 
80 90 100 
Day of Onset 
..1.11111 
Volwne 15, Nwnber 19 
Figure 2. Day of onset of 75 cases of Rubella separated by class ,in a school in Canberra, May 
through September, 1991 
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Table 1. Attack rates by classroom in 77 children with rubella in a Canberra school an 
preschool with 468 students May through September 1991. 
CLASS I TOTAL 
Preschool 75 
Kindergarten 51 
1/2 B 64 
l/2A 64 
3/4A 60 
3/4B 62 
5/6 92 
Total 468 
numbers of cases occurred on day 50, repre-
senting cases in 6 classes. 
Figure 2 presents the school children epi-
demic curve by class. The children in 
Kindergarten were the first in the school to 
develop rubella. Initial school cases occurred 
on days 1,9,10. The epidemic curve is not 
consistent with a common source outbreak. 
The incubation period for rubella is 14 to 23 
days, so children with illness onset on days 
9 and 10 did not acquire the disease from the 
child with onset day 1. Parents of these three 
children do not recall any contact with a 
person with a rash illness, and no apparent 
link exists between the three families. A child 
in class 3 / 4A, the first non kindergarten 
child in the school to develop the illness, 
became unwell on day 20. This child is a 
sibling of the kindergarten case with illness 
onset on day 9. 
The school is of open plan design and func-
tion. Each class has between 50 and 92 
students instructed by multiple teachers. 
The school has three separate classroom 
buildings, which accommodate combined 
classes 1st/2nd, 3rd/ 4th, 5th/ 6th respec-
tively. Kindergarten students are taught in a 
demountable building at the rear of the class 
3rd/ 4th block. The preschool is a separate 
building adjacent to the school. 
I < . ILL I ATTACK RATE 
PER 100 
10 13 
13 25 
13 20 
10 16 
6 10 
13 21 
12 13 
77 16 
The class specific attack rates are presented 
in Table 1. Attack rates did not vary mark-
edly with age. 
Twelve additional cases were linked to the 
school; five adults, one teenage sibling, five 
siblings under four years of age, and one 
seven year old sibling attending a nearby 
private school. This child is a sibling of a 
child in preschool. Three of the adult cases 
were fathers of children in the school. The 
remaining two adults were mothers, one 
known to be susceptible to rubella. 
Symptom results from the questionnaire are 
summarised in Table 2. The mean duration 
of illness was six days. Few of the children 
Table 2 Frequency of symptoms and signs 
in 89 cases of rubella , Canberra, 
May through September 1991. 
SYMPTOM 
coniunctivitis 
arthralgia 
arthralgia in 
children 
1 
% OF CASES 
82 
56 
52 
2zl 
91 
1 . Other symptoms included by parents as comments 
Table 3. Characteristics of 18 families with secondary intrafamilial spread of rubella, 
Canberra, May through September 1991. 
NUMBER OF CASES 
IN THE FAMILY 
2 
3 
4 
5 
6 
NUMBER 
13 
2 
1 
1 
1 
NUMBER OF -. 
SECONDARY 
' CASES ·· 
•· PER FAMILY ...... h. 
1 
2 
3 
4 
5 
TOTAL 
CASE.5 
13 
4 
3 
4 
5 
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had prodromal symptoms; 71 % of parents 
gave the same date for onset of illness and 
onset of rash. Sixty-seven percent of the 
children consulted their general practitioner. 
Ninety-two per cent of the cases reported 
past vaccination for measles and mumps. 
Family clusters 
Twenty-five families had more than one case 
in their household. The incubation periods 
were ronsistent with transmission from one 
family member to another in eighteen fami-
lies. Table 3 summarises these data. The total 
number of subsequent / secondary infec-
tions was 29, from 18 cases. The index to 
contact ratio equals 1 : 1.61. 
Discussion 
The data suggest this rubella outbreak is 
continuing at high endemic level. Sixteen 
percent of the school population have ac-
quired clinical disease over 101 days. 
The morbidity associated with this outbreak 
is striking. Sixty-seven percent of children 
consulted their general practitioner, sug-
gesting this was not mild disease. Fifty-two 
percent of the children, suffered from 
arthralgia. This is a surprisingly high fre-
quency of arthralgia in children. All five 
adults with rubella reported joint pain. Oas-
sically, arthritis/ arthralgia is reported in up 
to one third of adult women with rubella, but 
is less ~quently reported in men and chil-
dren 2, ,4_ Pruritus, which is occasionally 
reported in rubella infections4, occurred in 
9% of case~. 
The control of rubella varies widely between 
countries. In the USA rubella vaccine was 
licensed in 1%9, and a policy of universal 
immunisation of children was adopted. This 
strategy aims to control rubella infection in 
young children, reducing circulating virus, 
and thereby decreasing the risk of exposure 
to pregnant women. In the year of licensure 
in the USA the incidence of rubella cases 
notified was 28 per 100,000 population. In 
the prevaccine era rubella was predomi-
nantly a disease of school age children, with 
the highest rate in children aged 5 to 9 years. 
There was a dramatic decrease in numbers 
of cases of rubella and Congenital Rubella 
Syndrome (CRS) in the following 19 years. A 
rise in reported rubella and CRS occurred 
Figure 3. Incidence of rubella, National Notifiable Diseases Data 1955-1978,1990,1991, 
Communicable Diseases Network Australia• 
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from 1988 to 1990. The incidence rate for 
rubella infection in the USA in 1990 was 0.4 
per 100,000. USA outbreaks suggest that the 
recent rubella increase is from failure to vac-
cinate rather than vaccine failure. In 
February 1991 a Morbidity Mortality Weekly 
Report suggested several strategies may be 
required to improve rubella prevention and 
control, including initiating prompt and ag-
gressive control measures whenever 
outbreaks are reported5. 
The approach to rubella control in the United 
Kingdom differed from the USA. Selective 
vaccination of schoolgirls was commenced 
in the UK in 1970. In 1988 this programme 
was augmented by mass vaccination of both 
sexes using measles-mumps-rubella vaccine 
(M:MR) targeted at 1-2 year old children and 
4-5 year old children. 
Australia has also used a selective program 
of school girl vaccination which commenced 
in 1971. The Australian National Notifiable 
Disease data from 1955 to 1978, (Figure 3) 
show a decrease in rubella following vaccine 
introduction. The rapid fall of rubella cases 
in 1971 may have been in part an effect of 
vaccination as well as a natural decrease in 
cases. A continued decrease in rubella fol-
lowed during the next seven years. Rubella 
was removed from the National Health and 
Medical Research Council recommended list 
of notifiable diseases in 1978 but the Com-
municable Diseases Network-Australia has 
reintroduced the collection of national ru-
bella data this year. 
Currently CRS is separately notifiable in Tas-
mania, South Australia, Victoria, Northern 
Territory and Western Australia. Case defi-
nitions for CRS are complex6. CRS remains a 
problem in Australia as may be seen in the 
CDI virus reporting scheme data for the last 
10 years (p333, CDI, this issue). One case of 
rubella infection in the firsttrimesterofpreg-
nancy occurred in the Canberra region 
during the period of this school outbreak. 
Rubella infections are notifiable in New 
South Wales, Queensland, South Australia, 
Victoria, and the Australian Capital Terri-
tory. Only one case of rubella infection has 
been notified in the ACT in 1991. 
The Australian National Health and Medical 
Research Council recommended in Novem-
ber 1987, that the elimination or reduction of 
rubella in the community and further reduc-
tion of the incidence of CRS should be public 
health objectives. In 1987, it recommended 
that M:MR vaccine be routinely used at 12 -
15 months of age, replacing the measles-
mumps vaccine. The school girl rubella 
program is to be maintained indefinitely. 
This is in contrast to the UK where MMR is 
currently targeted at two age groups of 
young children. A National Health and 
Medical Research Council committee is cur-
rently considering the introduction of a two 
dose M:MR strategy. 
The incidence rate during this outbreak was 
at least 90 per 100,000 population ,which 
means considerable risk existed for s uscepti-
ble pregnant women. This study suggests 
that intervention in community outbreaks 
may be needed to lower the risk to these 
women. 
The MMR vaccine for 12 month old children 
replaced the measles mumps vaccine in July 
1989 in the ACT. There is now a cohort of 2 
year old children who have received 
vaccination for rubella. There remains a risk 
of school outbreaks over at least eight years 
until this cohort completes primary ed uca-
tion. Prior to vaccination, rubella outbreaks 
in the USA occurred on a 6 - 9 year cycle2 . In 
the UK an e~idemic pattern of a 4 year cycle 
is described . In the next eight years in Aus-
tralia there may be outbreaks in school age 
children. In view of Australia's rubella pub-
lic health policy, the role of intervention in 
outbreaks is worthy of debate. The Commu-
nicable Diseases Network provides the 
forum for national co-ordinated considera-
tion of Australia's approach to rubella 
control. 
The development of the Communicable Dis-
eases Network, including the creation of 
positions of registrars in epidemiology, has 
enabled this outbreak to be investigated. 
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I Rubella 
I 
! Winter outbreak in the Australian Capital Territory (ACT) 
I Australia. An outbreak of rubella occurred from 31 May 
1991 to 4 September 1991 in a Canberra primary school. 
Notification of measles in a 3-year old immunized child 
led to the investigation. Two siblings of this child attended 
the primary school where students had been absent with 
assumed rubella and measles . The school outbreak occur-
red during widespread rubella activity in the ACT, with at 
least 168 rubella cases from other primary schools. The 
Medical Officer of Health issued a statement to the com-
munity to warn of the risk for susceptible pregnant women. 
Methods 
Questionnaires distributed to families of children anending 
the primary school and a neighbouring preschool identified 
the cases of rubella. A person was considered to have had 
clinical rubella if he/she had had an illness comprised of 
fever and rash, with one or more of the following symptoms: 
arthritis/arthralgia, lyrnphadenopathy, or conjunctivitis and 
was epidemiologically linked to a confirmed case. A con-
firmed case included a child or adult with rubella virus 
isolation, a 4-fold rise in titre of rubella antibodies, or 
rubella-specific IgM in the serum. 
Results 
Eighty-nine cases of clinical rubella were identified in this 
school outbreak. Eleven cases were tested for rubella anti-
bodies; 8 were confirmed rubella . One serologically tested , 
case had no detectable antibodies; however, the serum had 
been collected on the day of onset of the rash. Two cases 
had IgG but not IgM antibodies, but the sera had been 
collected from these 2 children 44 days after the onset of 
rash. 
Seventy-seven of these 89 clinical cases of rubella oc-
curred in children attending the school or preschool. The 
overall attack rate was 77 out of 468, or 16% of the student 
population. Sixty per cent of cases were female . 
Twelve additional clinical cases were linked to the 
school: 5 adults, 1 teenage sibling, 5 siblings under 4 years 1 
, of age, and a 7-year old sibling attending a nearby private 
school. This child was a sibling of a child in preschool. Three 
of the adult cases were fathers of children in the school. The 
remaining 2 adults were mothers, one known to be sus-
ceptible to rubella. 
Symptom results from the questionnaire are summa-
rized in Table 1. The mean duration of illness was 6 days. 
Few of the children had prodromal symptoms; 71 % of 
parents gave the same date for onset of illness and onset 
of rash . Sixty-seven per cent of the children consulted 
their general practitioner and 92% of the cases reported past 
immunization for measles and mumps. 
Tobie 1 Frequency of symptoms and signs in 89 clinical cases of rubella, 
Canberra, Austrar.a, May-September 1991 
Symptom - Symptome 
Conjunctivitis - Conjonctivite 
Arihrclgio - Artnrolgie 
Arthralgio in children -Arthralgie chez l'enfont 
Lymphodenoocmv - Adenopo thie 
Pruritus - Pruri· 
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Rubeole 
Poussee hivernale en Australie (lerritoire federal de la capitole) 
Australie. Une poussce de rubcole s'est produitc du 31 mai 1991 
au 4 scpti.:mbre 1991 dans une ecole primairc de Canberra. La 1 
notification d'une rougeole chez un enfant vaccine age de 3 ans a 
entraine une enquete. Deu.x enfants de la meme famille frequen-
taient l'ecole primaire, ou !es elcves avaient ete absents en raison 1 
d'une rubeole et d'une rougeole presumees. La poussee en question 
est survenue au cours d'une periode de grande activite rubeoleuse 
dans le Territoire de la capitale ou 168 cas au mains de rubeole ont 
ete declares par les autres ecoles primaires. Le chef des sen;ces de 
sante du Territoire a prevenu la population du risque encouru par 
Jes femmes enceintes receptives. 
Methodes 
Les cas de rubeole ant pu etre identifies grace a des questionnaires 
distribues aux familles des enfants frequentant l'ecole primaire, ainsi 
qu'une ecole maternelle voisine. Une rubeole clinique etait diagnos-
tiquee dans taus Jes cas de maladie eruptive et febrile accompagnee 
d'un ou plusieurs syrnpt6mes tels qu'arthrite/arthralgie, adenopathie 
OU conjonctivite, et si le sujet etait epidemiologiquement lie a un 
cas confirme. Etait considere cornme un cas confirme l'enfant ou 
l'adulte chez qui l'on avait isole le virus de la rubeole, qui presentait 
un quadruplement du titre d'anticorps antirubeoleux ou des IgM 
seriques specifiques de la rubeole. 
Resultats 
On a recense 89 cas cliniques de rubeole au cours de cene poussee 
scolaire. Sur les 11 cas chez lesquels on a recherche des anticorps, 
8 avaient une rubeole confirmee. Chez un des cas, la serologie n'a 
pas pennis de deceler d'anticorps mais le serum avait ete preleve le 
jour de !'apparition de !'eruption. Deux cas presentaient des IgG et 
pas d'IgM, mais ii s'agissait de 2 enfants chez qui les serums n'avaient 
ete preleves que 44 jours apres !'apparition de !'eruption. 
Sur ces 89 cas cliniques de rubeole, 77 etaient des eleves de 
l'ecole primaire ou de l'ecole matemelle. Le taux d'anaque global a 
ete de 77 cas sur 468, soit 16% de la population scolaire . Les filles 
representaient 60% des cas. 
Douze autres cas cliniques avaient des liens familiaux avec les 
cas scolaires: 5 adultes, 1 adolescent, 5 enfants de mains de 4 ans 
et 1 enfant de 7 ans qui frequentait une ecole privee rnisine et 
appartenait a la meme fratrie qu'un enfant de l'ecole maternelle. 
Parrni Jes adultes, 3 etaient des peres d'enfants frequentant l'ecole. 
Les 2 autres etaient des meres, dont une que !'on savait receptive a 
la rubeole. 
Les resultats du questionnaire sur les syrnpt6mes figurent au 
Tableau 1. La duree moyenne de la maladie a ete de 6 jours. Les 
prodromes ant ete rares chez !es enfants; 71 % de parents om donne 
la merne date pour le debut de la maladie et !'apparition de !'eruption; 
67% des enfants ant ete Yus par leur generaliste et 92° o des cas 
avaient ete \·accines contre Ia rougeole et Jes oreillons. 
Tobleo t.: 1 Frequence des symptomes et des signes dans 89 cas cliniques de 
rubeole, Canberra, Australie, mai-septembre 1991 
Percentage of cases - Pourcentoge des cos 
s: 
)O 
52 
?~ 
9 
I 
I I 
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Familiy clusters I Serie de cos fammaux 
Twenty-five families had more than I case in their house-
hold . The incubation periods were consistent with trans-
mission from one familiy member to another in 18 families . 
The total number of subsequent/secondary infections was 
29, from 18 cases. The index to contact ratio thus equals 
1:1.61. 
Discussion 
The data suggest this rubella outbreak proceeded at a high 
endemic level. Sixteen per cent of the school population 
acquired clinical disease over 101 days. 
The morbidity associated with this outbreak is striking. 
Sixty-seven per cent of children consulted their general 
practitioner, suggesting this was not mild disease. Fifty-two 
per cent of the children suffered from arthralgia. This is 
a surprisingly high frequency of arthralgia in children. All 
5 adults with rubella reported joint pain. Classically, 
arthritis/arthralgia is reported in up to one-third of adult 
women with rubella, but is less frequently reported in men 
and children. Pruritus, which is occasionally reported in 
rubella infections, occurred in 9% of the cases. 
The control of rubella varies widely between countries. 
In the United States of America, rubella vaccine was li-
censed in 1969, and a policy of universal immunization of 
children was adopted. This strategy aims to control rubella 
infection in young children, reducing circulating viruses, 
and thereby decreasing the risk of exposure for pregnant 
women. In 1969 in the United States, the incidence of 
rubella cases notified was 28 per 100 000 population. In the 
prevaccine era, rubella was predominantly a disease of 
school-age children, with the highest rate in children aged 
5 to 9 years. There was a dramatic decrease in numbers of 
1 cases of rubella and congenital rubella syndrome (CRS) in 
the following 19 years. A rise in reported rubella and CRS 
occurred from 1988 to 1990. In 1990, the incidence rate 
for rubella infection in the United States was 0.4 per 
100 000. Outbreaks in that country suggest that the recent 
rubella increase is due to failure to vaccinate rather than 
vaccine failure. In February 1991, it was suggested that 
several strategies may be required to improve rubella pre-
vention and control, including initiating prompt and aggres-
sive control measures whenever outbreaks are reported. 1 
The approach to rubella control in the United Kingdom 1 
differed from the United States. Selective immunization of 
schoolgirls and susceptible adult women was introduced in 
1970. In 1988, this programme was expanded by the mass 
vaccination of both sexes using measles-mumps-rubella 
(~R) vaccine targeted at 1-2-year old children and 4-5- 1 
1 year old children. 1 
Australia has also used a selective programme of school-
girl nccination which started in 1971. The Australian 
Kational Notifiable Disease data from 1955 to 1978 
(Fig. 1) show a decrease in rubella following ,·accine intro-
duction. The rapid fall of rubella cases in 1971 may ha,·e 
been in part an effect of ,·accination as well as a natural 
' decrease in cases. A continued decrease in rubella followed 
during the ne,n 7 years. Rubella was remO\·ed from the 
recommended list of notifiable diseases in 1978 but the 
Communicable Diseases Ketwork-Australia reintroduced 
the collection of national rubella data in 1991. 
The Australian National Health and ~1edical Research 
Council recommended in ~o,·ember 1987 that the elimi-
nation or reduction of rubella in the community and funher 
reduction of the incidence of CRS should be public health 
objecti,·es. In 1987, it recommended that ~ L \ 1R ,·accine 
be routinely used at 12-15 months of age, replacing the 
measles-mumps ,·accine. The schoolgirl rubella immu-
nization programme is to be maintained indefinitely .• ..\ 
1 
cornminee is currently considering the introduction of a 
2-dose ~1.¼R strategy. 
See ~o. 18, J0Ql . pp. 128-131. 
See ~c, . 30. 1001 . pp. 21-; -22l1 . 
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11 y a eu plus d'un cas dans 25 familles. La durce de !'incubation 
concordait avec une transmission intrafamiliale dans 18 famillcs. 
Le nombre total d'infections consccutives/secondaires a ete de 29, 
a partir de 18 cas. Le rapport enrre cas initiaux et cas contacts est 
done de 1: 1,61. 
Discussion 
Les donnees laissent a penser que cene poussee de rubeole s'est 
maintenue a un niveau d'endemicite eleve. En 101 jours, 16% de 
la population scolaire a contracte la maladie clinique. 
La morbidite associee a cene poussee est frappante . Soixante-
sept pour cent des enfants ant ete vus par leur generaliste, ce qui 
indique que la maladie n'etait pas benigne, et 52% souffraient d'ar-
thralgie, chiffre etonnamment eleve chez l'enfant. Les 5 adultes 
ayant contracte la maladie se sent plaints de douleurs aniculaires. 
Ordinairement, c'est au maximum un tiers des femmes adultes 
aneintes de rubeole qui souffrent d'arthrite/arthralgie, la proportion 
etant mains elevee chez les hornmes et les enfants. Le prurit, qui 
est sign.ale occasionnellement dans les infections rubeoleuses, s'est 
produit dans 9% des cas. 
La lune contre la rubeole varie largement suivant les pays. Aux 
Etats-Unis d'Amerique, un vaccin centre la rubeole a re~ l'autori-
sation demise sur le marche en 1969, et l'on a adopte une politique 
de vaccination universelle des enfants. Cene strategie vise a prevenir 
}'infection rubeoleuse chez le jeune enfant, et a reduire ainsi le 
nombre de virus circulants, et, partant, le risque d'exposition pour 
les femmes enceintes. En 1969, }'incidence des cas notifies dt! 
rubeole etait, aux Etats-Unis, de 28 pour 100 000 habitants. Avant 
l'int.roduction de la vaccination, la rubeole touchait essentiellement 
les enfants d'age scolaire, et le taux le plus eleve se situait dans la 
tranche d'age de 5 a 9 ans. II y a eu une chute marquee du nombre 
de cas de rubeole et de syndrome rubeoleux congenital (SRC) dans 
les 19 annees qui ont suivi. Une augmentation des cas notifies de 
rubeole et de SRC s'est produite entre 1988 et 1990. En 1990, le 
taux d'incidence de !'infection rubeoleuse aux Etats-Unis etait de 
0,4 pour 100 000 habitants. Les poussees qui se sont produites dans 
ce pays donnent a penser que la recente augmentation des cas est 
due au fait de ne pas vacciner plutot qu'a un echec vaccinal. En 
fevrier 1 991 , il a ete indique que plusieurs strategies pourraient etre 
necessaires pour mieux prevenir et combattre la rubeole, notam-
ment !'adoption rapide de mesures de lune energiques chaque fois 
que des poussees sont signalees .1 
Au Royaume-Uni, l'approche adoptee differe de celle des 
Etats-Unis. La vaccination selective des ecolieres et des femmes 
adultes receptives a ete introduite en 1970. En 1988, on a elargi 
ce programme en administrant systematiquement le vaccin triple 
rougeole-oreillons-rubeole (ROR) aux enfants des deux sexes de 
1-2 ans et de 4-5 ans .= 
L 'Aust.ralie a egalement lance un programme selectif de vacci-
nation des ecolieres en 1971. Les donnees nationales sur les mala-
dies a declaration obligatoire ent.re 1955 et 1978 (Fig. 1) montrent 
une diminution de la rubeole apres !'introduction de la ,·accination. 
La chute rapide du nombre de cas de rubeole en 1971 peut et.re 
anribuee en partie a la \'accination mais aussi a une diminution 
naturelle de !'incidence. Pendant Jes 7 annees suinntes, cene baisse 
s'est poursui,ie . La rubeole a ete supprirnee en 1978 de la liste 
recommandee des maladies a declaration obligatoire, mais le 
Comm1111icable Diseases Xe1z:.:ork-Aus1ralia a reintroduit en 1991 la 
collecte nationale de donnees sur la rubeole . 
En no,·embre 1987, l'A.usrralia11 i\"ario11al Healrh and .\fed1cal 
Research Council a,·ait recommande comme objectifs de same 
publique !'elimination ou la reduction des cas de rubeole dans la 
population et une reduction plus poussee de !'incidence du SRC. 
En 1987, ii a recornmande d 'utiliser systematiquemem le nccin 
ROR a 12-15 mois, en remplacement du ,·accin rougeole-oreillons. 
Le programme de ,·accination des ecolieres cont.re la rubeole de,-rait 
etre maintenu en permanence . Cne commission erudie acruelle-
ment !'introduction d'une ,·accination ROR en 2 doses. 
\'oir ~ IS . 1001. pp . 128-131 
\"c,1r ~ 3t1 . 1091 . rr 217-22 ,' 
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Fig. l Incidence of rubella, National Notifiable Diseases data, Com-
municable Diseases Networ"' Austrafia,' 1955-1978, 1990, 
1991 
Fig. l Incidence de la rubeole, donnees nationales sur les maladies a dedaration 
obligatoire, Communicable Diseases Network, Australie, • 1955-1978, 
1990, 1991 
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The rubella incidence rare during this outbreak was at 
least 90 per 100 000 population, which means considerable 
risk existed for susceptible pregnant women. This report 
suggests that intervention in community outbreaks may be 1 
needed ro lower the risk for these women. 
The MMR vaccine for 12-month-old children replaced 
the measles-mumps vaccine in July 1989 in the ACT. There 
is now a cohort of 2-year-old children who have received 
vaccination against rubella. There remains a risk of school 
outbreaks o\·er at least 8 years until this cohort completes 
primary education. Prior to vaccination, rubella outbreaks 
in the Cnired States occurred on a 6-9 year cycle. In the 
United Kingdom, an epidemic pattern of a 4-year cycle is 
described. 1 
(Based on: Communicable Diseases Intelligence, Vol. 15, 
~o . 19, Sept. 1991 ; Department of Health, Housing and 
Community Sen-ices.) 
See :::-So . 3,1. l 99 I. pp . 217-220. 
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Le tawe d'incidence de la rubeole pendant la poussee susmen-
tionnee a ere d'au mains 90 cas pour 100 000 habitants, d'ou un 
risque considerable pour les femmes enceinres receptives. Le pre-
sent rapport permet de penser qu'en cas de poussee epidemique 
dans une comrnunaure, une intervention pourrair etre necessaire 
pour reduire le risque auquel ces femmes sont exposees. 
Dans le Terriroire federal de la capirale, le vaccin ROR admi-
nistre awe enfants de 12 mois a remplace le \·accin rougeole-oreillons 
en juillet 1989. 11 exisre mainrenanr une cohorte d'enfants de 2 ans 
qui om ere vaccines centre la rubeole . Jusqu'a ce que cette cohorte 
air atteinr la fin de l'enseignement primaire, soir pendant 8 ans au 
moins, un risque de poussee scolaire subsistera. AYant la vaccina-
tion, les poussees de rubeole awe Etars-Cnis se produisaienr suirnnr 
un cycle de 6 a 9 ans . Au Royaume-Gni, c'est un cycle epidemique 
de 4 ans qui est decrir. ! 
(D'apres: Communicable Diseases Intelligence, \ ·01. 15, ~ -- 19, 
Sept. 1991; Department of Health, Housing and Community 
Ser:ices) . 
\'01r :::-S 30. 1091. pp . 217-220 . 
Centres de vaccination contre la fievre jaune pour 
les voyages internationaux 
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Section 3 Infectious Diseases In Child Care Settings 
3.1 Staying Healthy in Child Care 
A working group for Infectious Diseases in Child Care, the Communicable Diseases 
Standing Committee (CDSC) of the National Health and Medical Research Council 
(NHMRC) was formed in 1992. The term of reference for the group was to develop 
guidelines for prevention of communicable disease in child care settings. The group 
had no funding and work was performed by mail and facsimile forwarded documents 
and telephone comments. My role was secretary to the group since its inception. I 
also undertook much of the work of reviewing literature, drafting and editing the 
document. The document, "Staying Healthy in Child Care", is based and expands 
upon the South Australian Government book "Infectious Diseases in Early Childhood 
Settings". "Staying Healthy in Child Care" aims to provide nationally consistent 
guidelines for prevention and management of communicable diseases in child care 
settings. Staying Healthy in Child Care was endorsed by the NHMRC council in 
November 1993. 
Funding for Production 
As a result of my work for the CDSC working group, the director for the new 
Commonwealth sick care program approached me to develop a suitable sick care 
"definition of illness" that would be acceptable to NHMRC (refer section 3.2) . The 
director offered funds for development of the definition. Because there was no money 
allocated by NHMRC or our Unit to enable design, production and printing of 
"Staying Healthy in Child Care", I offered to develop draft guidelines for sick care in 
exchange for assistance with the production costs for Staying Healthy in Child Care. 
The Children's Services Program of the Department of Human Services and Health 
has allocated $50,000 towards production of "Staying Healthy in Child Care" . This 
money has enabled procurement of illustrations, graphic design, posters and spiral 
binding to allow repeated photocopying. The book/kit will be available April 1994. 
1: 
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3.2 The Sick Care program 
The Australian Labor Party included as an election promise in 1990, the development 
of a program to meet the needs of parents with mildly ill children when they also 
have out of home, work commitments. Funds for this program were allocated in the 
Federal Budget 1993 . The Department of Industrial Relations is pursuing the 
arrangement of approved parental leave to care for unwell children. The Department 
of Human Services and Health is developing a program to enable mildly ill children 
to be cared for in a situation that allows the parent to remain at work. 
There is considerable community debate about whether non parental care of mildly ill 
children is desirable. The value of nurturing of children in our community has been 
raised as a factor to ensure parents are available for care of their ill child. Despite the 
community concerns, the sick care program is considered likely to continue. 
A pilot program of care of sick children operated from November 1992 to May 1993. 
This program had no organised health community input for admission criteria or 
protection of health of children or carer's. Pilot program services were encouraged to 
enlist the support of local health professionals in running the program. 
I became involved in the sick care program in April 1993 . Because of my work for 
"Staying Healthy in Child Care", the Director of the sick care program approached 
me for assistance. It was clear that the program needed health guidelines for 
protection of children and workers in a sick care room. I was hopeful at this stage 
that the guidelines could form a new chapter of "Staying Healthy in Child Care" . I 
reviewed the literature of sick care programs overseas. I developed the guidelines, 
with input from Dr Mark Ferson and Dr Jeff Hanna (working group members), to 
present to CDSC for comment . (Appendix A "Chapter 11 Sick Care Programs"). 
The need for and role of a sick care program were debated at the subsequent CDSC 
meeting. Because of considerable concern over the health and social aspects of the 
sick care program, it was decided to remove the sick care chapter from Staying 
Healthy in Child Care to enable further debate, comment and consideration. 
My involvement in the Sick Care program has been challenging. Development of a 
11 definition of illness II for children suitable for sick care is clearly a difficult task. 
This type of care depends upon many factors including; 
• the health and safety of the child; 
• the type of illness; 
• the child's immunisation status; 
• the child's well being and emotional needs; 
• the situation of the child's care,( e.g. group or individual); 
• whether the carer and the care place are familiar to the child; 
• the carer's familiarity with the illness; 
• the carer's familiarity with the child; 
• the carer's ability to meet the child's emotional needs; 
• the carer's immunisation status and 
• the carer's familiarity with prevention of spread of communicable diseases. 
Who, How and Where? 
The Who, How and Where of sick care highlight the complexity of the issues; 
• who is eligible for care and who is an eligible carer ? 
• How are eligibitily decisions made ?i 
• Where will sick care occur e.g. child's home, centre, another home in a 
single or group setting ? 
~ 
3.2 The Sick Care program 
Because of the many difficulties with care of sick children in a group setting, I 
suggested another model to the children's services team; 
• a sick care agency program. This allows for care of a child in the child's 
own home by a familiar carer, a worker attached to their normal child care 
setting. 
Although initially rejected , this proposal has gained popularity as the preferred model 
for sick care. This would allay many concerns about cross infection, familiarity of a 
carer and setting for the child and eligibility criteria for children. Safety issues in the 
home may be assessed by registration safety checks. 
The sick care program is still in a period of transition and evolution. Consideration is 
being given to the cost implications of the agency model. This is complicated by the 
need for award wages, which are considerably higher than current wages paid to other 
home based carers. The agency model limits the spread of communicable disease and 
enables care to occur in a familiar setting for the child. Consideration needs to be 
given to who determines a child and carer are eligible. Particular health issues of 
carer's, particularly pregnant women still need to be addressed. 
A new working group for sick care was suggested at the last CDSC meeting. When 
the model program is decidedby the Children's Services team, I will arrange for the 
working group to meet and develop recommendations. 
Mt involvement with sick care program has been an interesting learning experience. 
The implementation of new controversial policy that affects many areas such as 
health, child care and industrial relations is difficult. A new policy that questions 
social issues of parenting and work responsibilities generates heated debate. Although 
I was unable to provide significant input to developing earlier options, I would view 
my input to the sick care program as most rewarding if the agency model of care 
evolves. 
4.2 Australian Government Involvement in Eschericia coli 0157 :H7 
outbreak in US A, January 1993 
Over 500 laboratory confirmed cases of infection with E coli 0157:H7 occurred in the 
USA from November 1992 to February 1993. Report of a cluster of children with 
haemolytic uraemic syndrome to a state health department led to investigations 
identifying the outbreak. The source of the outbreak was identified as incompletely 
cooked hamburgers from a large chain of restaurants. The contaminated meat patties 
were from one meat processing plant. The processing plant records detailing origin 
of the meat used for the patties were poor; 9 sources of meat were potentially 
implicated, including 2 Australian abattoirs. Australia's potential role in providing 
contaminated meat was investigated by: 
• Inspection of the two implicated abattoirs; and 
• Evidence of E Coli 0157:H7 disease in humans in Australia. 
The Commonwealth Department of Primary Industries and Energy, Australian 
Quarantine Inspection Service (AQIS) arranged for immediate inspection of the two 
abattoirs.The inspection team was made up of two Commonwealth AQIS officers, a 
CSIRO representative who has been working on an E Coli 0157:H7 project ,a and an 
officer from the Commonwealth Department of Human Services and Health. The 
inspection team report was provided to the USA Food Safety Inspection Service 
(PSIS). I attended inspection of one of the Abattoirs. 
SECTION 3 APPENDIX A 
DRAFT CHAPTER 11 SICK CARE PROGRAI\1S; Guidelines for care of 
children who are mildly ill within child care settings. 
Introduction 
The Get Well Room's Physical Requirements 
Protocols within the Get Well Room 
Staff to work in the Get Well Room 
Children's daily program 
Selecting children for the Get Well Room. 
Managing Fever 
Administering Medicines 
Introduction 
Mild illness in children poses a difficulty for working parents and child care workers 
alike. A child with mild illness needs a flexible program that can be modified 
throughout the day. The child may not be well enough to cope with the rigors of a 
normal child care setting, yet may not require the individual attention provided by a 
parent home from work. Such a child may be able to be cared for in a Get Well 
facility within the centre. 
Such a facility may be a small get well centre at a workplace, a separate get well 
room in a centre or get well program provided in a carers home supported by a co-
ordination unit. 
These guidelines are suitable for use by all sick care services,but for ease of 
explanation centre based care has been used an example.Guidelines for care of mildly 
unwell children can only be interpreted as GUIDELINES . This background 
information will never replace the need for sound common sense and personal 
judgement in the management of sick care programs. 
A major concern for parents and staff in the care of children in sick care programs is 
the risk of spread of infection. Especially as children and adults may carry the germs 
that spread disease irrespective of whether they show signs of illness. It is for this 
reason that daily procedures that prevent spread of infection are important in the 
child care setting. INFECTION CONTROL PROTOCOLS IN THE GET WELL 
ROOM ARE THE SAME AS THE REST OF THE SERVICE. 
Handwashing is the most important factor in preventing spread of disease and is 
essential before leaving the Get Well Room. This is important in preventing potential 
spread of infection to other areas of the centre. 
Children in Get Well Room programs may need medication, ensure the Get Well 
Room staff are familiar with the guidelines for administering medicines. 
Children cared for in sick care programs in home day care settings should be assessed 
for eligibility of care in the same manner as children in centre based care. Infection 
control protocols are equally applicable in home settings. 
The Get Well Room's Physical Requirements 
Mildly unwell children must be able to be cared for in an area away from the main 
child care setting. This requires a separate play room with its own facilities. The size 
of the play room needs to conform with the required floor space for the expected 
maximum size of the group and must have areas for some children to rest on mats or 
cots whilst others are playing. Child care licensing authorities in each state can 
provide advice on the relevant requirements for space and staff. 
The room requires 
1. Its own bathroom area with a toilet, handbasin and nappy change table 
2. A telephone 
3. A handbasin near the door leading into the centre 
4. Kitchen sink and fridge (optional but desirable) 
5. Bathroom Scales for weighing children. 
Protocols within the Get Well Room 
HANDW ASHING 
HANDW ASHING is the main method of preventing spread of illness. The 
handwashing protocols used in the rest of the centre must also be adhered to in the 
Get Well Room, even if there is only one child in the room. Refer Chapter 1 
How Infections Spread and Handwashing 
WASH YOUR HANDS 
- EVERY TIME YOU LEAVE THE ROOM. This prevents organisms from 
being carried out of the room, for example into tearooms or kitchens 
by staff 
When you arrive at the centre/facility, preventing introduction of 
germs 
Before preparing or serving food. 
After changing a nappy. 
After wiping a nose - a child's or your own. 
After cleaning up messes (faeces or vomit). 
After you've been to the bathroom - either with a child or by 
yourself. 
- Before you eat. 
Before you leave the centre at the end of your day, to prevent taking 
germs home. 
WASH CHILDREN'S HANDS 
- EVERY TIME the child LEA YES the ROOM 
- When they arrive at the centre/facility, preventing introduction of 
germs. 
Before eating. 
After having their nappy changed. Their hands will become 
contaminated with germs whilst they are on the change mat. 
After using the toilet. 
After playing outside. 
- After touching nose secretions. 
- Before they leave the centre at the end of their day, preventing 
talcing germs home. 
Toys in the Get Well Room may be provided by other play rooms. However, before 
toys from the Get Well Room are returned to other rooms they must be washed. 
This is especially important for mouthed toys. Toys that are difficult to wash, e.g. 
books should be left in the Get Well Room. (Refer Chapter 3) 
Laundry from the Get Well Room should be washed separately from the centres 
laundry. Washing should be done in hot water. 
Garbage should be sealed within the area in plastic bags and then taken to the 
centre's garbage area. 
Ii 
Staff to work in the Get Well Room 
Staff need to be chosen carefully , both for their ability to provide for the special 
needs of the mildly unwell child and for their awareness of infectious diseases and 
commitment to preventing spread of infectious diseases. A registered nurse is not 
required for care of mildly ill children. However, a nurse should be available 
within the centre and able to give advice to the staff about which children should 
be in such a room. Staff in the room must have ready access to medical advice , 
(nurse within the centre, community nurse, general practitioner, public health unit). 
When establishing a Get Well Room the centre should seek a medical professional 
who is prepared to offer telephone advice. 
Review the records of the staff members' immunisation ( refer Immunisation chapter 
4) Relief staff should be asked to provide a copy of their immunisation records. It 
would be unwise to allow pregnant staff members, or women planning pregnancy to 
work in the Get Well Room. 
Relief staff members need to be familiar with the permission notes the parents have 
signed on enrolment of the child. These permission notes may allow for 
administration of paracetamol, first aid , and calling for ambulance or other 
medical support if required. 
To minimise the spread of infection it is wise for the staff member working in the 
rest and play room to only care for children enrolled in the program on that day . 
They should not care for other children in the centre on the same day . Nor should 
these staff be responsible for preparing meals for any other children in the centre. 
Staff Ratios for the care of mildly unwell children . 
The pilot sick care study of the Commonwealth Department of Health, Housing, 
Local Government and Community Services established staff to child ratios for 
centre base programs; 1 staff to 2 children . 
Children's daily program 
The children's daily program needs to be flexible to provide for each unwell child's 
needs. 
Meals and Snacks should be consumed within the room. Food may be provided 
from home or the kitchen area of the centre. However, any food prepared within 
the Get Well Room should not be given to children in other rooms. Similarly food 
, for example cut fruit, that is not eaten in the Get Well Room must not be taken 
out to children in the other areas of the centre. Food should not be shared between 
children. 
Sleep times, rest sessions in the Get Well Room may need to be more frequent than 
in the other rooms. Beds must be used and stored in the Get Well Room. Sheets 
and pillow cases must be washed daily in hot water. Vinyl mattresses must be 
cleaned , with soap and water, between use from one child to another. 
Outside play times 
Children should only play outside in an area set aside for the Get Well Room 
children. 
Selecting children for the Get Well room 
Non infective Illness 
1. Review the Child 
Immunisation Records 
Fully immunised for age 
2. Check if the Child has 
a Fever 
No Fever or 
Fever of Known Cause 
3. Consider the Type of 
Illness 
Mild lnf ective Illness 
Excludable Infective 
Illness, if the child is the 
only child in the Get 
Well room 
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1. Review the Child Immunisation Records 
Many severe childhood diseases are prevented by vaccination. Unimmunised 
children who are mildly unwell, with little or no definite signs of illness may be in 
the early stages of one of these diseases . 
Unimmunised children should not be included in any sick care program. 
When reviewing the child's immunisation record check the child has received all 
immunisations required to be given before their current age. Refer to the NH & 
MRC Immunisation Schedule (chapter 4) 
DO NOT include children who have FEVER OR SIGNS OF A COLD (runny 
nose,red eyes or cough) if they have not been immunised against 
- measles, mumps and rubella 
- whooping cough (pertussis) 
All of these diseases are highly infectious in the early stages at which time the only 
symptoms may be fever and a "cold". 
Children under 1 year are not vaccinated against MMR in most communities. If 
they have fever or signs of a cold they should not be included in the Get Well 
Room as they may be in the early stages of measles. They could then pass this 
infection onto other susceptible babies cared for in the Get Well Room. 
The records for whooping cough vaccination will probably show DTP (diphtheria 
tetanus pertussis) entries. Pertussis is whooping cough. Records of CDT 
(combined diphtheria and tetanus) means the child IS NOT immunised against 
whooping cough. 
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2. Check if the Child has a Fever (temperature over 37 degrees celsius) . 
It is not possible to state a temperature level to exclude a child from the program. 
Sometimes even a child with a low grade fever may not be suitable for the Get 
Well Room ( e.g. if the cause for the fever is not known). 
IF THE CHILD HAS A FEVER, IS THERE AN OBVIOUS CAUSE FOR THE 
FEVER? 
A child with a fever may be enrolled in the Get Well Room if there is a known or 
obvious cause for the fever; for example a middle ear infection. If fever is the only 
sign , and there is no obvious cause for the fever then this child is not eligible for 
the Get Well Room. Fever is often the first sign of many communicable diseases. 
The fever "of unknown origin" may represent the start of a highly contagious illness 
such as measles and the child could infect others at this time. 
For more information on Fever refer to Management of Fever at the end of this 
chapter. 
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3. Consider the Type of Illness 
Non Infective Illnesses where the child may be enrolled in the Get Well Room. 
A. Physical injury where the child may not be able to join the larger groups of 
children, 
B. Recovering from surgery 
C. Chronic non infective illness , with acute periods . These may make the child 
unable to cope with the normal child care setting e.g. mild asthma, teething, 
dermatitis 
Infective Illness where the child may be enrolled in the Get Well Room. 
A. Excludable Conditions where the child will be the only child in the room 
B. Mild infective Illness 
A. Excludable Conditions where the child will be the only child in the room 
Children with the following diseases that require exclusion ( according to NHMRC 
recommendations) from mainstream care may be enrolled in the Get Well Room IF 
THEY ARE THE ONLY CHILD IN THE ROOM. Further details on these specific 
diseases may be found in the second section of this book. 
Vomiting and Diarrhoea, including Camplyobacter 
Conjunctivitis 
Chicken Pox 
Impetigo 
Mumps 
IF MORE THAN ONE CHILD IN THE CENTRE HAS A SIMILAR ILLNESS the 
children may be grouped together in the Get Well Room. THIS SHOULD ONLY 
BE DONE WITH THE ASSISTANCE OF LOCAL PUBLIC HEALTH WORKERS 
It may be appropriate for children with mild CONTAINABLE diarrhoea or 
conjunctivitis to be cared for together ( cohorted ). 
Diarrhoea may be better contained in disposable nappies. Children whose faeces 
will leak out of nappies or who cannot manage to keep faeces in the toilet should 
not be admitted to a Get Well Room. 
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B. Mild infective illness. Further detail on each illness may be found in the second 
section of this book. 
Respiratory Diseases 
Common Cold 
Teach the child to cover his/her mouth when sneezing or coughing. Dispose of 
tissues soiled with nose and throat discharges.WASH HANDS after contact with 
soiled tissues and articles and after contact with nose and throat discharges. 
Sore throats 
If a child has a severe sore throat (symptoms of strep throat) , the child should be 
sent to a doctor for assessment. Good personal hygiene practices should be 
followed. Cover the nose and mouth when coughing or sneezing. Dispose of 
soiled tissues after wiping a runny nose. Always follow with proper handwashing. 
Do not share eating utensils, food or drinking cups. Disinfect toys that infants and 
toddlers put in their mouths. 
Ear Infections ( inner and outer ear) 
The child will probably oral antibiotics or ear drops and paracetamol. 
Any discharge from an ear should be treated as infectious, wash hands thoroughly. 
Gastrointestinal Diseases (see notes on diarrhoea outbreaks above) 
Worm infections Be sure that GOOD HANDW ASHING and CLEANING 
procedures are being carried out . 
Skin Diseases 
All children with rash and fever should be referred to a doctor. For general 
information on rashes refer page X 
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Erythema Infectiosum 
(Parvovirus b 19, Slapped Cheek Syndrome, Fifth Disease) 
A mild viral illness with fever, red cheeks and an itchy, lace like rash on the body 
and limbs.Parvovirus B 19 is transmitted by droplets, or secretions from the nose 
and throat. Complications are rare. Parvovirus causes miscarriage or still births in a 
SMALL percentage of women infected during pregnancy. Malformations DO NOT 
appear to occur in babies who survive this infection in the mother. 
Hand, Foot and Mouth disease, dried lesions only 
A viral illness with blisters often seen in the mouth and on the hands and 
feet. It is not a serious illness.The child is infectious as long as there is fluid in the 
blisters. The child should be excluded from all child care whilst these blisters are 
wet. However a child with dried lesions may be readmitted to both the normal child 
care setting and the rest and play setting. The faeces can remain infectious for 
several weeks, this in not a reason for continued exclusion. Good hand washing 
techniques and cleaning procedures need to be followed. 
Head Lice 
Children should be allowed to return to the normal child care setting after their first 
treatment. Nits (dead eggs) may still be present but the child is no longer infested 
and nits need not be removed. 
Pet Bites and S crate hes 
Some animal bites and scratches may be visibly infected within a day , whileothers 
may take up to ten days before infection is obvious. Ensure the sore is covered. 
Tetanus may occur after an animal bite so check that the child has received 
vaccination against tetanus ( DT or DTP at 2, 4, 6, 18mths and prior to school 
entry) 
...w 
R ingworm!Tinea , After Treatment has been S carted 
Ringworm is not actually a worm, but a spreading area of fungal dermatitis. It is 
passed on by direct skin contact or indirectly by touching contaminated articles, 
clothing and floors. Ringworm of the skin appears as a flat, spreading ring-shaped 
lesion. The edge is usually reddish often containing fluid or pus but may also be 
dry and scaly or moist and crusted. The centre of the patch may appear to be 
healing. 
Scabies and other mites causing skin disease ( 0 ne day after treatment 
Scabies is an infectious disease of the skin caused by a mite. Scabies 1s not an 
indication of poor hygiene.Scabies and other mites usually cause intense itching. 
Treatment involves application of insecticidal cream, lotion or solution as prescribed 
by a doctor. If spread has occurred within the centre/facility, all staff and 
children will need to be treated at the same time. 
School Sores (Impetigo ) only after treatment is staned and zf the sore is 1,v ell 
covered. 
Impetigo is a bacterial skin infection caused by the 11 staph 11 or 11 strep 11 organism (or 
both). This infection can easily spread to other parts of the infected person's body, 
or to otber people by direct contact with sores or contaminated clothes. Sores on 
exposed surfaces should be covered \vith a dressing. The incubation period for 
impetigo is 1 - 3 davs. 
Thrush 
Exclusion of babies and children \-Vith thrush from the normal child care setting 1s 
XOT necessary .. Thrush commonly occurs in very young babies and young infants 
and often presents inside the mouth as white spots or flakes that cannot be removed 
bv cleaning the mouth. Spread takes place by contact with excretions of mouth 
skin, vagina and faeces. Be sure good hand washing techniques and cleaning 
procedures are being practised 
Warts 
Warts are caused by a papova virus infection of the skin. After treatment the warts 
are not contagious.The wart virus may enter via moist skin surface, abrasions, cuts, 
and so it is important to get children to: 
1. Dry hands well after washing. 
2. Cover abrasion and cuts with band-aids or clean dressings. 
3. Wear shoes to protect feet. 
Be sure good handwashing techniques and cleaning procedures are 
being practised. 
Other Diseases 
HIV/AIDS 
Human Immunodeficiency Virus infection (HIV, AIDS virus) 
There is no evidence of spread from child to child in schools or child care centres 
through normal social contact.A child with HIV infection may be more likely than 
others to pick up infection from other children in a sick care program . For the 
protection of the child with HIV the parents should discuss the sick care program 
with the child's doctor.(See HIV page X) 
Cytomegalovirus (CMV) infection 
Shedding of CMV in urine and saliva is common in children under the age of five. 
Exclusion of these children from the service is NOT necessary. Most CMV 
infections cause either no symptoms or only mild symptoms. The virus is spread 
person-to-person by close contact with infectious body secretions (saliva, urine, 
breast milk, tears, blood, cervical secretions, and semen) which enter through 
mucous membranes and cuts in the skin. Most women (50-60%) have been infected 
with CMV in the past and cannot be infected with the virus again. However, 
women who are infected with CMV for the first time while PREGNANT may infect 
their unborn baby. GOOD HANDW ASHING must be undertaken after contact with 
body secretions, and especially after changing nappies or assisting in toilet care. 
Avoid kissing infants on the mouth (hugging is acceptable). 
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HEPATITIS B 
Exclusion of a child with Hepatitis B from the normal child care setting is NOT 
necessary .Hepatitis B is an infection of the liver caused by the hepatitis B virus. 
Frequently, this virus is carried without symptoms.Symptoms, if present, may 
include abdominal discomfort, loss of appetite, nausea, fever, tiredness, joint pain, 
dark urine, and yellow skin or eyes (jaundice).Hepatitis B is infectious for about 
one month before jaundice occurs, to about one to three months after jaundice 
occurs. Some people may carry the virus for life.A strong emphasis needs to be 
place upon good handwashing technique and cleaning and disinfecting practices. 
Prevent scratching, biting or violent/aggressive behaviour. Cover any open sores , 
cuts and abrasions that are weeping or moist. 
Toxoplasmosis 
Person to person spread does not occur, apart from transmission of 
infection from pregnant mothers to their unborn children.Toxoplasmosis in pregnant 
women can result in effects on unborn children ranging from no symptoms, to 
rashes and damage to the nervous system, liver and other organs. Toxoplasmosis 
acquired after birth usually results in either no symptoms or mild illness. When 
mild illness occurs, it commonly involves enlarged lymph nodes, muscle pain, 
intermittent fever and generally feeling ill. 
..Mill 
Other Infective Illnesses that are Not Appropriate for the Get Well Room 
Children with diseases marked ** may be considered for Get Well Room if they are 
the only child in the room. 
Respiratory complaints 
Bronchiolotis (RSV) ,Bronchitis , Croup, Influenza,Tu berculosis (TB) 
Whooping Cough ( Penussis) 
Gastrointestinal complaints, Vomiting and Diarrhoea 
Gastroententeritis ** Campy lobacter* * ,Cryptosporidiosis** , 
R otav irus* *, Salmonella, Shigella 
Giardiasis**, 
Skin Complaints (all children with rash and fever should see a doctor) 
Chickenpox** , Hand Foot and Mouth disease with wet blisters, Measles, Roseola, 
Rubella ( german measles), Scarlet Fever, School sores if the sore cannot be 
covered ( Impetigo), 
OTHER complaints 
Conjunctiv itis** , Haemophilus influenzae b infections , Hepatitis A, Meningitis, 
Meningococcal Infections, Mumps**, Polio , Diphtheria 
~Ianagement of Fever 
The normal body temperature is 37 degrees celsius. Most fevers in children are 
caused bv minor infections like the common cold, a raised temperature is not 
usually a cause for alarm. A child with a high temperature needs extra fluids to 
drink.The times to worry about a child with a fever are the following 
- when the temperature is over 39 degrees celsius 
- when the temperature stays high for more than six hours at a time 
- when the fever keeps recurring over one or two days 
- when the fever does not respond to paracetamol ( 15mg per kg of body 
weight) 
-when it is associated with other significant symptoms such as vomiting , 
diarrhoea, drowsiness, severe headache, fitting. 
Try to lower a child's fever b 
1. Giving the child paracetamol at an appropriate dose. This is 15mg per kg of body 
weight. See the table belo\l 
- · Removing extra clothing , tepid sponging or bathing the child, fanning the child. 
The recommended paracetamol dose for reducing fever in children is 15mg per kg 
Table X. This will often be a larger volume than is printed on the paracetamol 
bottle. Check the child's weight before administering the paracetamol Also check 
the paracetamol elixir is 120mg of paracemtamol /5ml ( Paracetamol preparations 
are available in higher concentrations for children over -+ ). 
Children with a high fever sometimes have convulsions. this is quite frightening at 
t normally causes no harm. Lie the child on the side so saliva runs out of the 
mouth. Take the child ro a hospital or nearest doctor. 
Table X Paracetamol Doses for Children, four hourly doses of liquid paracetamol * 
Weight Kg Elixir* Infant 
120mg/5ml Drops 
60mg/0.6ml 
4 2.5ml 0.6ml 
5 3.0ml 0.6ml 
6-7 4.0ml 0.9ml 
8-9 5.0ml 1.2ml 
10-11 6.0ml 1.5ml 
12-13 7.0ml 1.8ml 
14-15 8.0ml 2.1ml 
16-17 10.0ml 2.4ml 
18-19 11.0ml -
20-21 12.0ml -
22-23 13.0ml -
24-27 15.0ml -
* Only use these measures for paracetamol that is 120mg/5ml. Check the 
concentration of paracetamol elixir as a higher concentration is also available in a 
preparation for over 4 year olds. 
Administering Medicines In Child Care Centres 
Medication provided must be in its original container. 
Parents need to complete an authorisation form , and example is on the next page. 
The dose authorised by the parent should be checked with the instructions on the 
container. If the instructions given by the parent differ from those on the container 
this needs to be checked again with the parent. The parent should write down the 
desired dose and reason for the different dose. 
The medication should be prepared by a qualified child care worker and checked by 
another staff member. Both these staff need to complete the administration record. 
All authorisation details 
Child's name 
Date 
Medication Name 
The dose prepared by the trained staff member. 
Following administaion of medication , the child should be observed for any 
reactions. These should be noted on the form and reported to parents. 
Approval for administration of medicines, to be completed by the parent. 
Date .... ./. .... ./ ..... . 
Child's name ............................................................................. . 
Parent's name .............................................................................. . 
Name of Medication ............................................................................................. ........ . 
Dose to be given .............................. volume/number tablets 
at ........................... time 
and at ......................... time 
Special instructions for giving medicine ; 
.............................................................................................................................................. 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Administering Medication Record , to be completed by staff 
Date ........ / ........ / ....... .. 
Child's Name 
Checked by 
Medication Dose Time Given 
Any reactions that may be attributed to the medication 
Staff Administering 
.............................................................................................................................................. 
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Section 4.1 Child Care Centre Investigations and Advice 
Early in my placement I expressed my interest, and willingness to assist with episodes 
of infectious diseases in day care settings. I have worked primarily with the 
Children's Day Care Services Child Care Advisers of the Family Services Branch of 
hte ACT Housing and Community Services Bureau. In 1991, I helped to develop 
ACT guidelines for exclusion of sick children from child care settings. I have acted 
as a resource person, providing telephone support to advisers and co-ordinators of 
child care services. I receive telephone enquires approximately once each week. Some 
examples of the enquiries are; 
• how to manage a child with impetigo on the face; 
• staff concerns about Hepatitis B; 
• appropriate disinfectants to use in the centres; 
• how to minimise risk of transmission of hand foot and mouth disease and 
• the risk a child with middle ear infection draining pus from the ear may 
pose to other children. 
On three occasions, I visited child care centres because of the numbers of cases 
involved or concern about the risk to other children in the centre. Two of these 
episodes were outbreaks of diarrhoea. In both gastroenteritis outbreaks, the child care 
adviser was notified near the end of the epidemic. The third investigation was of a 
case of pertussis. The work performed in the investigation was my own, I discussed 
each step with Dr Cathy Mead ACT Medical Officer of Health. The work is prepared 
ready for comment by Dr Mead with whom I hope to submit the article to the CDI 
(refer section 4.1.1 A case of pertussis in an ACT Child Care Centre). 
I 
A 
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4.1 Child Care Centre Investigations and Advice 
Outbreaks of Vomiting and Diarrhoea 
The first outbreak was at a child care centre within the Australian National 
University. Cases of diarrhoea were predominantly in babies in the nursery and adults 
of close contact. By the time of my visit, children had been refused admission to the 
nursery whilst it underwent thorough cleaning. I reviewed the infection control 
protocols, daily practices of nappy changing and hand washing and food preparation 
and serving. The staff sought my advice on some aspects of hand washing and nappy 
changing. I arranged for testing of faeces from 5 babies and two adults in the centre. 
The cause of the diarrhoea was not identified. No new cases occurred after the 
investigation. 
The second outbreak was cases of diarrhoea at a child care centre in Woden ACT. 
Forty five cases of vomiting and diarrhoea in children and close adults were 
identified. I reviewed the policies and practices of infection control . The centre was 
due to have a fund raising carnival two days after my visit. Plans had been made to 
serve food at the carnival, some prepared at the time of the carnival and other food 
donated by parents. I advised food should not be sold if it had been prepared in 
homes of children or staff from the centre and that all food handlers on the day of 
the carnival protected the food by wearing gloves. No subsequent cases of vomiting 
and diarrhoea were linked to the carnival. I arranged for testing of faeces from 6 
babies and 4 adults connected with the centre. Rotavirus was implicated as the cause 
of the outbreak, identified in 6 stool samples. 
4.1.1 A Case of Pertussis in an ACT Child Care Centre. 
In August 1993, the ACT Department of Health received notification that an 18 month 
old boy in an ACT Child Care centre had developed pertussis ( whooping cough ) . The 
child attended a community child care centre and had been cared for in the centre's 
nursery room at the onset of symptoms. 
Background 
The child care centre, established in 1993, is licensed to care for 55 children in three 
groups: 15 children under 18 months of age , 18 children aged 18 months to 3 years of 
age and 22 preschool children aged 3 - 5 years. The nursery children mix with children 
from other groups for short periods in the morning and afternoon. 
The centre has a written health policy that is given to all parents at the time of 
enrolment. The policy lists exclusion requirements for specific diseases, fever and 
antibiotic administration. The health policy does not mention infection control protocols 
or immunisation records. Immunisation in Long Day Care centres is compulsory in the 
ACT, unless a written statement is provided from a doctor stating the child cannot be 
immunised1• Original records of immunisation are requested to be presented to the co-
ordinator who completes an immunisation record for the centre. 
4.1.1 A Case of Pertussis in an ACT Child Care Centre. 
Methods 
We identified close contacts of the child with pertussis; 17 babies and 6 staff members. 
Sixteen of the babies had received 3 doses of Diphtheria, Tetanus, Pertussis (DTP) 
vaccine, one had received one dose of DTP vaccine. We reviewed the centre held 
immunisation records for all children attending the centre. To assess side effects of 
erythromycin we distributed a questionnaire 23 staff and parents two weeks after the 
investigation. 
Action 
The index case had not mixed with children other than those in the nursery in the 
preceding three weeks. We recommended erythromycin chemoprophylaxis for 17 babies 
and 6 staff . The index case and older sibling also received erythromycin .. The older 
sibling had continued to attend the centre after diagnosis and before Health Department 
notification. We advised the sibling be excluded from the centre until erythromycin had 
been administered for 5 days. 
Results 
No further cases of pertussis occurred. 
Post treatment questionnaires were returned by 91 percent of parents and staff . The 
duration of medication completed ranged from 5 to 31 days, median 14, mean 13 days. 
Side effects were reported in 60 % of children and 1 % of adults ( Table 1 ) . Mild 
gastrointestinal disturbance was responsible for 38 % of side effects. One child 
developed a rash , vomiting and diarrhoea 24 hours after commencing the antibiotic. 
Rotavirus antigen was present in her faeces and she was hospitalised because of 
dehydration. 
4.1.1 A Case of Pertussis in an A CT Child Care Centre. 
Table 1 Side effects reported from erythromycin chemoprophylaxis, 15 children and 6 
adults, an ACT child care centre, August 1993. 
Side Effects 
No side effects 
Diarrhoea 
Other gastrointestinal disturbance 
Rash , Vomiting and Diarrhoea 
Immunisation Records 
% of children 
40 % 
33 % 
20 % 
7% 
% of 
total 
52 % 
24 % 
19 % 
5% 
Immunisation records, appropriate for the child's age, were incomplete for 34 percent 
of children. The proportion of completed records varied with age. Immunisation records 
were incomplete for 47 percent of babies in the nursery, 38 percent of toddlers and 19 
percent of preschool aged children. There was no record of any immunisation for three 
children , recent immigrants. 
We reviewed completed records for the age each vaccine was given to determine whether 
immunisations were given at ages recommednded by the National Health and Medical 
research Council (NHMRC). Less than 1 percent of DTP vaccinations were given 1 
month after the due date. Forty children were over 12 months of age and had received 
Measles, Mumps, Rubella vaccine (MMR). Eleven of these (28 percent) received MMR 
later than 12 months of age , mean 14.3. These children would be classified as receiving 
immunisation late according to current NHMRC recommendations of MMR at 12 months 
of age. However, at the time these immunisations were given, the NHMRC 
recommendation was to administer MMR at 12 to 15 months of age. 
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4.1.1 A Case of Pertussis in an ACT Child Care Centre. 
Discussion 
Pertussis was not rransmitted from the index case to other children in the child care 
cenrre. This successful outcome may have been due to a number of factors, a natural 
occurrence, partial immunity in the children who had received one to three doses of DTP 
or the success of chemoprophylaxis. 
Side effects were commonly reported in children who received erythromycin. It is 
difficult to be certain that some of the reported side effects were not effects of 
concomitant rotavirus infection. 
The immunisation records of children in the cenrre were poorly maintained. Legislation 
ensuring immunisation for all children attending child care is insufficient. The difficulties 
in maintaining an immunisation register in a setting with many children of varying 
immunisable age need to be addressed. We are looking at methods to assist child care 
workers to maintain age appropriate records. 
Reference 
1. ACT Long Day Care License Condition Clause 24(d) 
,,,,·• 
4.2 Australian Government Involvement in Eschericia coli 0157:H7 outbreak in USA, 
January 1993 
Abattoir Inspection 
I became familiar with the Hazard Analysis Critical Control Point (HACCP) strategy 
used by the food industry to minimise the risk of contamination of food. Each food 
is assessed for its potential hazard using six hazard categories. For example one 
category is products that are not treated by a terminal heating process after packaging 
or when cooked at home. The critical control points are potential risk points in food 
production. These high risk steps are managed and observed to m1n1mise 
contamination. For example, soon after slaughter, cattle are eviscerated. The 
contamination risk at this stage is two fold; stomach contents may regurgitate and 
bowel contents may leak from the rectum. Sealing the alimentary canal to prevent 
leakage is a crucial step to prevent contamination. During the inspection we looked 
for presence of contamination, existence of opportunities for contamination and 
opportunities for microbiological growth. Microbiological samples were collected for 
testing for presence of£ coli 0157:H7. 
There was no evidence of faecal or ingesta contamination, nor presence of 
contamination. Delays of up to 20 minutes in the requirement for freezing of chilled 
packed beef were detected , the meat remained at -4 to 2 degrees celsius during this 
time. The variation from requirements was not likely to result in any increase in E 
coli. 
4.2 Australian Government Involvement in Eschericia coli 0157:H7 outbreak in USA , 
January 1993 
Evidence of E coli 0157:H7 disease in humans in Australia. 
There is no routine surveillance of E coli 0157:H7 in Australia. Detection of the 
organism in faeces would not occur with normal processing methods for faecal 
pathogens, specific culture media is required to enable detection. This media is 
unlikely to be used unless specific reference is made to a history of Haemolytic 
Uraemic Syndrome or a special study is being undertaken. One such study was 
performed at the Camperdown Children's Hospital in 1991. Of 1,843 stools from 
cases of acute diarrhoea , only 2 were E coli 0157 and neither of these possessed the 
flagella antigen H7. Three unpublished cases of E coli O 157 :H7 have occurred in 
Australia in 1986, 1989 and 1992. It appeared unlikely that E coli O 157 :H7 was a 
significant cause of morbidity in the Australian population. 
4.2 Australian Government Involvement in Eschericia coli 0157:H7 outbreak in USA, 
January 1993 
Australian E coli 0157:H7 and other enteropathogens meeting July 1993 
I attended a meeting of veterinary and medical scientists, representatives from 
Australian Quarantine Inspection Service (AQIS) and Meat Research Corporation 
(MRC). The objectives of the meeting were to develop a program which meets the 
projected requirements of the United States Department of Agriculture (USDA) for 
the surveillance, monitoring, control and reporting of enteropathogens of importance 
(particularly E coli O 157 :H7) to the Australian export and domestic meat industries. 
The USDA were expected to introduce new standards of zero tolerance of faecal, 
ingesta or hair contamination of meat. It was possible that microbiological testing of 
all imported meat for E coli 0157:H? would be required. The recommendations of 
the meeting included: 
• Improved abattoir microbiological survey information is required (MRC 
baseline study); 
• Education of the community on the prevention of food poisoning through 
improved handling in the retail chain and at home is required ( National 
Food Authority); 
• On farm survey information of E coli 0157:H? is the second veterinary 
priority after abattoir baseline studies; 
• National Enteric Pathogen Surveillance Scheme (National Salmonella 
Surveillance Scheme NSSS) information needs to be fed into the National 
Animal Health Information Systems 
( NSSS and Bureau of Resource Sciences) 
• Entero-haemorrhagic E coli should be monitored through human health 
surveillance 
(Communicable Diseases Network and Australian Paediatric Surveillance Unit ); 
• All isolates of verocytotoxigenic E coli should be reported to the NEPSS/ 
NSSS. 
4.2 Australian Government Involvement in Eschericia coli 0157:H7 outbreak in USA, 
January 1993 
Experience Gained 
Through this involvement I gained a better understanding of the influence of industry 
· and export trade on food production. I made valuable contacts with animal and food 
government and non government bodies in Australia. As a result of these contacts the 
Surveillance and Evaluation unit now receives notification of all food recall actions 
by the National Food Authority. In the field I experienced one food production 
process, explored the HACCP principles and the difficulties in protecting food from 
contamination. The abattoir inspection gave me invaluable experience and a greater 
appreciation of occupational health and safety risks. 
The result of the outbreak in the US has been a significant change in requirements of 
production of Australian meat for export. The US approach is a "farm to table " 
approach and includes an education campaign to ensure adequate cooking of food. In 
addition to "zero tolerance" of contamination , all raw meat and poultry products in 
the USA are required to be labelled with safe handling instructions. Exported 
Australian meat to the US must now be labelled; 
Safe Handling Instructions 
This Product was inspected for your safety. Some animal products may contain 
bacteria that could cause illness if the product is mishandled or cooked improperly. 
For your protection follow these safe handling instructions. 
Keep refrigerated or frozen. Thaw in refrigerator or microwave. 
Keep raw [meats or poultry] separate from other foods. Wash working surface 
including cutting boards, utensils, and hands after touching [ meat or poultry]. 
Cook thoroughly. 
Refrigerate leftovers within 2 hours. 
4.2 Australian GoYemment Involvement in Eschericia coli 0157:H7 outbreak in USA, 
January 1993 
Meat that is intended for overseas export but remains in Australia may remain 
labelled with safe handling instructions. Inconsistent labelling may lead to confusion 
in the Australian market. Whilst accepting the pressures of overseas trade and the 
right of importing countries to apply standards to food, I find it incongruous that 
different standards apply to the domestic product. 
Section 4.3 Blue Green Algae 
In late 1991, a large bloom of Blue Green algae, Cyanobacteria, occurred in New 
South Wales rivers. Concomitantly, Blue Green algae were detected in lakes in 
Victoria and South Australia. Human health risks, investigation and management 
alternatives were reviewed in a meeting on 16 December 1991 between 
representatives from the Health Departments of affected States (i.e.NSW,Vic and SA), 
the Commonwealth Health Department and scientific researchers. I attended the 
meeting as the Commonwealth representative. 
My initial role in the water outbreak of Blue Green Algae was to provide advice and 
recommendations to the Commonwealth Department of Human Resources and Health. 
One Australian report of blue green algal disease was in November 1989 when 
gastroenteritis and hepatitis was investigated in 139 children and 10 adults in Palm 
Island Community Qld. A variety of lakes and rivers across Australia have been 
reported to have episodes of algal blooms. I reviewed the published literature and 
reviewed papers on the effects on people and water management policies. 
Blue Green algae include many species. The most commonly reported are Anabaena, 
Microcystis, Nodularia and Oscillatoria. Anabaena may produce a neurotoxin that has 
not been reported to have affected humans to date. Microcystis, Nodularia and 
Oscillatoria may produce hepatotoxins and enterotoxins. 
The occurrence of Blue Green algal blooms follows a complex combination of : 
• nutrients enabling growth , nutrient enriched or eutrophic water; 
• water flow, depth of water , stratification of the water column and 
• warm temperatures. 
4.3 Blue Green Algae 
Management of a bloom may include the use of algicides, a short term treatment that 
has been used is copper sulphate. However, this treatment of the algal bloom will not 
remove toxin presence. On the contrary, if the algal cells have commenced production 
of toxin, rupture of the cells by copper sulphate will increase the toxin release. 
Chlorination will have a similar effect on rupture of the blue green algae cells. 
Granular activated carbon has been shown to remove algal toxins and may be useful 
for drinking water supplies. The toxins are heat stable and will not be removed from 
water by boiling. Ongoing surveillance of algal counts and Health warnings to the 
community to avoid water exposure and ingestion are the probably the most effective 
current management practices. 
One of the difficulties in investigation of human effects of blue green algae is the 
variety of symptoms that may be associated with ingestion or superficial exposure. 
Case reports of human effects of blue- green algae include symptoms of; 
• skin irritation, 
• hay fever like response, 
• conjunctivitis, 
• mucosal blisters, 
• asthma, 
• vomiting, diarrhoea, abdominal pain, 
• headache, 
• arthralgia and 
• respiratory distress. 
Many of the reports of presumed cyanobacterial poisoning of humans have been 
criticised because they lacked case definitions and analytical epidemiology. 
4.3 Blue Green Algae 
Following the December meeting, I believed a consistent case definition would be 
useful for investigation of human effects of algal bloom in Australia. I aimed for a 
case definition that was high in sensitivity and lacking in specificity. When the 
disease was better understood , specificity of the case definition could be improved. I 
developed a draft case definition and forwarded the definition to all States and 
Territory Health Departments for comment in January 1992. Minor wording 
recommendations were made by 5 State{ferritory Health Departments, one agreed a 
case definition was desirable but should not be developed until current studies on the 
health effects were complete and two states did not reply. Following is the proposed 
definition of Blue Green algae associated illness as at 11 March 1992 incorporating 
the recommended changes: 
4.3 Blue Green Algae 
A case of Blue Green Algae associated illness is defined as; 
or 
A.) a person with the onset of any of the following after contact with water 
known to contain toxin producing Blue Green algae 
1. Eye irritation or conjunctivitis 
2. Mouth or lip vesicles/blisters 
3. Sneezing, rhinorrhoea conjunctival and pharyngeal itching, 
obstruction of nasal passages, lacrimation ( hay fever), not 
experienced in previous seasons. 
B.) a person with the onset of any of the following after ingestion* of water 
from water supplies known to contain toxin producing Blue Green algae. 
1. Vomiting or diarrhoea 
2. Myalgia 
3. Fever, cough and pleuritic chest pain and/or clinical or 
radiological signs of lower respiratory tract infection. 
4. Right upper quadrant abdominal pain, and/or hepatomegally and /or 
jaundice and/or elevated liver enzymes. 
* The water may be ingested by drinking or accidental ingestion e.g. in recreational 
pursuits. 
4.3 Blue Green Algae 
I believed further development of the case definition was premature because of the 
complexity of the definition and the opportunity to await results of ongoing studies. 
I have pursued my interest in Blue Green algae with the Australian Society for 
Microbiology. A well attended symposia was held in Perth 1993 meeting. A large 
number of water and algal experts presented Australian data on algal outbreaks and 
management. Unfortunately, the session was attended by few workers in human 
health. 
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Section 4.4 Laboratory reports of Toxoplas mosis, CDI Laboratory "Pathogen 
Surveillance Scheme" 1986 to 1991 
4.4.1 Results 
During the six year period of surveillance by the CDI Pathogen Scheme, there were 
414 reports of positive Toxoplasma gondii serologic tests. Ninety one percent of the 
reports were provided by three laboratories: Fairfield Hospital, Melbourne (22%); 
Institute of Clinical Pathology and Medical Research (ICPMR) Westmead, Sydney 
(34%); and State Health Laboratory, Brisbane (34%). Postcode information was not 
included in this surveillance scheme, therefore further analysis by area is not 
possible. 
An increase in laboratory reports occurred in 1989 (Figure 1). The increase was 
predominantly reports from ICPMR, Westmead. The reason for this increase cannot 
be readily ascertained, over half of these reports had no diagnosis coded and 
eighteen percent mentioned reticuloendothelial disease. Only one report included 
HIV infection in clinical information. 
There was no seasonal trend. 
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Figure 1: Number of Reports of Serologic evidence of infection with Toxoplasma gondii, 
CO/ Laboratory Pathogen Scheme 1986 to 1991 
Figure 2: Reports of Serological Evidence of Infection with Toxoplasma gondii 
by Age Group and Sex, CO/ Laboratory pathogen Scheme 1986 to 1991 
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Figure 3: Serologic Evidence of Infection with Toxoplasma gondii in 25 Pregnant Women 
and 15 Neonates, by Year, COi Laboratory Pathogen Scheme 1986 to 1991 
4.4.1 Results 
Age and Sex 
The predominant age groups for reports in both sexes were 15 to 24 and 25 to 34 
years. These two age groups comprise 73% of all reports (Figure 2). The data 
collected about age in the "Pathogen Scheme" was by age category, therefore age 
groups cannot be further subdivided. Gender was provided in 407 reports, there was 
a female predominance, the male to female ratio being 0.7: 1. 
General Clinical Information 
Four patients had died: a stillborn infant; an infant who suffered sudden infant death 
(age unknown); a neonate and an 63 year old adult with central nervous system 
toxoplasmosis. Although codes for clinical diagnosis were included for all reports, 
30 percent recorded no diagnosis. In 20 percent reticuloendothelial disease was the 
clinical diagnosis, 7 .5 percent were apparently healthy and 6 percent had only 
malaise. 
Congenital Disease 
Congenital disease was stated as the clinical diagnosis in seven reports: three 
neonates, one in the age group 1 to 12 months; two aged 15 to 24 years; and in the 
one age group 25 to 44 years. No additional clinical information was provided for 
these patients. 
4.4.1 Results 
Toxoplasmosis Infection in Pregnant Women 
Analysis of the Pathogen Scheme dataset for pregnancy is difficult, because coding 
for pregnancy was not provided to the laboratories. 
There were 25 reports of infection in pregnancy, identified through comments 
provided with reports (Figure 3). Other reports of Toxoplasmosis in pregnancy may 
exist within this data but cannot be identified. 
The method of detection was provided in 24 of the reports in pregnant women; in 23 
cases the diagnosis was made by IgM Elisa technique , and one diagnosis made by 
a single high titre by immuno fluorescence. 
The clinical information provided for pregnant patients included 5 asymptomatic and 
one patient with reticuloendothelial disease. Clinical outcome was provided for 5 of 
the reported infections in pregnancy: 2 stillborn, 1 fetal death in utero, 1 termination 
for hydrocephalus and 1 neonatal death ( reported also as a neonate). The period of 
gestation at which Toxoplasmosis was diagnosed was provided for four cases: 
gestation of 8 , 9, 22 and 25 weeks . 
The age group for pregnant women with acute toxoplasmosis was provided for 22 
cases: 4 within the age group 15 - 24 years and 18 within the age group 25-44 years. 
The ratio of reports by age group of Toxoplasmosis in pregnancy is therefore 
1 ( 15 to 24 years ) : 4.5 ( 25 to 44 years). 
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4.4.1 Results 
Toxoplas mosis Infection Detected in Neonates 
There were 15 reports of serologic evidence of infection in neonates. (Figure 3). 
Three neonates had a clinical history of congenital disease and three of the reports 
of Toxoplasmosis in neonates were from overseas patients. 
Excluding mild fever, there are 8 reports of affected neonates (Table 1). One reported 
infection in a neonate was included as an outcome of a reported infection in 
pregnancy. 
The method of detection was provided 14 reports about neonates; IgM Elisa 10 , 
IgM immuno fluorescence 3, direct antigen detection in CSF by immuno fluorescence 
one and one unspecified. 
Table 1. Clinical Information in 15 Neonates with Serologic Evidence of Infection 
with Toxoplasma gondii,, CDI Laboratory Pathogen Scheme, 1986 to 1991 
Congenital Disease 3 
Central Nervous Svstem Disease 2 
Heoatic Disease 1 
Gastrointestinal Disease 1 
Death* 1 
Mild Fever 1 
No Clinical Information 6 
Total reports 15 
* Report received for infection in pregnancy and neonatal outcome 
4.4.1 Results 
Episodes of Toxoplas mosis Infection during Gestation 
There was a total of 39 episodes of infection during pregnancy in the six years; 25 
pregnancies and 15 neonates, one duplicate neonate and mother. The morbidity and 
mortality reported in these 39 episodes were 8 affected neonates and 4 unsuccessful 
pregnancies. 
Incidence of Toxoplas mosis 
The CDI Pathogen scheme data are not national figures . However 91 % of reports 
have been provided by large reference laboratories in the three eastern states. 
If the total number of confinements in 1991 for Queensland, NSW and Victoria 1 are 
used as the denominator, the incidence of infection with Toxoplasmosis during 
pregnancy in 1991 was 3.6 per 100,000 pregnancies. 
The CDI Pathogen scheme reports of neonatal Toxoplasmosis in NSW, QLD and 
VIC in 1990 and 1991 yield an incidence of 1.28 per 100,000 births in the three 
eastern states. 
4.4.2 Discussion 
Limitations of Pathogen Scheme Data for Infection during Gestation 
These data do not document the outcome of Toxoplasmosis infections in pregnancy. 
The ratio of reponed affected neonates to reported infections in pregnancy ( 12:39) 
cannot be construed as the outcome of Toxoplasmosis in pregnancy . The infections 
in pregnancy have not been followed to provide outcome reports. Toxoplasmosis 
infections in neonates may be more likely to have been reported than positive tests 
in pregnant women. 
There are little available Australian data on Toxoplasmosis. Laboratory based data 
provide limited reliable clinical information. Such data are also restricted to reports 
of patients on whom serological testing has been performed. The data presented in 
this article rely on a sentinel laboratory scheme and therefore are not comprehensive 
national figures of incidence for toxoplasmosis. The ability to draw conclusions from 
the figure of incidence of 3.6 per 100,000 pregnancies is clearly limited because the 
reports of Toxoplasmosis infection in pregnancy are incomplete. In addition it is 
further restricted by estimating numbers of pregnancies from confinements alone, and 
by the assumption that all pregnant women in the 3 states would have diagnostic 
specimens sent to the 3 laboratories. 
An incidence of neonatal Toxoplasmosis of 1.28 per 100,000 births is a gross 
underestimate of the incidence, since congenital disease may not be evident in the 
first month of life and surveillance of the disease is limited. Overseas reports identify 
an incidence for Congenital Toxoplasmosis to be between 130 to 650 per 100,000 
live births2,3 
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4.4.2 Discussion 
Reports in Older Women 
The age specific occurrence of reports of Toxoplasmosis in pregnancy in the CDI 
data are surprising, with a ratio of 1 ( 15 to 24 years) : 4.5 ( 25 to 44 years). The ratio 
of confinements in Australian women in these age groups is 1( 24 and under) : 2.85 (25 
to 40 and over) 1 • Older women may be more likely to be tested for Toxoplasmosis; 
be more likely to present for antenatal care ; be more aware of Toxoplasmosis. 
Similarly, the medical profession may monitor older pregnant women more actively. 
Prevention 
Acquisition of Toxoplasmosis is by ingestion of matured oocysts and tissue cysts. 
Only primary infection in a seronegative women is dangerous for the fetus. 
Prevention may be achieved by: 
• education of women at risk, 
• allowing natural infection in girls during childhood, 
• vaccination of cats, the definitive host and/or 
• screening for acute Toxoplasmosis in pregnancy. 
Education of women includes advice of precautionary measures during pregnancy: 
washing hands before eating , care in areas where cats may defecate, and avoidance 
of eating poorly cooked meat . Primary prevention, by education, has been shown to 
decrease the seroconversion to Toxoplasma gondii in pregnancy by 63 %.4· 
Prevention may be achieved by ensuring women are immune to Toxoplasmosis before 
entering child bearing years. There is a protective role of primary infection in young 
girls. One simple way is to allow potential exposure of children (not pregnant 
women) to oocysts is in gardening and sandpit play. 
Vaccination of all cats, to interrupt maturation of oocysts would be difficult to 
implement and costly . 
4.4.2 Discussion 
The requirements for a screening program include the availability of; a sensitive test 
to identify women at risk, specific tests to confirm toxoplasmosis infection in 
pregnancy and effective treatment. These criteria are met for Congenital 
Toxoplasmosis, and screening is widespread in some European countries. 
However, screening pregnant women in Australia needs to be considered carefully. 
It is difficult to justify screening for Toxoplasmosis in pregnancy given limited 
knowledge of the Australian incidence of congenital disease. Screening in pregnancy 
needs to be performed at frequent intervals because there may be few clinical 
symptoms. The costs of screening and treating pregnant women falls dramatically 
when a large proportion of the population are already immune to the disease. When 
women are immune, or seropositive, no further testing is necessary during the 
pregnancy. Seropositivity in pregnant women varies between areas, and has been 
found to be 47 % in Austria, 53% in Belgium, 22% in England and 84 % in France2• 
The high level of immunity in France has been attributed to a dietary preference for 
eating undercooked meat. Screening programs in Austria have decreased the 
incidence of prenatal toxoplasmosis from 50 - 70 per 10,000 births in 1975 to 1 per 
10,000 births in 1992. 
Before screening is instituted in Australia we need more information on the 
background serological status in Australian women and the incidence of congenital 
disease. Serological surveys in microbiology laboratories can provide serological 
status of women of reproductive age. However, laboratory data are inadequate to 
determine the incidence of congenital disease. 
4.4.2 Discussion 
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Section 5 Su1nmary of Practical Epide1niological Experience Gained 
LabDOSS 
Establishing a new surveillance system was invaluable experience. I learnt 
• how to approach a new scheme, 
• the practical issues in development, 
• the sensitivities of data ownership, 
• how invaluable is the enthusiasm of scientific laboratory staff , 
• how to program a detailed, user friendly data entry system in Epilnfo, 
• how to develop a method for easy data extraction, 
• how to tailor a system to meet the needs of those providing the data and 
• how important this is for a system to work, 
• how to analyse surveillance results, 
• how to develop analysis programs in Epilnfo, 
• methods of presentation of results, 
• the limitations of surveillance data and 
• how surveillance data may be used to develop and monitor public health 
interventions. 
I developed an appreciation of other surveillance systems: the role of Notifiable 
Diseases and the difficulties in collection of this data; the National Salmonella 
Surveillance Scheme; Malaria surveillance; Gonococcal Surveillance; the Australian 
Paediatric Surveillance Unit and the new National Meningococcal Network .. 
5. Summary of Practical Epidemiological Experience Gained 
Rubella Outbreak 
I learnt through this investigation: 
• alternative ways to approach a community outbreak, 
• how valuable if the information provided by local practitioners, 
• the value of a case definition, 
• how to collect and analyse data in the field, 
• how to appropriately use laboratory tests to establish a diagnosis, 
• the value of school based surveillance of absenteeism, 
• the resources required to perform an investigation and 
• how to arrange public health intervention; use of the media and direct 
contact with parents of babies considered exposed to measles. 
5. Summary of Practical Epidemiological Experience Gained 
Child Care 
Through my work in Child Care I gained awareness of the role of the Communicable 
Diseases Standing Committee (CDSC) and Public Health Committee (PHC) of the 
NHMRC. I experienced being the secretary, and worker, for a CDSC working group 
which was to produce a document to improve the health of children in child care 
settings. 
Development of "Staying Healthy in Child Care" required review of literature, 
development of guidelines, consultation with workers in child care, the general public 
and health communities. Endorsement of the document by NHMRC council in 
November was rewarding. I am continuing to learn intricacies of progressing a 
document from final draft, through professional editing, graphic design, illustrations, 
printing requirements, marketing, media strategy, and a launch by the Commonwealth 
Minister/s of Health and/or Family and Children's Services. 
Sick Care 
My role with the sick care program has been challenging. I have experienced the 
development of new policy towards a functioning program. I have understood the 
controversial nature of the new policy and helped to resolve difficulties in 
implementation and concerns by a variety of groups including union representatives, 
child care workers, health care workers and parents. I have learnt the need for 
extensive consultation and slow development of programs addressing sensitive issues. 
Child Care Centre Investigations and Advice 
I believe my practical role with child care in the ACT has been helpful in my 
understanding of the issues facing the sick care program and usefulness of "Staying 
Healthy in Child Care". Many of the questions raised in my work with child care 
advisers were able to be addressed in "Staying Healthy in Child Care." 
S. Summary of Practical Epidemiological Experience Gained 
E coli 0157:H7 
I attained a better understanding of food borne disease, difficulties in surveillance of 
food borne illness and the public health opportunities of prevention of food borne 
disease. 
My appreciation of the effects of trade issues on development of policy for 
Australian exports has also been heightened. I experienced the working conditions in 
an abattoir and developed a network of contacts with the National Food Authority and 
Australian Quarantine Inspection Service. 
Blue Green Algae 
Through my involvement with Blue Green Algae I became aware of the difficulties in 
establishing surveillance of an illness that is not well understood. I learnt of land and 
water management policies that may affect development of algal blooms. I learnt of 
the extensive work performed in Australia on the water conditions enabling growth, 
documentation of algal blooms, testing of toxins from the blooms. I developed a draft 
National case definition with input from the States and Territories. 
5. Summary of Practical Epidemiological Experience Gained 
Management Experience 
In March 1993, the AIDS and Communicable Diseases Branch was restructured to 
four units: Prevention and Care, Strategy and Co-ordination, Education and 
Surveillance and Evaluation. For a period of 4 months, I acted as Director of the 
Surveillance and Evaluation Unit. I gained management skills and useful experience 
by undertaking the following; 
• preparing briefs for the Commonwealth Minster of Health, 
• preparing responses to ministerial enquiries, 
• expanding the Unit to incorporate the AIDS evaluation and developed 
strategies for ongoing evaluation of AIDS and other programs, 
• planning expansion of surveillance functions of the Unit, 
• supervising 11 staff, 
• undertaking recruitment action to ensure the Unit's functions were 
progressed effectively; 
• managing Unit finances and 
• attending training programs for new managers. 
5. Summary of Practical Epidemiological Experience Gained 
Other Experience 
I presented the following papers at scientific meetings; 
• Proposal of a New Surveillance Scheme , PHA Melbourne, ASM 
Gold Coast 1991; 
• LabDOSS 1992 data ASM Perth, September 1993; 
• Staying Healthy in Child Care and the Sick Care Program 
PHA Sydney, October 1993 
I played an ongoing role in the production of the CD I ; preparation of surveillance 
reports, review of articles submitted for publication and provided written editorial 
comments. 
Overseas travel advice for communicable diseases was provided on a roster basis by 
the medical officers in the Communicable Diseases Section in 1991 and 1992 .. For 
the first 18 months of my placement I gave overseas travel advice over the telephone 
for half a day every week. 
I regularly attended meetings of the ACT Consultative Committee of Communicable 
Diseases as the Commonwealth Department of Health representative. 
I am grateful for the experience of a Masters of Applied Epidemiology placement in 
the Commonwealth Department of Human Resources and Health. I enjoyed working 
as part of the sections multidisciplinary team and valued being part of a wider public 
health network. 
